
<html lang="en"     class="pb-page"  data-request-id="a8c1f8ef-a0a9-4bb8-bf51-e6068da6bd0a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm5011786;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2014.57.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="2013 Philip S. Portoghese Medicinal Chemistry Lectureship: Drug Discovery Targeting Allosteric Sites†" /></meta><meta name="dc.Creator" content="Craig W.  Lindsley" /></meta><meta name="dc.Description" content="The identification of sites on receptors topographically distinct from the orthosteric sites, so-called allosteric sites, has heralded novel approaches and modes of pharmacology for target modulati..." /></meta><meta name="Description" content="The identification of sites on receptors topographically distinct from the orthosteric sites, so-called allosteric sites, has heralded novel approaches and modes of pharmacology for target modulati..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 15, 2014" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5011786" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5011786" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5011786" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5011786" /></link>
        
    
    

<title>2013 Philip S. Portoghese Medicinal Chemistry Lectureship: Drug Discovery Targeting Allosteric Sites | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5011786" /></meta><meta property="og:title" content="2013 Philip S. Portoghese Medicinal Chemistry Lectureship: Drug Discovery Targeting Allosteric Sites†" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0011.jpeg" /></meta><meta property="og:description" content="The identification of sites on receptors topographically distinct from the orthosteric sites, so-called allosteric sites, has heralded novel approaches and modes of pharmacology for target modulation. Over the past 20 years, our understanding of allosteric modulation has grown significantly, and numerous advantages, as well as caveats (e.g., flat structure–activity relationships, species differences, “molecular switches”), have been identified. For multiple receptors and proteins, numerous examples have been described where unprecedented levels of selectivity are achieved along with improved physiochemical properties. While not a panacea, these novel approaches represent exciting opportunities for tool compound development to probe the pharmacology and therapeutic potential of discrete molecular targets, as well as new medicines. In this Perspective, in commemoration of the 2013 Philip S. Portoghese Medicinal Chemistry Lectureship (Lindsley, C. W. Adventures in allosteric drug discovery. Presented at the 246th National Meeting of the American Chemical Society, Indianapolis, IN, September 10, 2013; The 2013 Portoghese Lectureship), several vignettes of drug discovery campaigns targeting novel allosteric mechanisms will be recounted, along with lessons learned and guidelines that have emerged for successful lead optimization." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5011786"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5011786">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5011786&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5011786&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5011786&amp;href=/doi/10.1021/jm5011786" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 7485-7498</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm501175v" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">2013 Philip S. Portoghese Medicinal Chemistry Lectureship: Drug Discovery Targeting Allosteric Sites<a class="ref internalNav" href="#title" aria-label="†">†</a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Craig+W.++Lindsley">Craig W. Lindsley</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Departments of Pharmacology and Chemistry, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Specialized Chemistry Center (MLPCN), Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#91f2e3f0f8f6bffdf8fff5e2fdf4e8d1e7f0fff5f4e3f3f8fde5bff4f5e4"><span class="__cf_email__" data-cfemail="4e2d3c2f2729602227202a3d222b370e382f202a2b3c2c27223a602b2a3b">[email protected]</span></a>. Phone: 615-322-8700. Fax: 615-345-6532.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5011786&amp;href=/doi/10.1021%2Fjm5011786" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 7485–7498</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 2, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 August 2014</li><li><span class="item_label"><b>Published</b> online</span>15 September 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 September 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5011786" title="DOI URL">https://doi.org/10.1021/jm5011786</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5011786"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3739</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5011786" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;2013 Philip S. Portoghese Medicinal Chemistry Lectureship: Drug Discovery Targeting Allosteric Sites&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;W. Lindsley&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;7485-7498&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5011786&quot;},&quot;abstract&quot;:&quot;The identification of sites on receptors topographically distinct from the orthosteric sites, so-called allosteric sites, has heralded novel approaches and modes of pharmacology for target modulation. Over the past 20 years, our understanding of allosteric modulation has grown significantly, and numerous advantages, as well as caveats (e.g., flat structure–activity relationships, species differences, “molecular switches”), have been identified. For multiple receptors and proteins, numerous examples have been described where unprecedented levels of selectivity are achieved along with improved physiochemical properties. While not a panacea, these novel approaches represent exciting opportunities for tool compound development to probe the pharmacology and therapeutic potential of discrete molecular targets, as well as new medicines. In this Perspective, in commemoration of the 2013 Philip S. Portoghese Medicinal Chemistry Lectureship ( Lindsley, C. W. Adventures in allosteric drug discovery . Presented at the 24&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5011786&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5011786" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5011786&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5011786" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5011786&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5011786" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5011786&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5011786&amp;href=/doi/10.1021/jm5011786" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5011786" /></input><a href="/doi/pdf/10.1021/jm5011786" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5011786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5011786%26sid%3Dliteratum%253Aachs%26pmid%3D25180768%26genre%3Darticle%26aulast%3DLindsley%26date%3D2014%26atitle%3D2013%2BPhilip%2BS.%2BPortoghese%2BMedicinal%2BChemistry%2BLectureship%253A%2BDrug%2BDiscovery%2BTargeting%2BAllosteric%2BSites%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D18%26spage%3D7485%26epage%3D7498%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291713" title="Polyacrylamide">Polyacrylamide</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291071" title="Nicotinamide">Nicotinamide</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jmcmar.2014.57.issue-18/20140925/jmcmar.2014.57.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The identification of sites on receptors topographically distinct from the orthosteric sites, so-called allosteric sites, has heralded novel approaches and modes of pharmacology for target modulation. Over the past 20 years, our understanding of allosteric modulation has grown significantly, and numerous advantages, as well as caveats (e.g., flat structure–activity relationships, species differences, “molecular switches”), have been identified. For multiple receptors and proteins, numerous examples have been described where unprecedented levels of selectivity are achieved along with improved physiochemical properties. While not a panacea, these novel approaches represent exciting opportunities for tool compound development to probe the pharmacology and therapeutic potential of discrete molecular targets, as well as new medicines. In this Perspective, in commemoration of the 2013 Philip S. Portoghese Medicinal Chemistry Lectureship (<contrib-group person-group-type="allauthors">Lindsley, C. W.</contrib-group>Adventures in allosteric drug discovery. Presented at the 246th National Meeting of the American Chemical Society, Indianapolis, IN, September 10, <span class="NLM_year">2013</span>; The 2013 Portoghese Lectureship), several vignettes of drug discovery campaigns targeting novel allosteric mechanisms will be recounted, along with lessons learned and guidelines that have emerged for successful lead optimization.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="title"><span><h4></h4></span><span><p class="last">This Award Address was presented at the 246th National Meeting of the American Chemical Society in Indianapolis, IN, September 13, 2013.</p></span></div></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">I Introduction: Background on Allosteric Modulation. Novel Approaches for Therapeutics</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While the first concepts regarding allosterism were put forth in the 1960s, only in the past decade, with advances in molecular pharmacology and functional screening technology, has the impact of this alternative approach for target modulation been realized.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12">(2-12)</a> Indeed, the discovery of topologically distinct allosteric (from the Greek as “other site”) binding sites for a diverse range of receptor and protein families (GPCRs, ion channels, caspases, kinases, and phospholipases) has provided unparalleled opportunities to obtain druggable small molecules with exquisite selectivity and unique pharmacological profiles.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12">(2-12)</a> Here, an allosteric ligand binds the target at a topographically distinct allosteric site and either potentiates or inhibits the binding and/or signaling of an orthosteric ligand by taking advantage of conformational flexibility of the receptor and/or protein.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12">(2-12)</a> The clinical success and safety of benzodiazepines (BZDs) <b>1</b>–<b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">01</a>), the first allosteric modulator drugs, which potentiate the effect of γ-aminobutyric acid (GABA) at the ionotropic GABA<sub>A</sub> receptor are in direct opposition to the adverse and potentially lethal effects of orthosteric GABA<sub>A</sub> agonists.<a onclick="showRef(event, 'ref4 ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref4 ref11 ref13">(4, 11, 13)</a> Further exploration within the BZD class elucidated multiple modes of allosteric pharmacology: positive allosteric modulators (PAMs), which potentiate GABA<sub>A</sub> receptor response, negative allosteric modulators (NAMs), which decrease channel activity, and silent allosteric modulators (SAMs, or no affect ligands, NALs) that bind to the allosteric site and block both PAM and NAM activity without any effect on receptor signaling alone.<a onclick="showRef(event, 'ref4 ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref4 ref11 ref13">(4, 11, 13)</a> These data fueled the concept of allosteric modulation in modern drug discovery leading to the identification of allosteric modulators for other ion channels, kinases, phospholipases, and G-protein-coupled receptors (GPCRs).<a onclick="showRef(event, 'ref11 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref13 ref14">(11, 13, 14)</a> Moreover, multiple allosteric modulators are now in various stages of clinical development<a onclick="showRef(event, 'ref11 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref13 ref14">(11, 13, 14)</a> as well as marketed therapeutics (cinacalcet, <b>4</b>, a calcium sensing receptor PAM, and maraviroc, <b>5</b>, a CCR<sub>5</sub> NAM).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The first allosteric modulators with clinical success were benzodiazepines (BZDs), GABA<sub>A</sub> PAMs. The generic BZD core <b>1</b> and important medications <b>2</b> (Valium) and the tricylic analog <b>3</b> (Xanax) are shown. Also shown are structures of the two marketed GPCR allosteric modulators: cinacalcet (<b>4</b>), a calcium sensing receptor PAM, and maraviroc (<b>5</b>), a CCR<sub>5</sub> NAM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Over the past 13 years, our laboratories at Merck and within the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> have pioneered allosteric modulation as a pharmacological approach to modulate kinases, GPCRs, ion channels, and phospholipases,<a onclick="showRef(event, 'ref11 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref13 ref14">(11, 13, 14)</a> and we have introduced a plethora of important small molecule tools for use by the biomedical research community (via the VCNDD and the Molecular Libraries Probe Center Network, or MLPCN).<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Clearly, allosteric ligands afford unprecedented selectivity (by targeting evolutionary less conserved binding sites), enhanced chemical tractability, and improved physiochemical properties.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12">(2-12)</a> In the course of our research programs, we have encountered numerous caveats surrounding allosteric ligand pharmacology and chemical optimization (ligand bias, species differences, “molecular switches”, flat SAR, the “fluorine walk”) for which we have developed guidelines and strategies to enhance the odds of a successful lead optimization campaign.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14">(2-12, 14)</a> These general concepts have all been extensively reviewed elsewhere;<a onclick="showRef(event, 'ref11 ref12 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref14">(11, 12, 14)</a> thus, this Perspective will focus on the defining allosteric modulator programs that gave rise to these principles along with programs that transitioned from conceptual preclinical postulates into human clinical trials.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">II Allosteric Modulation of Kinases: The Case of Akt</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15603" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15603" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein phosphorylation is a ubiquitous cellular signaling process mediated by the action of kinases, and dysfunction within this system gives rise to numerous human diseases from diabetes to cancer.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> Despite the presence of >500 kinases in humans and a highly conserved orthosteric ATP (<b>6</b>) binding site, numerous small molecule drugs have received FDA approval; however, selectivity versus the kinome remains a major challenge, especially for kinase family with multiple isoforms/isoenzymes.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Today, we recognize four major types of kinase inhibitors: type I (classical ATP mimetics), type II, (ATP-site binders that extend into an adjacent allosteric site), type III (bind exclusively at an allosteric site, near the ATP-site), and type IV (bind exclusively at an allosteric site, distinct and remote from the ATP-site).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Type IV inhibitors pharmacologically can induce structural reorganization, stabilize inactive conformations, prevent substrate recognition, induce degradation, and/or occupy autoinhibitory sites by targeting a limited number of inactive kinase conformations, such as disruption of a conserved αC-helix.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28">(25-28)</a> To date, allosteric kinase inhibitors have been developed for Akt, Abl, JNK1, mTOR, CDK2, CHK1, IGF-1R, and PDK1, which possess chemotypes distinct from classical ATP mimetics and excellent selectivity versus the kinome.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> However, with respect to a nascent Akt kinase inhibitor program at Merck in early 2001, this was virgin territory and to pursue a novel, nontraditional (not ATP-competitive ligand) approach, was viewed with skepticism.</div><div class="NLM_p">In 2001, the modulation of discrete signaling targets in PTEN/PI3K pathway was a major focus for oncology drug discovery.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> At this time, Akt (PKB), a serine/threonine kinase in the AGC family of kinases (e.g., PKA, PKC, SGK), was known to be an oncogene, and an attractive kinase target though small molecule ligands were classical ATP-competitive, typified by the pan-kinase inhibitor staurosporine <b>7</b> or lipid analogs such as <b>8</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> In mammals, there are three isoforms/isoenyzmes of Akt (Ak1, Akt2, and Akt3) with different physiological roles that share greater than 85% homology (>95% at the ATP pocket). Structurally, each Akt isoform contains an N-terminal pleckstrin homology (PH) domain, a kinase domain, and a C-terminal regulatory domain. Akt was known to be comformationally flexible existing in the cytoplasm in a closed, inactive PH-in conformation, where the PH domain shields the ATP binding pocket and blocks phosphorylation of Ser473/T308.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37">(30-37)</a> Upon PIP3 recruitment to the plasma membrane, Akt then adopts a PH-out conformation that exposes Ser473/T308 for phosphorylation by PDK1 and mTORC2 (in 2001, it was believed to be a putative PDK2).<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37">(30-37)</a> Could this unique conformational flexibility of Akt engender allosteric sites that could effectively “lock” Akt into an inactive (PH-in) conformation and thus inhibit both the activity and the activation of Akt (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A)? Beyond this critical question, the objectives for this nascent project involved the development of small molecule tools to assess the apoptotic response of selective inhibition of Akt1, Akt2, and dual Akt1/2 inhibition, and once clear, the development of an oral Akt clinical candidate for the treatment of cancer. Notwithstanding the issues surrounding kinome selectivity, also developing Akt inhibitors with isoform selective inhibition by targeting the ATP-binding site seemed improbable and unlikely, as no selective Akt kinase inhibitors were known, and no one had yet attempted to achieve isoform selective inhibition of Akt. Thus, we chose a different and unprecedented, for that time, approach.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of adenosine triphosphate (ATP) <b>6</b>, the prototypical ATP-competitive, pan-kinase inhibitor staurosporine <b>7</b>, and a PIP lipid analog <b>8</b>. In 2001, <b>6</b> and <b>7</b> were examples of known Akt inhibitors, but neither were selective versus the kinome or other PH-domain containing proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A high-throughput screen (HTS) was performed, and as expected, the “usual suspects” (ATP mimetics) resulted. An exceptional biochemist on the program, Stanley Barnett, then performed ATP kinetics with the HTS hits and found a lone compound <b>9</b>, a functionalized quinoxaline, that was noncompetitive with ATP and was dissimilar from classical ATP-competitive ligands (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Moreover, <b>9</b> was active at Akt1 and Akt2 but inactive (IC<sub>50</sub> values of >250 μM) at Akt3 or against Akt 1 and Akt2 mutants lacking the PH domain as well as PKA, PKC, and SGK. Moreover, <b>9</b> inhibited both the activity and the activation of Akt. These data strongly suggested that the binding site for <b>9</b> resided within the PH domain or required the PH domain, thus suggesting an allosteric mode of inhibition.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Extensive mutagenesis work and biochemical studies supported a model wherein <b>9</b> was a two-site, allosteric binder, with a high affinity site in the PH domain, inducing a conformational change to a second site in the catalytic domain, locking Akt into a closed, PH-in conformation.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> As this was a nascent program, chemistry support was limited to a single medicinal chemist, but significant optimization of <b>8</b> was required to meet the program objectives. Here, we developed the technology enabled synthesis (TES) approach of iterative parallel synthesis and fragment libraries, coupled with microwave-assisted organic synthesis and mass-directed preparative LCMS, to leverage technology for accelerating lead optimization with limited human resources.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In short order, we had identified a key piperidine benzimidazole moiety that significantly enhanced Akt activity along with cores that afforded the required Akt1-selective <b>10</b>, Akt2-selective <b>11</b>, and dual Akt1/2 selective inhibitors <b>12</b>.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Like <b>9</b>, <b>10</b>–<b>12</b> were PH-domain dependent inhibitors, noncompetitive with ATP, and allosteric. Early proof-of-concept studies demonstrated that inhibition of both Akt1 and Akt2 was required for maximal apoptotic effect and that <b>12</b> could inhibit both basal and IGF-stimulated Akt1 and Akt2 phosphorylation in mouse lung.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Effort then focused on development of a clinical candidate<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and addition of a larger medicinal chemistry team that ultimately delivered MK-2206 (<b>13</b>), the first allosteric, oral Akt kinase inhibitor that enhanced antitumor efficacy by standard chemotherapeutics and was efficacious in patients with solid tumors in phase II (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Years later, the proposed mechanism of Akt inhibition was confirmed both by X-ray crystallography, whereby a cocrystal of Akt and <b>12</b> illustrated that <b>12</b> binds in a hydrophobic pocket formed by residues within the PH and kinase domains, and by fluorescence resonance energy transfer (FRET) data showing that <b>12</b> locked Akt into a PH-in conformation, preventing phosphorylation of S473 and T308.<a onclick="showRef(event, 'ref14 ref41'); return false;" href="javascript:void(0);" class="ref ref14 ref41">(14, 41)</a> Serendipitously, the allosteric approach with <b>13</b> also enabled our project team to side-step a major issue only recently disclosed. Upon binding, ATP-competitive Akt inhibitors induce hyperphosphorylation engendering regulatory phosphorylation; in contrast, <b>13</b> inhibits drug-induced hyperphosphorylation,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> thus increasing the therapeutic window noted for <b>13</b> and newer back-up compounds from Merck. Overall, this first venture into allosteric drug space was fruitful and demonstrated the value of a commitment to basic science and novel approaches for target modulation to advance into the clinic and paved the way for a career focused on allosteric mechanisms of target modulation.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Akt biology and allosteric inhibitors. (A) Loss of function mutations or deletions in PTEN leads to high levels of PIP3 which recruits Akt from the cytoplasm, where it exists in an inactive, PH-in conformation to the plasma membrane, where the PH domains binds to PIP3 leading to a PH-out conformation exposing T308 and Ser473 for phosphorylation by PDK1 and mTORC2, and active Akt. Inset: a model by which an allosteric inhibitor could stabilize the PH-in conformation, thus blocking both the activity and activation of Akt. Detailed mutagenesis, biochemical, and later X-ray studies confirmed that allosteric Akt inhibitors <b>9</b>–<b>13</b> adhere to this model of inhibition. (B) HTS lead <b>9</b> was found to be the first allosteric inhibitor of Akt. An iterative parallel synthesis and MAOS approach (TES) delivered key tool compounds with unprecedented selectivity for Akt1 (<b>10</b>), Akt2 (<b>11</b>), or both Akt1 and Akt2 (<b>12</b>). Subsequent intense medicinal chemistry provided MK-2206 (<b>13</b>) an orally bioavailable pan-allosteric Akt inhibitor that advanced into clinical trials and displayed efficacy against solid tumors in phase II.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">III Allosteric Modulation of GPCRs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">G-protein-coupled receptors, also referred to as seven-transmembrane receptors (7TMRs), account for >50% of all known drugs, and with the exception of <b>4</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and <b>5</b>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> the remaining FDA-approved drugs bind at the orthosteric site and modulate receptor function by blocking the action of the native agonist (competitive antagonism), inhibition of constitutive activity (inverse agonism), or direct activation (agonism).<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14">(2-12, 14)</a> The historical reason for this trend lies in the assays employed in their discovery: radioligand displacement assays that targeted the orthosteric site.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14">(2-12, 14)</a> Despite this success, many GPCRs are still without ligands and selectivity remains an issue, with desensitization resulting from prolonged activation, and based on the nature of the orthosteric ligands (neurotransmitters (family A), amino acids (family C), and large peptides (family B)), ligands often possess poor physiochemical properties (especially for CNS targets). With the advent of high throughout functional assays, it became possible to identify ligands that modulate GPCR function without regard to the binding site, which heralded the dramatic growth of allosteric modulators and a new frontier in pharmacology.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14">(2-12, 14)</a> Like the BZDs,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> GPCRs allosteric modulators can act as PAMs, NAMs, NALs (SAMs), ago-PAMs, partial antagonists, and even allosteric agonists (activating the GPCR in the absence of native agonist). It has been demonstrated time and again the advantages of allosteric modulation: (1) both subtype and overall selectivity, (2) maintenance of activity dependence (state dependence), (3) temporal and spatial aspects of endogenous physiological signaling, (4) less densensitization, and (5) fewer side effects. However, there are also challenges: (1) steep shallow SAR, (2) species differences (due to less evolutionary conservation of allosteric sites), (3) signal bias, (4) “molecular switches”, (5) allosteric ligands that can act at multiple distinct, overlapping, and nonoverlapping sites on the same receptor, and (6) the impact of homo- versus heterodimer pharmacology.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14">(2-12, 14)</a> This field has been extensively reviewed in a <i>Journal of Medicinal Chemistry</i> Perspective<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> as well as in multiple other venues;<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref12 ref14'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref12 ref14">(2-10, 12, 14)</a> therefore, this section will serve to highlight the GPCR allosteric modulator programs from our laboratories that helped establish this field and defined guiding principles (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) for allosteric ligand optimization.</div><figure id="cht1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0012.jpeg" id="GRAPHIC-d3314e664-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Once again, we return to Merck in 2001, where Jeff Conn was the Director of Neuroscience and my medicinal chemistry group was supporting his nascent programs targeting metabotropic glutamate receptors (mGlus) where the orthosteric agonist is glutamate (<b>14</b>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> At this time, mGlu<sub>5</sub> NAMs, such as MPEP (<b>15</b>), were well-known (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>),<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and Dr. Conn postulated that mGlu<sub>5</sub> PAMs should then be pharmacologically possible. If so, PAMs could avoid the epileptiform activity of mGlu<sub>5</sub> agonists<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and represent a potential novel therapeutic mechanism, via the NMDA hypofunction hypothesis,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> to improve cognition and treat schizophrenia.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cartoon of the metabotropic glutamate receptor subtype 5 (mGlu<sub>5</sub>) showing the structure and binding site of the endogenous agonist glutamate (<b>14</b>) in the extracellular Venus fly trap domain and the prototypical allosteric ligand, MPEP (<b>15</b>) an mGlu<sub>5</sub> NAM, that binds within the transmembrane domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, there were no reports of mGlu<sub>5</sub> PAMs, and management was not supportive of an HTS campaign. Therefore, to initiate a PAM effort, we examined the historical mGlu<sub>5</sub> NAM HTS data and looked for compounds that potentiated the glutamate EC<sub>80</sub> (as opposed to the classical PAM EC<sub>20</sub> screening paradigm). Despite “noisy” data, we identified two compounds worthy of follow-up. The first was a benzaldazine series represented by DFB (<b>16</b>), the first mGlu<sub>5</sub> PAM (EC<sub>50</sub> = 2.6 μM), with the anticipated PAM pharmacology and was shown to bind at the well-characterized MPEP NAM site (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> SAR around <b>16</b> was surprising in that subtle changes led to an equipotent mGlu5 NAM (<b>17</b>) and <b>18</b>, the first mGlu<sub>5</sub> SAM (now termed a NAL).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> At this point, we had yet to see this as a general phenomenon which we later (in 2008) coined “molecular switches”,<a onclick="showRef(event, 'ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49">(47-49)</a> but rather it was viewed as an anomaly. Interestingly, the other hit <b>19</b> also behaved as a PAM and potentiated NMDA receptor currents, but pharmacological characterization indicated that it, as well as an advanced mGlu<sub>5</sub> PAM in this series CPPHA (<b>20</b>),<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> did not bind at the MPEP site, thus providing evidence that there are two allosteric sites on mGlu<sub>5</sub> that can enable positive allosteric modulation of the receptor. In parallel to the iterative parallel synthesis that delivered <b>20</b>, we also performed fragment libraries around <b>20</b> that led to CDPPB (<b>21</b>), the first centrally active mGlu<sub>5</sub> PAM that validated this novel mechanism in preclinical models of schizophrenia and cognition.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> Surprisingly, <b>21</b> was shown to bind at the MPEP site, and many other laboratories utilized <b>21</b> to demonstrate antipsychotic-like effects in multiple animal models as well as enhancement of synaptic plasticity and cognitive function. However, Merck elected to stop the mGlu<sub>5</sub> PAM program in favor of other schizophrenia programs.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. The first mGlu<sub>5</sub> PAMs <b>16</b> and <b>20</b> and the subsequent optimization that led to the discovery of two distinct allosteric sites on mGlu<sub>5</sub> that can potentiate receptor function and the key in vivo proof of concept mGlu<sub>5</sub> PAM <b>21</b> that validated the mechanism and pharmacological approach for treatment of multiple symptom clusters of schizophrenia.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After these initial reports, multiple companies and academic laboratories initiated mGlu<sub>5</sub> PAM programs, and now there are over 40 distinct chemotypes reported as mGlu<sub>5</sub> PAMs, both for the MPEP and for the non-MPEP binding sites, with increasing examples of therapeutic efficacy.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Upon moving to Vanderbilt to once again partner with Jeff Conn and establish the VCNDD,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> we initiated a new mGlu<sub>5</sub> PAM project with a full “triple add” HTS campaign,<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14">(2-12, 14)</a> which afforded a plethora of fundamentally new mGlu<sub>5</sub> PAM and NAM leads. Key to our new Center was to have a dedicated, NIH-funded basic science effort to parallel the drug discovery effort that generated in vivo tool compounds that enabled a “deep dive” into target biology to inform the drug discovery teams. Shortly after developing patented mGlu<sub>5</sub> PAMs, we partnered the program with Janssen and quickly developed a broad intellectual property suite en route to a new medical entity (NME), while our basic science team provided keen insights into the biology of mGlu<sub>5</sub> potentiation. For example, we identified mGlu<sub>5</sub> PAMs that closely resembled MPEP, yet did not bind in a competitive manner with the MPEP binding site, leading us to realize that PET tracers for the program had to be generated from within the exact same scaffold as the candidate to ensure translational utility (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Furthermore, a critical observation with MPEP site ligands, as an extension to the early observations with <b>16</b>–<b>18</b>,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> was a general phenomenon we coined “molecular switches”.<a onclick="showRef(event, 'ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49">(47-49)</a> Here, we noted that the mode of pharmacology of an mGlu<sub>5</sub> partial antagonist <b>22</b> could be switched to a PAM <b>23</b> by the addition of a methyl group in the 4-position of the distal phenyl ring (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The addition of a 2-aminomethyl group to the 2-position of the pyrimidine provided <b>24</b>, a potent mGlu<sub>5</sub> PAM that displayed in vivo efficacy in antipsychotic models.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> All other structural modifications to <b>22</b> engendered full mGlu<sub>5</sub> NAM activity. Other series proved impervious to “molecular switches”, and these series were more favorable as leads toward an NME. As we will discuss later, the phenomenon of “molecular switches” is not only limited to mGlu<sub>5</sub> or class C GPCRs but is also prevalent with allosteric ligands for class A and class B GPCRs as well.<a onclick="showRef(event, 'ref12 ref14 ref49'); return false;" href="javascript:void(0);" class="ref ref12 ref14 ref49">(12, 14, 49)</a></div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. “Molecular switches” within MPEP site mGlu<sub>5</sub> allosteric ligands. Subtle structural modifications modulate the mode of pharmacology. <b>24</b> proved to be a potent PAM with in vivo activity in antipsychotic models, demonstrating the mode of pharmacology “switch” in vitro was mirrored in vivo.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The observation that incorporation of a small, polar moiety could engender a “switch” in the mode of pharmacology caused serious concern regarding the potential for CYP-mediated “molecular switches” from oxidative metabolism. Here, the academic effort with “tool compounds” informed the drug discovery team to judiciously characterize metabolites. About this time, Merck reinitiated an mGlu<sub>5</sub> PAM program through a partnership with Addex Pharmaceuticals and had published a report on mechanism-based toxicity based on data within a series of mGlu<sub>5</sub> PAMs, represented by 5PAM523 (<b>25</b>).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> In this study, fluorojade staining showed necrotic neurons in the auditory cortex and hippocampus (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>); moreover, these findings, in part, led Merck to once again abandon their mGlu<sub>5</sub> PAM program. We were aware of this, as well as the potential for neurotoxicity and seizure liabilities (known for group I mGlu agonists) with PAMs that possessed agonist activity, e.g., ago-PAMs. Once again, our academic, deep science effort realized the need for both high- and low-expressing mGlu<sub>5</sub> cell lines as well as the need to have a native preparation, which was found in astrocytes (they natively express mGlu<sub>5</sub>). For PAMs such as VU0242465 (<b>26</b>) which displayed ago-PAM activity in both cell lines and also displayed mGlu<sub>5</sub> agonism in astrocytes, we knew they potentiated long-term depression (LTD) alone and induced behavioral disturbances (seizures) when dosed in rats and were to be avoided. However, we were very surprised when VU0403602 (<b>27</b>), a pure PAM both in cell lines and in astrocytes, was found to induce significant seizure activity.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Studies with MTEP demonstrated that the adverse seizure activity was mGlu<sub>5</sub> mediated, with a full blockade of seizure activity with 10 mg/kg MTEP. On the basis of our concern of CYP-mediated “molecular switches” and the presence of a hydroxyl moiety in the amide of <b>26</b>, we also pretreated rats with aminobenzotriazole (ABT), a pan-CYP inhibitor, prior to <b>27</b> and found that the seizure activity was completely suppressed and equivalent to 10 mg/kg MTEP. Thus, the seizures were mGlu<sub>5</sub> mediated, most likely mGlu<sub>5</sub> allosteric agonism, and the activity was due to a metabolite and not the parent <b>27</b>. Metabolic identification studies then showed that the major metabolite M1 (<b>28</b>) was due to oxidation of the cyclobutyl moiety, and this secondary alcohol proved to be a potent mGlu<sub>5</sub> allosteric agonist, a similar moiety to that found in <b>26</b>. NOE studies and synthesis later demonstrated that there was also stereochemical bias in the “molecular switch” with the trans-isomer <b>29</b> possessing potent (EC<sub>50</sub> = 400 nM) allosteric agonist activity, while the cis-isomer <b>30</b> remained a pure PAM (EC<sub>50</sub> = 33 nM).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Thus, this was the first reported example of an in vivo, CYP-mediated “molecular switch”, and subsequent allosteric modulator programs now closely monitor major metabolites and their pharmacology/selectivity.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. mGlu<sub>5</sub> PAMs and ago-PAMs leading to seizure liability and neurotoxicity. Pure PAM <b>27</b> also induced seizures, but studies found that a CYP-mediated “molecular switch” afforded a racemic secondary alcohol metabolite <b>28</b> that modulated the mode of pharmacology from pure PAM to allosteric agonist and gave rise to the adverse effect liability and not the parent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, the concept of stimulus/signal bias was well-known in the context of GPCR allosteric modulators, and in the case of mGlu<sub>5</sub>, potentiation of NMDA receptor currents represented the major adverse effect liability once allosteric agonism had been addressed. Under this principle, we evaluated several mGlu<sub>5</sub> PAMs and found a compound that did not potentiate NMDA receptor currents directly, yet displayed robust efficacy, akin to mGlu<sub>5</sub> PAMs that potentiated NMDA receptor currents, in preclinical rodent models of antipsychotic activity, potentiated hippocampal LTD and LTP and yet showed no acute adverse effects or short-term excito- or neurotoxicity (fluorojade staining) in rats, in contrast to <b>25</b>;<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> however, these results do not ensure an absence of toxicity in other species or upon higher and/or chronic dosing regimens.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Nevertheless, the value of a strong basic science effort, operating in parallel to the drug discovery effort, afforded unique insights that enabled the delivery of an approved mGlu<sub>5</sub> PAM NME in less than 3 years from the initiation of the collaboration.</div><div class="NLM_p">It is important to note that the “molecular switch” phenomenon can also be beneficial.<a onclick="showRef(event, 'ref14 ref49'); return false;" href="javascript:void(0);" class="ref ref14 ref49">(14, 49)</a> We and others have reported numerous examples where a small structural modification to a core has engendered unique, desired pharmacology or afforded access, through a change in subtype selectivity, to ligands for a receptor subtype that were previously unavailable.<a onclick="showRef(event, 'ref58 ref59 ref60 ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref58 ref59 ref60 ref61 ref62 ref63">(58-63)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a> shows three recent examples of the latter. Taking advantage of the promiscuity of MPEP site mGlu<sub>5</sub> PAM ligands, we noted that mGlu<sub>5</sub> PAM <b>30</b> (mGlu<sub>5</sub> EC<sub>50</sub> = 270 nM) had weak activity as an mGlu<sub>3</sub> NAM (mGlu<sub>3</sub> IC<sub>50</sub> > 10 μM) and felt this could be exploited to access the first selective mGlu<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> NAMs.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> A diversity-oriented synthesis effort identified a “molecular switch”, again in the 4-position of the distal phenyl ring, in the form of a methoxy moiety. SAR was “flat” as anticipated, yet we were able to access VU0463597 (<b>31</b>, ML289) as the first highly selective mGlu<sub>3</sub> NAM (mGlu<sub>3</sub> IC<sub>50</sub> = 650 nM, mGlu<sub>2</sub> IC<sub>50</sub> > 10 μM), which was devoid of mGlu<sub>5</sub> activity (both PAM and NAM).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Further lead optimization and utilization of the “fluorine walk” provided the more selective mGlu<sub>3</sub> NAM probe VU06024017 (<b>32</b>, ML337); however, the key moiety that engender activity at mGlu<sub>3</sub>, the 4-methoxy group, was also the lone metabolic liability, undergoing a rapid oxidative dealkylation to an inactive congener.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Steric and electronic modification to both the ether and the pendent aromatic ring led to a significant diminution in potency. Ultimately, this led to the introduction of another valuable tool in the allosteric modulator tool box: deuterium incorporation and reliance on the stronger C–D bond. Replacement of the OCH<sub>3</sub> with a OCD<sub>3</sub> (<b>33</b>) maintained the pharmacological profile, yet reduced in vitro and in vivo clearance by ∼50%, enabling <b>33</b> to serve as a valuable in vivo tool to study selective mGlu<sub>3</sub> inhibition.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Beneficial “molecular switches”. (A) Delivery of the first highly selective mGlu<sub>3</sub> NAM <b>31</b> by virtue of a 4-OMe “molecular switch” on an mGlu<sub>5</sub> PAM scaffold. Subsequent optimization and “fluorine walk” provided <b>32</b>, which was further optimized for DMPK properties by deuterium incorporation, as in <b>33</b>, to overcome “flat” SAR. (B) The allosteric sites on mGlu<sub>4</sub> and mGlu<sub>1</sub> historically cross-talk, and taking advantage of a “double molecular switch”, an mGlu<sub>1</sub> PAM with properties suitable for in vivo studies resulted. (C) An M<sub>1</sub> HTS identified <b>37</b> as an M<sub>1</sub>, M<sub>3</sub>, M<sub>5</sub> PAM. A “molecular switch” in the form of a 5-OCF<sub>3</sub> group engendered selectivity for M<sub>5</sub>, while addition of small heterocycles to replace the 4-Br moiety afforded selective M<sub>1</sub> PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Likewise, many mGlu<sub>4</sub> PAMs and mGlu<sub>1</sub> NAMs are known in the literature, but there are few mGlu<sub>1</sub> PAMs and none with properties suitable for in vivo studies.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> It is well established since the first report of (−)-PHCCC as an mGlu<sub>4</sub> PAM (and weak mGlu<sub>1</sub> NAM) that there was cross-talk between the mGlu<sub>4</sub> and mGlu<sub>1</sub> allosteric sites.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> However, optimization efforts were able to separate these activities delivering highly selective mGlu<sub>4</sub> PAMs, such as <b>34</b>.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Further chemical optimization and modification to the imide moiety provided <b>35</b>, an equally potent and highly selective mGlu<sub>1</sub> NAM via a “molecular switch”.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Replacement of the imide in <b>35</b> with a phthalimide, as in <b>36</b>, induced another “molecular switch”, in essence a “double molecular switch” from <b>34</b>, leading to a highly selective mGlu<sub>1</sub> PAM, with properties enabling dissection of an emerging role of <i>GRM1</i> mutation in schizophrenia as well as in vivo studies (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>B).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><div class="NLM_p">Finally, this is not restricted to class C GPCRs or mGluRs. The phenomenon of “molecular switches” is prevalent across all families of GPCRs, where it has been instrumental in the development of highly subtype selective muscarinic acetylcholine (mAChR) ligands (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>C). For instance, an HTS to identify M<sub>1</sub> PAMs generated a unique hit: a pan-G<sub>q</sub> coupled, M<sub>1</sub>, M<sub>3</sub>, M<sub>5</sub>-triple PAM <b>37</b> with equivalent low micromolar activity across the three subtypes.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71, 72)</a> A matrix library (9 × 12), surveying nine functionalized isatins and 12 different benzyl moieties, uncovered a 5-OCF<sub>3</sub> moiety as “molecular switch” that provided the first highly selective M<sub>5</sub> PAM, <b>38</b> (ML129).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Further optimization with iterative libraries and the “fluorine walk” afforded an <i>N</i>-Me pyrrole as a “molecular switch” leading to a highly selective M<sub>1</sub> PAM, <b>39</b> (ML137).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Both of these findings led to further optimization programs and high quality in vivo tools to probe M<sub>1</sub> and M<sub>5</sub> function in the CNS.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. In pursuit of a better xanomeline. Shown are structures of xanomeline (<b>40</b>) and subsequent M<sub>1</sub> allosteric agonists <b>41</b>–<b>44</b>, which demonstrated that all were bitopic with receptor reserve-dependent pharmacology (e.g., brain region-specific activity) and thus not tractable as a therapeutic approach. PAMs of either M<sub>1</sub> (<b>45</b> and <b>46</b>) or M<sub>4</sub> (<b>47</b> or <b>48</b>) have emerged as important in vivo tools to demonstrate that this mode of pharmacology is superior to allosteric agonism with true mAChR selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Before leaving GPCRs, it is important to discuss a related pharmacological approach that is often confused with PAMs: allosteric agonism. While PAMs require the orthosteric agonist and potentiate its activity, an allosteric agonist binds at a site distinct from the orthosteric site and is capable of activating the receptor in the absence of the orthosteric ligand.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12">(2-12)</a> This approach has been largely isolated to the M<sub>1</sub> mACh receptor, based on the clinical proof of concept studies with xanomeline (<b>40</b>), an M<sub>1</sub>/M<sub>4</sub> preferring agonist, in patients with either Alzheimer’s disease or schizophrenia (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> However, like all mAChR M<sub>1</sub> agonists developed in the 1990s, the true lack of subtype selectivity led to activation of peripheral M<sub>2</sub>/M<sub>3</sub> receptors and adverse events precluded further development, despite efficacy noted in PhII trials.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12">(2-12)</a> These data led to the quest for selective M<sub>1</sub> and/or M<sub>4</sub> allosteric agonists. Many weak partial and functionally selective M<sub>1</sub> allosteric agonists were disclosed, and a prototypical example is TBPB (<b>41</b>);<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> yet <b>41</b> and related congeners were found to be bitopic, meaning the ligand bound to an allosteric site on M<sub>1</sub> that led to functionally selective M<sub>1</sub> activation, but when screened in antagonist mode, they were full antagonists of the M<sub>2</sub>–M<sub>5</sub>, and in competition binding studies, as the concentration was increased, the orthosteric radioligand, [<sup>3</sup>H]NMS was fully displaced.<a onclick="showRef(event, 'ref60 ref74 ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref60 ref74 ref75 ref76">(60, 74-76)</a> Therefore, the “allosteric agonists” bind with high affinity at an allosteric site, but all also bind at the orthosteric site. This was further supported by modulating the basicity of the central piperidine ring of <b>41</b> with the β-F congener <b>42</b> and disrupting a key hydrogen bind at the allosteric site that led to pan-mAChR (M<sub>1</sub>-M<sub>5</sub>) antagonism.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Finally, we demonstrated that two additional partial M<sub>1</sub> allosteric agonists <b>43</b> and <b>44</b><a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> displayed receptor reserve-dependent pharmacology in native brain tissue preparations that translated into in vivo behavioral outcomes.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Thus, although there was early optimism with the approach, it became clear that allosteric agonists were actually a “second coming” of the M<sub>1</sub> agonists of the 1990s, laden with unpredictable activity across brain regions and susceptibility to peripheral M<sub>2</sub>/M<sub>3</sub> issues due to high receptor reserve and bitopic binding/pharmacology.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Therefore, after years of effort and dedicated basic science, it became clear that M<sub>1</sub> (e.g., <b>45</b> and <b>46</b>)<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78, 79)</a> and M<sub>4</sub> PAMs (e.g., <b>47</b> and <b>48</b>)<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80, 81)</a> would be the desired pharmacological approach to achieve true mAChR subtype selectivity and advance into the clinic to validate the clinical data with <b>40</b>. Preclinically, it is clear that M<sub>4</sub> plays a larger role as an antipsychotic agent with modest cognition enhancing activity, whereas the reverse is true for M<sub>1</sub>.<a onclick="showRef(event, 'ref78 ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref78 ref79 ref80 ref81">(78-81)</a> A program we initiated at Merck provided the first reported M<sub>1</sub> PAM, BQCA (<b>45</b>), where all the principles discussed (iterative parallel synthesis, matrix libraries, and the “fluorine walk”) were critical in lead optimization and ultimately led to the development of MK-7622 (structure not officially disclosed) which is currently in phase II clinical trials, and efficacy data are eagerly awaited.</div><div class="NLM_p last">Finally, our group has contributed important small molecule allosteric modulators for other GPCRS including mGlu<sub>1</sub> (PAMs and NAMs), mGlu<sub>3</sub> (NAMs), mGlu<sub>4</sub> (PAMs and NAMs), mGlu<sub>5</sub> (PAMs and NAMs), pan group III mGluRs (PAMs), M<sub>1</sub> (PAMs and allosteric agonists), M<sub>4</sub> (PAMs), M<sub>5</sub> (PAMs and NAMs), and even class B GPCRs such as GLP-1 (PAMs).<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref14">(2-12, 14)</a> These programs gave rise to the principles outlined in Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a> and referred to throughout this Perspective. While targeting allosteric sites has provided highly selective druglike compounds with good CNS exposure to understand the physiological underpinnings and therapeutic potential of many discrete GPCRs, it is not a panacea. Judicious evaluation of species differences must be adhered to along with the “triple add” primary screen to capture molecular switches, which carries forward into DMPK to understand the pharmacology of metabolites. Furthermore, stimulus bias can be beneficial as well as harmful; therefore, pharmacological characterization across a broader panel of assays to assess stimulus bias must be performed on HTS lead series and prior to focusing on a given scaffold. Although insights from mutagenesis work as to the origin of “molecular switches” have been helpful, the surge of new X-ray crystal structures of relevant GPCRS, some with allosteric ligands bound,<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> is very exciting and will hopefully pave the way for a greater understanding of allosteric SAR.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">IV Allosteric Modulation of Phopsphodiesterases: The Case of Phospholipase D (PLD)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07523" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07523" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phospholipase D (PLD) is a phospholipase that catalyzes the production of choline and phosphatidic acid (PA), an important lipid second messenger involved in a myriad of critical signaling and metabolic pathways by the hydrolysis of phosphatidylcholine.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Mammals possess two isoforms of PLD, termed PLD1 and PLD2 (sharing 53% homology), both of which are differentially regulated and possess independent physiological roles. Structurally, PLD, like Akt, is a highly flexible enzyme that consists of a highly conserved active site (composed of two histidine-lysine-aspartate amino acid domains) and both N-terminal phox homology (PX) and PH regulatory domains.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Extensive biochemical data and genetic studies have implicated dysfunction in PLD signaling and/or PLD overexpression in cancer, viral infection, and CNS disorders; however, the therapeutic potential of modulating PLD function remained elusive for over 20 years since its discovery because of a lack of selective and PLD isoform specific small molecules. Indeed, the field has been driven by the use of <i>n</i>-butanol (<b>49</b>), which competes for water in a transphosphatidylation reaction with water (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Development of allosteric, isoform selective PLD inhibitors <b>51</b>–<b>54</b>, utilizing DOS, iterative parallel synthesis, the “fluorine walk” and “molecular switches”, all of which were borrowed from the allosteric GPCR field.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A 2007 short report from Novartis described halopemide (<b>50</b>), an atypical antipsychotic agent, and a collection of 12 related congers as PLD inhibitors.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Upon recognition of clinical trial data with <b>50</b>, wherein both isoforms of PLD were inhibited in man with normal biochemistry and without adverse events generated great interest in a field lacking small molecule tools.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Because of the presence of a PH domain in PLD and the piperdine benzimidazolone moiety in <b>50</b>, we believed <b>50</b> may be inhibiting the enzyme through an allosteric mechanism, akin to Akt, and that the dual PLD1/2 inhibitor <b>50</b> could represent an attractive lead from which to access PLD1 and PLD2 selective compounds. Thus, our laboratory in collaboration with Alex Brown and his laboratory initiated a diversity-oriented synthesis campaign around <b>50</b>, followed by iterative parallel synthesis and the “fluorine walk” (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), to develop the first direct, isoform selective PLD inhibitors <b>51</b> (1700-fold PLD1 selective) and <b>52</b> (75-fold PLD2 selective).<a onclick="showRef(event, 'ref86 ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref86 ref87 ref88">(86-88)</a> Mutants lacking the N-terminus (PX and PH domains) lost PLD activity (again similar to Akt), and when combined with other biochemical and enzyme kinetic studies, it became clear that these compounds were indeed allosteric. Despite value in aiding to more clearly define the individual contributions of PLD1 and PLD2 in various systems and diseases, poor DMPK and physiochemical properties precluded robust in vivo studies.<a onclick="showRef(event, 'ref86 ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref86 ref87 ref88">(86-88)</a> Further chemical optimization led to the discovery of the potent dual PLD1/2 inhibitor ML299 (<b>53</b>) and a second generation PLD2 selective probe ML298 (<b>54</b>).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Both showed improved ancillary pharmacology but only marginally improved DMPK profiles and physiochemical properties. Here, we noted a “molecular switch” in the form of a “magic methyl” that enhanced PLD1 activity ∼50-fold in the piperidine benzimidazolone series represented by <b>51</b> but could reverse PLD2 selectivity over 250-fold in the triazaspirone series, represented by <b>53</b>.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> While further optimization to improve DMPK continues, the tools in hand elucidated a wealth of information regarding the therapeutic potential of PLD inhibition, especially PLD2. For example, <b>52</b> was critical in studies that identified PLD as a novel regulator of Akt in glioblastoma multiforme (GBM).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a><b>52</b> enabled studies that showed PA as an essential component for the membrane recruitment and activation of Akt, as well as a direct protein–protein interaction between PLD2 and Akt. Inhibition of PLD<sub>2</sub> by <b>52</b> decreases activation of Akt leading to cell death through inhibition of autophagic flux and a back door by which to inhibit Akt.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Furthermore, we demonstrated that infection by influenza virus stimulates phospholipase D (PLD) activity and PLD colocalizes with influenza during infection.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Inhibition of PLD2 with <b>52</b> delayed viral entry and reduced viral titers in vitro and in vivo, as well as enhancing survival against a broad panel of influenza strains (H1, H3, H5, and H7).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Once again, development of highly isoform selective PLD inhibitors, by targeting an allosteric mechanism, advanced our understanding of the deeper signaling biology and uncovered therapeutic potential in oncology and virology. Moreover, principles, strategies, and issues for optimization of GPCR allosteric ligands carried over into phospholipases.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">V Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Allosteric modulation has fundamentally altered our ability to prosecute “tough” targets and successfully develop ligands. Here, in commemoration of the 2013 Philip S. Portoghese Medicinal Chemistry Lectureship, several vignettes of drug discovery campaigns targeting novel allosteric mechanisms for kinases, phospholipases, and G-protein-coupled receptors were described that gave rise to general principles for successful optimization. On the basis of the broad applicability and success of allosteric modulation, we wish to move beyond classical drug repurposing to “receptor repurposing” and re-engage targets that failed because of the ligands/chemotypes with new functional HTS campaigns and subsequent development of allosteric ligands and exploit fundamentally new chemotypes and biased signaling profiles. Phase II clinical data are eagerly awaited for multiple allosteric modulators (Akt, M<sub>1</sub> PAMs, etc.) to further validate the approach to improve human health and impact unmet medical needs.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm5011786" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig W. Lindsley</span> - <span class="hlFld-Affiliation affiliation">Departments of Pharmacology
and Chemistry, Vanderbilt Center for Neuroscience Drug Discovery,
Vanderbilt Specialized Chemistry Center (MLPCN), Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fd9e8f9c949ad3919493998e919884bd8b9c9399988f9f949189d3989988"><span class="__cf_email__" data-cfemail="0f6c7d6e6668216366616b7c636a764f796e616b6a7d6d66637b216a6b7a">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Funding was received from BMS and AZ for allosteric modulators of mGlu4 and M4, respectively.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Biography</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Craig W. Lindsley</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=BIO-d3314e1752-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Craig W. Lindsley</b> is Director of Medicinal Chemistry for the Vanderbilt Center for Neuroscience Drug Discovery in Nashville, TN, and holds the William K. Warren, Jr. Chair in Medicine. He received his doctorate in 1996 from the University of California, Santa Barbara, and pursued postdoctoral studies at Harvard University, MA. In 2001, he moved to Merck and developed a streamlined approach for lead optimizaton that resulted in the delivery of six preclinical candidates, including the first isoenzyme-selective allosteric AKT-kinase inhibitors, as well as the first positive allosteric modulators of the mGlu<sub>5</sub> and M<sub>1</sub>. In 2006, he accepted Associate Professor appointments in Pharmacology and Chemistry at Vanderbilt University, and in 2009 he was promoted to full Professor and is the founding Editor-in-Chief for <i>ACS Chemical Neuroscience</i>.</p></figure></div><div class="ack" id="ACK-d3314e1766-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">First and foremost, medicinal chemists must acknowledge Professor Philip S. Portoghese, Editor-in-Chief of the <i>Journal of Medicinal Chemistry</i> for almost 40 years, who helped shape the practice of medicinal chemistry into the discipline it is today. Second, I must thank Jeff Conn, my colleague and partner in our adventures through allosteric drug discovery; there is no better molecular pharmacologist or drug hunter. Funding from NIH for support of our research in allosteric modulators of GPCRS and in particular NIMH (Grant MH082867), NIDA (Grant DA023947), and the MLPCN (Grant U54MH084659), as well as Janssen, AstraZeneca, Bristol-Myers Squibb, and Seaside Therapeutics, is acknowledged. Dr. Lindsley also thanks the Warren family and Foundation for establishing the William K. Warren Jr. Chair in Medicine. Finally, thanks are given to Merck (2001–2006) for establishing a culture enabling advances in fundamental science in pursuit of novel drug discovery approaches.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i8" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i8"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i9" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i9"> Abbreviations Used</h2><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">NAM</td><td class="NLM_def"><p class="first last">negative allosteric modulator</p></td></tr><tr><td class="NLM_term">SAM</td><td class="NLM_def"><p class="first last">silent allosteric modulator</p></td></tr><tr><td class="NLM_term">NAL</td><td class="NLM_def"><p class="first last">no affect ligand</p></td></tr><tr><td class="NLM_term">BZD</td><td class="NLM_def"><p class="first last">benzodiazepine</p></td></tr><tr><td class="NLM_term">GABA<sub>A</sub></td><td class="NLM_def"><p class="first last">γ-aminobutyric acid</p></td></tr><tr><td class="NLM_term">mAChR</td><td class="NLM_def"><p class="first last">muscarinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">mGluR</td><td class="NLM_def"><p class="first last">metabotropic glutamate receptor</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism/pharmacokinetic</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">GLP1</td><td class="NLM_def"><p class="first last">glucagon-like peptide 1</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">CRC</td><td class="NLM_def"><p class="first last">concentration–response curve</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screen</p></td></tr><tr><td class="NLM_term">DFB</td><td class="NLM_def"><p class="first last">3,3′-difluorobenzaldazine</p></td></tr><tr><td class="NLM_term">CDPPB</td><td class="NLM_def"><p class="first last">3-cyano-<i>N</i>-(1,3-diphenyl-1<i>H</i>-pyrazol-5-yl)benzamide</p></td></tr><tr><td class="NLM_term">MPEP</td><td class="NLM_def"><p class="first last">2-methyl-6-(phenylethynyl)pyridine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53735" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53735" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 91 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Adventures in allosteric drug discovery</span>. Presented at the 246th National Meeting of the American Chemical Society, Indianapolis, IN, September 10,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>The 2013 Portoghese Lectureship.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+W.+Lindsley&title=Adventures+in+allosteric+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAdventures%2520in%2520allosteric%2520drug%2520discovery%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. J.</span><span> </span><span class="NLM_article-title">Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1124%2Fpr.108.000992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=20392808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=265-304&author=T.+Kenakinauthor=L.+J.+Miller&title=Seven+transmembrane+receptors+as+shapeshifting+proteins%3A+the+impact+of+allosteric+modulation+and+functional+selectivity+on+new+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery</span></div><div class="casAuthors">Kenakin, Terry; Miller, Laurence J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">265-304</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  It is useful to consider seven transmembrane receptors (7TMRs) as disordered proteins able to allosterically respond to a no. of binding partners.  Considering 7TMRs as allosteric systems, affinity and efficacy can be thought of in terms of energy flow between a modulator, conduit (the receptor protein), and a no. of guests.  These guests can be other mols., receptors, membrane-bound proteins, or signaling proteins in the cytosol.  These vectorial flows of energy can yield std. canonical guest allostery (allosteric modification of drug effect), effects along the plane of the cell membrane (receptor oligomerization), or effects directed into the cytosol (differential signaling as functional selectivity).  This review discusses these apparently diverse pharmacol. effects in terms of mol. dynamics and protein ensemble theory, which tends to unify 7TMR behavior toward cells.  Special consideration will be given to functional selectivity (biased agonism and biased antagonism) in terms of mechanism of action and potential therapeutic application.  The explosion of technol. that has enabled observation of diverse 7TMR behavior has also shown how drugs can have multiple (pluridimensional) efficacies and how this can cause paradoxical drug classification and nomenclatures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3xCdUTrHggbVg90H21EOLACvtfcHk0liTGtTGHo7w6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbM&md5=fa2394cfb3ae2ecdde09775b50b45b8b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.108.000992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.108.000992%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26atitle%3DSeven%2520transmembrane%2520receptors%2520as%2520shapeshifting%2520proteins%253A%2520the%2520impact%2520of%2520allosteric%2520modulation%2520and%2520functional%2520selectivity%2520on%2520new%2520drug%2520discovery%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D265%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Fenton, A. W.</span><span> </span><span class="NLM_article-title">Allostery: an illustrated definition for the “second secret of life”</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=420-425&author=A.+W.+Fenton&title=Allostery%3A+an+illustrated+definition+for+the+%E2%80%9Csecond+secret+of+life%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFenton%26aufirst%3DA.%2BW.%26atitle%3DAllostery%253A%2520an%2520illustrated%2520definition%2520for%2520the%2520%25E2%2580%259Csecond%2520secret%2520of%2520life%25E2%2580%259D%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2008%26volume%3D33%26spage%3D420%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopolous, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Allosteric modulators of GPCRs as a novel approach to treatment of CNS disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=41-54&author=P.+J.+Connauthor=A.+Christopolousauthor=C.+W.+Lindsley&title=Allosteric+modulators+of+GPCRs+as+a+novel+approach+to+treatment+of+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DChristopolous%26aufirst%3DA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulators%2520of%2520GPCRs%2520as%2520a%2520novel%2520approach%2520to%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D41%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">G-protein coupled receptors: from classical modes of modulation to allosteric mechanisms</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb800116f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=530-542&author=T.+M.+Bridgesauthor=C.+W.+Lindsley&title=G-protein+coupled+receptors%3A+from+classical+modes+of+modulation+to+allosteric+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fcb800116f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb800116f%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DG-protein%2520coupled%2520receptors%253A%2520from%2520classical%2520modes%2520of%2520modulation%2520to%2520allosteric%2520mechanisms%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2008%26volume%3D3%26spage%3D530%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">G protein-coupled receptors allosterism and complexing</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=323-374&author=A.+Christopoulosauthor=T.+Kenakin&title=G+protein-coupled+receptors+allosterism+and+complexing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DG%2520protein-coupled%2520receptors%2520allosterism%2520and%2520complexing%26jtitle%3DPharmacol.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D323%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric binding sites on cell surface receptors: novel targets for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=198-210&author=A.+Christopoulos&title=Allosteric+binding+sites+on+cell+surface+receptors%3A+novel+targets+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520binding%2520sites%2520on%2520cell%2520surface%2520receptors%253A%2520novel%2520targets%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D198%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kenakin, T. P.</span><span> </span><span class="NLM_article-title">7TM receptor allostery: putting numbers to shapeshifting proteins</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=460-469&author=T.+P.+Kenakin&title=7TM+receptor+allostery%3A+putting+numbers+to+shapeshifting+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26atitle%3D7TM%2520receptor%2520allostery%253A%2520putting%2520numbers%2520to%2520shapeshifting%2520proteins%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D460%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Lane, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdul-Ridha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span> </span><span class="NLM_article-title">Regulation of G protein-coupled receptors by allosteric ligands</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn400005t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1yhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=527-534&author=R.+J.+Laneauthor=A.+Abdul-Ridhaauthor=M.+Canals&title=Regulation+of+G+protein-coupled+receptors+by+allosteric+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of G Protein-Coupled Receptors by Allosteric Ligands</span></div><div class="casAuthors">Lane, J. Robert; Abdul-Ridha, Alaa; Canals, Meritxell</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-534</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topog. distinct, druggable, allosteric sites may be present on all G protein-coupled receptors (GPCRs).  As such, targeting these sites with synthetic small mols. offers an attractive approach to develop receptor-subtype selective chem. leads for the development of novel therapies.  A crucial part of drug development is to understand the acute and chronic effects of such allosteric modulators at their corresponding GPCR target.  Key regulatory processes including cell-surface delivery, endocytosis, recycling, and down-regulation tightly control the no. of receptors at the surface of the cell.  As many GPCR therapeutics will be administered chronically, understanding how such ligands modulate these regulatory pathways forms an essential part of the characterization of novel GPCR ligands.  This is true for both orthosteric and allosteric ligands.  In this Review, we summarize our current understanding of GPCR regulatory processes with a particular focus on the effects and implications of allosteric targeting of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKrOeC3g251bVg90H21EOLACvtfcHk0li8b0iI75Giag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1yhtrY%253D&md5=e95af61d6cdc720069c9d9dd8de8ff5c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcn400005t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400005t%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DR.%2BJ.%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DCanals%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520G%2520protein-coupled%2520receptors%2520by%2520allosteric%2520ligands%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D527%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Monod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J.-P.</span><span> </span><span class="NLM_article-title">On the nature of allosteric transitions: a plausible model</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1956&pages=88-118&author=J.+Monodauthor=J.+Wymanauthor=J.-P.+Changeux&title=On+the+nature+of+allosteric+transitions%3A+a+plausible+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonod%26aufirst%3DJ.%26aulast%3DWyman%26aufirst%3DJ.%26aulast%3DChangeux%26aufirst%3DJ.-P.%26atitle%3DOn%2520the%2520nature%2520of%2520allosteric%2520transitions%253A%2520a%2520plausible%2520model%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1956%26spage%3D88%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Melancon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Allosteric modulation of 7 transmembrane spanning receptors: theory, practice and opportunities for CNS drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1445</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201139r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1445-1464&author=B.+J.+Melanconauthor=C.+R.+Hopkinsauthor=M.+R.+Woodauthor=K.+A.+Emmitteauthor=C.+M.+Niswenderauthor=A.+Christopoulosauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Allosteric+modulation+of+7+transmembrane+spanning+receptors%3A+theory%2C+practice+and+opportunities+for+CNS+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm201139r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201139r%26sid%3Dliteratum%253Aachs%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulation%2520of%25207%2520transmembrane%2520spanning%2520receptors%253A%2520theory%252C%2520practice%2520and%2520opportunities%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1445%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meiler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span> </span><span class="NLM_article-title">Opportunities and challenges in discovery of allosteric modulators of GPCRs for treatment of CNS disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=692-708&author=P.+J.+Connauthor=C.+W.+Lindsleyauthor=J.+Meilerauthor=C.+M.+Niswender&title=Opportunities+and+challenges+in+discovery+of+allosteric+modulators+of+GPCRs+for+treatment+of+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26atitle%3DOpportunities%2520and%2520challenges%2520in%2520discovery%2520of%2520allosteric%2520modulators%2520of%2520GPCRs%2520for%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D692%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Mohler, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritschy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, U.</span><span> </span><span class="NLM_article-title">A new benzodiazepine pharmacology</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2002&pages=2-8&author=H.+F.+Mohlerauthor=J.+M.+Fritschyauthor=U.+Rudolph&title=A+new+benzodiazepine+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DH.%2BF.%26aulast%3DFritschy%26aufirst%3DJ.%2BM.%26aulast%3DRudolph%26aufirst%3DU.%26atitle%3DA%2520new%2520benzodiazepine%2520pharmacology%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D300%26spage%3D2%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wenthur, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Drugs for allosteric sites on receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1146%2Fannurev-pharmtox-010611-134525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=24111540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVSqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=165-184&author=C.+J.+Wenthurauthor=P.+R.+Gentryauthor=T.+P.+Matthewsauthor=C.+W.+Lindsley&title=Drugs+for+allosteric+sites+on+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs for allosteric sites on receptors</span></div><div class="casAuthors">Wenthur, Cody J.; Gentry, Patrick R.; Mathews, Thomas P.; Lindlsye, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">165-184</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The presence of druggable, topog. distinct allosteric sites on a wide range of receptor families has offered new paradigms for small mols. to modulate receptor function.  Moreover, ligands that target allosteric sites offer significant advantages over the corresponding orthosteric ligands in terms of selectivity, including subtype selectivity within receptor families, and can also impart improved physicochem. properties.  However, allosteric ligands are not a panacea.  Many chem. issues (e.g., flat structure-activity relationships) and pharmacol. issues (e.g., ligand-biased signaling) that are allosteric centric have emerged.  Notably, the fact that allosteric sites are less evolutionarily conserved leads to improved selectivity; however, this can also lead to species differences that can hinder safety assessment.  Many allosteric ligands possess mol. switches, wherein a small structural change (chem. or metabolic) can modulate the mode of pharmacol. or receptor subtype selectivity.  As the field has matured, as described here, key principles and strategies have emerged for the design of ligands/drugs for allosteric sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx6zv9s5vbLLVg90H21EOLACvtfcHk0lj1F27CngxxOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVSqtrs%253D&md5=56aff98cecab954cbabac96c94f25f47</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-010611-134525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-010611-134525%26sid%3Dliteratum%253Aachs%26aulast%3DWenthur%26aufirst%3DC.%2BJ.%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDrugs%2520for%2520allosteric%2520sites%2520on%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D54%26spage%3D165%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wagenen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colloton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbon, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shatzen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scully, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D.</span><span> </span><span class="NLM_article-title">Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1124%2Fjpet.103.057273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=14593085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlSqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2004&pages=627-635&author=E.+F.+Nemethauthor=W.+H.+Heatonauthor=M.+Millerauthor=J.+Foxauthor=M.+F.+Balandrinauthor=B.+C.+Van+Wagenenauthor=M.+Collotonauthor=W.+Karbonauthor=J.+Scherrerauthor=E.+Shatzenauthor=G.+Rishtonauthor=S.+Scullyauthor=M.+Qiauthor=R.+Harrisauthor=D.+Laceyauthor=D.+Martin&title=Pharmacodynamics+of+the+type+II+calcimimetic+compound+cinacalcet+HCl"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl</span></div><div class="casAuthors">Nemeth, Edward F.; Heaton, William H.; Miller, Michael; Fox, John; Balandrin, Manuel F.; Van Wagenen, Bradford C.; Colloton, Mathew; Karbon, William; Scherrer, Jon; Shatzen, Edward; Rishton, Gilbert; Scully, Sheila; Qi, Meiying; Harris, Robert; Lacey, David; Martin, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">627-635</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Calcimimetic compds., which activate the parathyroid cell Ca2+ receptor (CaR) and inhibit parathyroid hormone (PTH) secretion, are under exptl. study as a treatment for hyperparathyroidism.  This report describes the salient pharmacodynamic properties, using several test systems, of a new calcimimetic compd., cinacalcet HCl.  Cinacalcet HCl increased the concn. of cytoplasmic Ca2+ ([Ca2+]i) in human embryonic kidney 293 cells expressing the human parathyroid CaR.  Cinacalcet HCl (EC50 = 51 nM) in the presence of 0.5 mM extracellular Ca2+ elicited increases in [Ca2+]i in a dose- and calcium-dependent manner.  Similarly, in the presence of 0.5 mM extracellular Ca2+, cinacalcet HCl (IC50 = 28 nM) produced a concn.-dependent decrease in PTH secretion from cultured bovine parathyroid cells.  Using rat medullary thyroid carcinoma 6-23 cells expressing the CaR, cinacalcet HCl (EC50 = 34 nM) produced a concn.-dependent increase in calcitonin secretion.  In vivo studies in rats demonstrated cinacalcet HCl is orally bioavailable and displays approx. linear pharmacokinetics over the dose range of 1 to 36 mg/kg.  Furthermore, this compd. suppressed serum PTH and blood-ionized Ca2+ levels and increased serum calcitonin levels in a dose-dependent manner.  Cinacalcet was about 30-fold more potent at lowering serum levels of PTH than it was at increasing serum calcitonin levels.  The S-enantiomer of cinacalcet (S-AMG 073) was at least 75-fold less active in these assay systems.  The present findings provide compelling evidence that cinacalcet HCl is a potent and stereoselective activator of the parathyroid CaR and, as such, might be beneficial in the treatment of hyperparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJiwFjyTkZmbVg90H21EOLACvtfcHk0lhZXavnXR2LDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlSqurg%253D&md5=c31bff7be63a9455622b387668b1cde5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.057273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.057273%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DHeaton%26aufirst%3DW.%2BH.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DVan%2BWagenen%26aufirst%3DB.%2BC.%26aulast%3DColloton%26aufirst%3DM.%26aulast%3DKarbon%26aufirst%3DW.%26aulast%3DScherrer%26aufirst%3DJ.%26aulast%3DShatzen%26aufirst%3DE.%26aulast%3DRishton%26aufirst%3DG.%26aulast%3DScully%26aufirst%3DS.%26aulast%3DQi%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DLacey%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DD.%26atitle%3DPharmacodynamics%2520of%2520the%2520type%2520II%2520calcimimetic%2520compound%2520cinacalcet%2520HCl%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D308%26spage%3D627%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span> </span><span class="NLM_article-title">Maraviroc, a chemokine CCR5 receptor antagonist for the treatment of HIV infection and AIDS</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=669-681&author=N.+A.+Meanwellauthor=J.+F.+Kadow&title=Maraviroc%2C+a+chemokine+CCR5+receptor+antagonist+for+the+treatment+of+HIV+infection+and+AIDS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DMaraviroc%252C%2520a%2520chemokine%2520CCR5%2520receptor%2520antagonist%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%2520and%2520AIDS%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D669%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span>For information on the VCNDD, see the following: <a href="http://www.vcndd.com/" class="extLink">http://www.vcndd.com/</a> (accessed August 1,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+information+on+the+VCNDD%2C+see+the+following%3A+http%3A%2F%2Fwww.vcndd.com%2F+%28accessed+August+1%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span>For information on the MLPCN and available probe compounds, see the following: <a href="https://mli.nih.gov/mli/mlpcn/" class="extLink">https://mli.nih.gov/mli/mlpcn/</a> (accessed August 1,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+information+on+the+MLPCN+and+available+probe+compounds%2C+see+the+following%3A+https%3A%2F%2Fmli.nih.gov%2Fmli%2Fmlpcn%2F+%28accessed+August+1%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. J.</span><span> </span><span class="NLM_article-title">Structural basis for control by phosphorylation</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">2209</span><span class="NLM_x">–</span> <span class="NLM_lpage">2242</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr000225s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVSis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=2209-2242&author=L.+N.+Johnsonauthor=R.+J.+Lewis&title=Structural+basis+for+control+by+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Control by Phosphorylation</span></div><div class="casAuthors">Johnson, Louise N.; Lewis, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2209-2242</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 178 refs.  Topics discussed include eukaryotic protein phosphorylation, phospho-signaling and protein/protein assocn., phosphorylation signaling order/disorder transitions and protein/protein dissocn., evolution of control of phosphorylases by phosphorylation, and prokaryotic signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJI8Pig56m7bVg90H21EOLACvtfcHk0liGU3hioMe4BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVSis74%253D&md5=f4423d804035acc474d4f309cf3af966</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcr000225s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr000225s%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520control%2520by%2520phosphorylation%26jtitle%3DChem.%2520Rev.%26date%3D2001%26volume%3D101%26spage%3D2209%26epage%3D2242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span> </span><span class="NLM_article-title">Protein phosphorylation in signaling</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2005&pages=286-290&author=T.+Pawsonauthor=J.+D.+Scott&title=Protein+phosphorylation+in+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26atitle%3DProtein%2520phosphorylation%2520in%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2005%26volume%3D30%26spage%3D286%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Protein kinases—the major drug targets of the twenty-first century?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%E2%80%94the+major+drug+targets+of+the+twenty-first+century%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases%25E2%2580%2594the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xuong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowadski, J. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2154</span><span class="NLM_x">–</span> <span class="NLM_lpage">2161</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00060a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=2154-2161&author=J.+Zhengauthor=L.+Eyckauthor=R.+Karlssonauthor=N.+Xuongauthor=S.+S.+Taylorauthor=J.+M.+Sowadski&title=Crystal+structure+of+the+catalytic+subunit+of+cAMP-dependent+protein+kinase+complexed+with+MgATP+and+peptide+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi00060a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00060a005%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DEyck%26aufirst%3DL.%26aulast%3DKarlsson%26aufirst%3DR.%26aulast%3DXuong%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DSowadski%26aufirst%3DJ.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520catalytic%2520subunit%2520of%2520cAMP-dependent%2520protein%2520kinase%2520complexed%2520with%2520MgATP%2520and%2520peptide%2520inhibitor%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D2154%26epage%3D2161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hantschel, O.</span><span> </span><span class="NLM_article-title">Structure, regulation, signaling, and targeting of Abl kinases in cancer</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1177%2F1947601912458584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=23226581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSktr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=436-446&author=O.+Hantschel&title=Structure%2C+regulation%2C+signaling%2C+and+targeting+of+Abl+kinases+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, regulation, signaling, and targeting of abl kinases in cancer</span></div><div class="casAuthors">Hantschel, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">436-446, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Abl kinases are prototypic cytoplasmic tyrosine kinases and are involved in a variety of chromosomal aberrations in different cancers.  This causes the expression of Abl fusion proteins, such as Bcr-Abl, that are constitutively activated and drivers of tumorigenesis.  Over the past decades, biochem. and functional studies on the mol. mechanisms of Abl regulation have gone hand in hand with progression of our structural understanding of autoinhibited and active Abl conformations.  In parallel, Abl oncoproteins have become prime mol. targets for cancer therapy, using ATP (ATP)-competitive kinase inhibitors, such as imatinib.  Abl-targeting drugs serve as a paradigm for our understanding of kinase inhibitor action, specificity, and resistance development.  In this review article, I will review the mol. mechanisms that are responsible for the regulation of Abl kinase activity and how oncogenic Abl fusions signal.  Furthermore, past and ongoing efforts to target Abl oncoproteins using ATP-competitive and allosteric inhibitors, as well as future possibilities using combination therapy, will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfQtqXVsETdrVg90H21EOLACvtfcHk0livwzakkYvycg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSktr7E&md5=f3b1114eb39b1f79d8d00a287d2b9a89</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1177%2F1947601912458584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601912458584%26sid%3Dliteratum%253Aachs%26aulast%3DHantschel%26aufirst%3DO.%26atitle%3DStructure%252C%2520regulation%252C%2520signaling%252C%2520and%2520targeting%2520of%2520Abl%2520kinases%2520in%2520cancer%26jtitle%3DGenes%2520Cancer%26date%3D2012%26volume%3D3%26spage%3D436%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Palmieri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giulio, R.</span><span> </span><span class="NLM_article-title">αC Helix displacement as a general approach for allosteric modulation of protein kinases</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=1-8&author=L.+Palmieriauthor=R.+Giulio&title=%CE%B1C+Helix+displacement+as+a+general+approach+for+allosteric+modulation+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmieri%26aufirst%3DL.%26aulast%3DGiulio%26aufirst%3DR.%26atitle%3D%25CE%25B1C%2520Helix%2520displacement%2520as%2520a%2520general%2520approach%2520for%2520allosteric%2520modulation%2520of%2520protein%2520kinases%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Betzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riazul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubbers, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakkaraj, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schönbrunn, E.</span><span> </span><span class="NLM_article-title">Discovery of a potential allosteric ligand binding site in CDK2</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb100410m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Gisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=492-501&author=S.+Betziauthor=A.+Riazulauthor=M.+Mathewauthor=D.+J.+Lubbersauthor=H.+Hanauthor=S.+R.+Jakkarajauthor=G.+I.+Georgauthor=E.+Sch%C3%B6nbrunn&title=Discovery+of+a+potential+allosteric+ligand+binding+site+in+CDK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potential Allosteric Ligand Binding Site in CDK2</span></div><div class="casAuthors">Betzi, Stephane; Alam, Riazul; Martin, Mathew; Lubbers, Donna J.; Han, Huijong; Jakkaraj, Sudhakar R.; Georg, Gunda I.; Schonbrunn, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">492-501</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) are key regulatory enzymes in cell cycle progression and transcription.  Aberrant activity of CDKs has been implicated in a no. of medical conditions, and numerous small mol. CDK inhibitors have been reported as potential drug leads.  However, these inhibitors exclusively bind to the ATP site, which is largely conserved among protein kinases, and clin. trials have not resulted in viable drug candidates, attributed in part to the lack of target selectivity.  CDKs are unique among protein kinases, as their functionality strictly depends on assocn. with their partner proteins, the cyclins.  In an effort to identify potential target sites for disruption of the CDK-cyclin interaction, we probed the extrinsic fluorophore 8-anilino-1-naphthalene sulfonate (ANS) with human CDK2 and cyclin A using fluorescence spectroscopy and protein crystallog.  ANS interacts with free CDK2 in a satn.-dependent manner with an apparent Kd of 37 μM, and cyclin A displaced ANS from CDK2 with an EC50 value of 0.6 μM.  Co-crystal structures with ANS alone and in ternary complex with ATP site-directed inhibitors revealed two ANS mols. bound adjacent to one another, away from the ATP site, in a large pocket that extends from the DFG region above the C-helix.  Binding of ANS is accompanied by substantial structural changes in CDK2, resulting in a C-helix conformation that is incompatible for cyclin A assocn.  These findings indicate the potential of the ANS binding pocket as a new target site for allosteric inhibitors disrupting the interaction of CDKs and cyclins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGlhg8YO4Yl7Vg90H21EOLACvtfcHk0lj6OYxA-Ju9pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Gisb4%253D&md5=893aed13b1638f7626fbb4851014fe6e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcb100410m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100410m%26sid%3Dliteratum%253Aachs%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DRiazul%26aufirst%3DA.%26aulast%3DMathew%26aufirst%3DM.%26aulast%3DLubbers%26aufirst%3DD.%2BJ.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DJakkaraj%26aufirst%3DS.%2BR.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DSch%25C3%25B6nbrunn%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520a%2520potential%2520allosteric%2520ligand%2520binding%2520site%2520in%2520CDK2%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D492%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Busschots, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Garcia, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piiper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzari, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neimanis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arencibia, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, R. M.</span><span> </span><span class="NLM_article-title">Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1016%2Fj.chembiol.2012.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=22999883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2ksbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1152-1163&author=K.+Busschotsauthor=L.+A.+Lopez-Garciaauthor=C.+Lammiauthor=A.+Strobaauthor=S.+Zeuzemauthor=A.+Piiperauthor=P.+M.+Alzariauthor=S.+Neimanisauthor=J.+M.+Arencibiaauthor=M.+Engelauthor=J.+O.+Schulzeauthor=R.+M.+Biondi&title=Substrate-selective+inhibition+of+protein+kinase+PDK1+by+small+compounds+that+bind+to+the+PIF-pocket+allosteric+docking+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site</span></div><div class="casAuthors">Busschots, Katrien; Lopez-Garcia, Laura A.; Lammi, Carmen; Stroba, Adriana; Zeuzem, Stefan; Piiper, Albrecht; Alzari, Pedro M.; Neimanis, Sonja; Arencibia, Jose M.; Engel, Matthias; Schulze, Joerg O.; Biondi, Ricardo M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1152-1163</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The PIF-pocket of AGC protein kinases participates in the physiol. mechanism of regulation by acting as a docking site for substrates and as a switch for the transduction of the conformational changes needed for activation or inhibition.  We describe the effects of compds. that bind to the PIF-pocket of PDK1.  In vitro, PS210 is a potent activator of PDK1, and the crystal structure of the PDK1-ATP-PS210 complex shows that PS210 stimulates the closure of the kinase domain.  However, in cells, the prodrug of PS210 (PS423) acts as a substrate-selective inhibitor of PDK1, inhibiting the phosphorylation and activation of S6K, which requires docking to the PIF-pocket, but not affecting PKB/Akt.  This work describes a tool to study the dynamics of PDK1 activity and a potential approach for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCik10255dpLVg90H21EOLACvtfcHk0lh3ced-_6L0ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2ksbvO&md5=8efdcf836d5d910e979a2640709c1d4e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DBusschots%26aufirst%3DK.%26aulast%3DLopez-Garcia%26aufirst%3DL.%2BA.%26aulast%3DLammi%26aufirst%3DC.%26aulast%3DStroba%26aufirst%3DA.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DPiiper%26aufirst%3DA.%26aulast%3DAlzari%26aufirst%3DP.%2BM.%26aulast%3DNeimanis%26aufirst%3DS.%26aulast%3DArencibia%26aufirst%3DJ.%2BM.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DSchulze%26aufirst%3DJ.%2BO.%26aulast%3DBiondi%26aufirst%3DR.%2BM.%26atitle%3DSubstrate-selective%2520inhibition%2520of%2520protein%2520kinase%2520PDK1%2520by%2520small%2520compounds%2520that%2520bind%2520to%2520the%2520PIF-pocket%2520allosteric%2520docking%2520site%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D1152%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Lopez-Garcia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fröhner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Süss, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navratil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindie, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, T. J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzari, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, R. M.</span><span> </span><span class="NLM_article-title">Allosteric regulation of protein kinase PKCζ by the N-terminal C1 domain and small compounds to the PIF-pocket</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1016%2Fj.chembiol.2011.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=22118680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeqs7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1463-1473&author=L.+Lopez-Garciaauthor=J.+O.+Schulzeauthor=W.+Fr%C3%B6hnerauthor=H.+Zhangauthor=E.+S%C3%BCssauthor=N.+Weberauthor=J.+Navratilauthor=S.+Amonauthor=V.+Hindieauthor=S.+Zeuzemauthor=T.+J.+D.+Jorgensenauthor=P.+M.+Alzariauthor=M.+Engelauthor=R.+M.+Biondi&title=Allosteric+regulation+of+protein+kinase+PKC%CE%B6+by+the+N-terminal+C1+domain+and+small+compounds+to+the+PIF-pocket"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Regulation of Protein Kinase PKCζ by the N-Terminal C1 Domain and Small Compounds to the PIF-Pocket</span></div><div class="casAuthors">Lopez-Garcia, Laura A.; Schulze, Joerg O.; Froehner, Wolfgang; Zhang, Hua; Suess, Evelyn; Weber, Nadja; Navratil, Jeanette; Amon, Sabine; Hindie, Valerie; Zeuzem, Stefan; Jorgensen, Thomas J. D.; Alzari, Pedro M.; Neimanis, Sonja; Engel, Matthias; Biondi, Ricardo M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1463-1473</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Protein kinases are key mediators of cellular signaling, and therefore, their activities are tightly controlled.  AGC kinases are regulated by phosphorylation and by N- and C-terminal regions.  Here, the mol. mechanism of inhibition of atypical PKCζ was studied and it was found that the inhibition by the N-terminal region cannot be explained by a simple pseudosubstrate inhibitory mechanism.  Notably, it was found that the C1 domain allosterically inhibits PKCζ activity and verified an allosteric communication between the PIF-pocket of atypical PKCs and the binding site of the C1 domain.  Finally, low-mol.-wt. compds. were developed that bind to the PIF-pocket and allosterically inhibit PKCζ activity.  This work establishes a central role for the PIF-pocket on the regulation of PKCζ and allows one to envisage development of drugs targeting the PIF-pocket that can either activate or inhibit AGC kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe4nR0hoXIfbVg90H21EOLACvtfcHk0lhSZldcxi8Jcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeqs7nF&md5=fb2fef02f710e6cd2084d5cf1bd3c6d2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Garcia%26aufirst%3DL.%26aulast%3DSchulze%26aufirst%3DJ.%2BO.%26aulast%3DFr%25C3%25B6hner%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DS%25C3%25BCss%26aufirst%3DE.%26aulast%3DWeber%26aufirst%3DN.%26aulast%3DNavratil%26aufirst%3DJ.%26aulast%3DAmon%26aufirst%3DS.%26aulast%3DHindie%26aufirst%3DV.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DJorgensen%26aufirst%3DT.%2BJ.%2BD.%26aulast%3DAlzari%26aufirst%3DP.%2BM.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DBiondi%26aufirst%3DR.%2BM.%26atitle%3DAllosteric%2520regulation%2520of%2520protein%2520kinase%2520PKC%25CE%25B6%2520by%2520the%2520N-terminal%2520C1%2520domain%2520and%2520small%2520compounds%2520to%2520the%2520PIF-pocket%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D1463%26epage%3D1473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Fischmann, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhood, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannarino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V. S.</span><span> </span><span class="NLM_article-title">Crystal structures of MEK1 binary and ternary complexes with nucleotides and inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2661</span><span class="NLM_x">–</span> <span class="NLM_lpage">2674</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi801898e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=2661-2674&author=T.+O.+Fischmannauthor=C.+K.+Smithauthor=T.+W.+Mayhoodauthor=J.+E.+Myersauthor=P.+Reichertauthor=A.+Mannarinoauthor=D.+Carrauthor=H.+Zhuauthor=J.+Wongauthor=R.-S.+Yangauthor=H.+V.+Leauthor=V.+S.+Madison&title=Crystal+structures+of+MEK1+binary+and+ternary+complexes+with+nucleotides+and+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fbi801898e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801898e%26sid%3Dliteratum%253Aachs%26aulast%3DFischmann%26aufirst%3DT.%2BO.%26aulast%3DSmith%26aufirst%3DC.%2BK.%26aulast%3DMayhood%26aufirst%3DT.%2BW.%26aulast%3DMyers%26aufirst%3DJ.%2BE.%26aulast%3DReichert%26aufirst%3DP.%26aulast%3DMannarino%26aufirst%3DA.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DR.-S.%26aulast%3DLe%26aufirst%3DH.%2BV.%26aulast%3DMadison%26aufirst%3DV.%2BS.%26atitle%3DCrystal%2520structures%2520of%2520MEK1%2520binary%2520and%2520ternary%2520complexes%2520with%2520nucleotides%2520and%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D2661%26epage%3D2674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, R.</span><span> </span><span class="NLM_article-title">Strategies for the selective regulation of kinases with allosteric modulators: exploiting exclusive structural features</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb300663j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCls7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=58-70&author=Z.+Fangauthor=G.+Christianauthor=R.+Daniel&title=Strategies+for+the+selective+regulation+of+kinases+with+allosteric+modulators%3A+exploiting+exclusive+structural+features"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural Features</span></div><div class="casAuthors">Fang, Zhizhou; Gruetter, Christian; Rauh, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-70</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The modulation of kinase function has become an important goal in modern drug discovery and chem. biol. research.  In cancer-targeted therapies, kinase inhibitors have been experiencing an upsurge, which can be measured by the increasing no. of kinase inhibitors approved by the FDA in recent years.  However, lack of efficacy, limited selectivity, and the emergence of acquired drug resistance still represent major bottlenecks in the clinic and challenge inhibitor development.  Most known kinase inhibitors target the active kinase and are ATP competitive.  A second class of small org. mols., which address remote sites of the kinase and stabilize enzymically inactive conformations, is rapidly moving to the forefront of kinase inhibitor research.  Such allosteric modulators bind to sites that are less conserved across the kinome and only accessible upon conformational changes.  These mols. are therefore thought to provide various advantages such as higher selectivity and extended drug target residence times.  This review highlights various strategies that have been developed to utilizing exclusive structural features of kinases and thereby modulating their activity allosterically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSjxxztmczXrVg90H21EOLACvtfcHk0ljfWTZ5J6wdiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCls7bN&md5=50864096bf66229ff74482a9b56847d6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcb300663j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300663j%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DChristian%26aufirst%3DG.%26aulast%3DDaniel%26aufirst%3DR.%26atitle%3DStrategies%2520for%2520the%2520selective%2520regulation%2520of%2520kinases%2520with%2520allosteric%2520modulators%253A%2520exploiting%2520exclusive%2520structural%2520features%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D58%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Hennessy, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Exploiting the PI3K/AKT pathway for cancer drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1038%2Fnrd1902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=16341064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=988-1004&author=B.+T.+Hennessyauthor=D.+L.+Smithauthor=P.+T.+Ramauthor=Y.+Luauthor=G.+B.+Mills&title=Exploiting+the+PI3K%2FAKT+pathway+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery</span></div><div class="casAuthors">Hennessy, Bryan T.; Smith, Debra L.; Ram, Prahlad T.; Lu, Yiling; Mills, Gordon B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">988-1004</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Evolving studies with several different targeted therapeutic agents are demonstrating that patients with genomic alterations of the target, including amplification, translocation and mutation, are more likely to respond to the therapy.  Recent studies indicate that numerous components of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway are targeted by amplification, mutation and translocation more frequently than any other pathway in cancer patients, with resultant activation of the pathway.  This warrants exploiting the PI3K/AKT pathway for cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq40Fg-hLrrMbVg90H21EOLACvtfcHk0ljilqe2ZTZdLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI&md5=faecabc3a6799137d133afb37d139ceb</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd1902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1902%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DB.%2BT.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRam%26aufirst%3DP.%2BT.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DExploiting%2520the%2520PI3K%252FAKT%2520pathway%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D988%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.2174%2F1568026053507714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=15853641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=109-125&author=S.+F.+Barnettauthor=M.+T.+Bilodeauauthor=C.+W.+Lindsley&title=The+Akt%2FPKB+family+of+protein+kinases%3A+a+review+of+small+molecule+inhibitors+and+progress+towards+target+validation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation</span></div><div class="casAuthors">Barnett, Stanley F.; Bilodeau, Mark T.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-125</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent advances in the development and biol. evaluation of small mol. inhibitors for the serine/threonine kinase Akt (PKB).  Akt plays a pivotal role in cell survival and proliferation through a no. of downstream effectors.  Recent studies indicate that unregulated activation of the PI3K/Akt pathway is a prominent feature of many human cancers and Akt is over-expressed or activated in all major cancers.  Akt is considered an attractive target for chemotherapy and it was postulated that inhibition of Akt alone or in combination with std. cancer chemotherapeutics will reduce the apoptotic threshold and preferentially kill cancer cells.  The development of specific and potent inhibitors will allow this hypothesis to be tested in animals.  The majority of small mol. inhibitors in this nascent field are classic ATP-competitive inhibitors which provide little specificity.  Phosphatidylinositol (PI) analogs were reported to inhibit Akt, but these inhibitors may also have specificity problems with respect to other PH domain contg. proteins and may have poor bioavailability.  None of the inhibitors in these classes were reported to have Akt isoenzyme specificity.  Recently, novel allosteric inhibitors were reported which are pleckstrin homol. domain dependent and exhibit Akt isoenzyme selectivity.  Inhibitors in this class may have sufficient potency and specificity to test for tumor efficacy in animal models and recently reported preliminary expts. are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLzMZqnXaA5bVg90H21EOLACvtfcHk0lh23x-YAU6-vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLY%253D&md5=44734cf0124197d3c4d5d9be5f7499ca</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1568026053507714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507714%26sid%3Dliteratum%253Aachs%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DThe%2520Akt%252FPKB%2520family%2520of%2520protein%2520kinases%253A%2520a%2520review%2520of%2520small%2520molecule%2520inhibitors%2520and%2520progress%2520towards%2520target%2520validation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D109%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.2174%2F156802610790980602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=20180757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFKnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=458-477&author=C.+W.+Lindsley&title=The+Akt%2FPKB+family+of+protein+kinases%3A+a+review+of+small+molecule+inhibitors+and+progress+towards+target+validation%3A+a+2009+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update</span></div><div class="casAuthors">Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-477</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent advances in the development and biol. evaluation of small mol. inhibitors for the serine/threonine kinase Akt (PKB) as a reprise of our 2005 review with new data from the 2006-2009 time period.  Akt plays a pivotal role in cell survival and proliferation through a no. of downstream effectors.  Recent studies indicate that unregulated activation of the PI3K/Akt pathway is a prominent feature of many human cancers and Akt is over-expressed or activated in all major cancers.  Akt is considered an attractive target for cancer therapy and inhibition of Akt alone or in combination with std. cancer chemotherapeutics has been postulated to reduce the apoptotic threshold and preferentially kill cancer cells.  Recently, several series of small mol., ATP-competitive inhibitors have been reported with a range of Akt potencies and selectivities.  Phosphatidylinositol (PI) analogs have been reported to inhibit Akt, but these inhibitors may also have specificity problems with respect to other pleckstrin homol. (PH) domain contg. proteins and may have poor bioavailability.  In addn., novel allosteric inhibitors have been reported which are PH domain dependent, exhibit selectivity for the individual Akt isoenzymes and inhibit the activity and the activation of Akt.  Compds. within these classes Akt inhibitors have sufficient potency and specificity which have culminated in recent reports of efficacy in tumor xenograft models.  Moreover, Merck just disclosed pos. Phase I data with an oral allosteric Akt inhibitor (MK-2206).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsF3tzEhRty7Vg90H21EOLACvtfcHk0ljgXlHw6Sdqfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFKnsr0%253D&md5=ea76a6057c31b029d0308f74dd293051</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F156802610790980602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790980602%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DThe%2520Akt%252FPKB%2520family%2520of%2520protein%2520kinases%253A%2520a%2520review%2520of%2520small%2520molecule%2520inhibitors%2520and%2520progress%2520towards%2520target%2520validation%253A%2520a%25202009%2520update%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D458%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kumar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">AKT crystal structure and AKT-specific inhibitors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">7493</span><span class="NLM_x">–</span> <span class="NLM_lpage">7501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=7493-7501&author=C.+Kumarauthor=V.+Madison&title=AKT+crystal+structure+and+AKT-specific+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DC.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DAKT%2520crystal%2520structure%2520and%2520AKT-specific%2520inhibitors%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D7493%26epage%3D7501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Cheng, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicosia, S. V.</span><span> </span><span class="NLM_article-title">The Akt/PKB pathway: molecular target for cancer drug discovery</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">7482</span><span class="NLM_x">–</span> <span class="NLM_lpage">7492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=7482-7492&author=J.+Q.+Chengauthor=C.+W.+Lindsleyauthor=G.+Z.+Chengauthor=H.+Yangauthor=S.+V.+Nicosia&title=The+Akt%2FPKB+pathway%3A+molecular+target+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DCheng%26aufirst%3DG.%2BZ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DNicosia%26aufirst%3DS.%2BV.%26atitle%3DThe%2520Akt%252FPKB%2520pathway%253A%2520molecular%2520target%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D7482%26epage%3D7492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. Q.</span><span> </span><span class="NLM_article-title">Targeting phosphatidylinositol-3 kinase/Akt pathway for cancer therapy</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1250</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1250-1258&author=D.+Kimauthor=G.+Z.+Chengauthor=C.+W.+Lindsleyauthor=H.+Yangauthor=J.+Q.+Cheng&title=Targeting+phosphatidylinositol-3+kinase%2FAkt+pathway+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DG.%2BZ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26atitle%3DTargeting%2520phosphatidylinositol-3%2520kinase%252FAkt%2520pathway%2520for%2520cancer%2520therapy%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D6%26spage%3D1250%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R.</span><span> </span><span class="NLM_article-title">Allosteric Akt (PKB) kinase inhibitors. Discovery and SAR of isozyme selective inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=761-764&author=C.+W.+Lindsleyauthor=Z.+Zhaoauthor=M.+E.+Dugganauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=H.+E.+Huberauthor=J.+R.+Huffauthor=G.+D.+Hartmanauthor=W.+Leisterauthor=A.+Kralauthor=S.+Fuauthor=P.+J.+Hancockauthor=K.+A.+Haskellauthor=R.+E.+Jonesauthor=R.+Robinson&title=Allosteric+Akt+%28PKB%29+kinase+inhibitors.+Discovery+and+SAR+of+isozyme+selective+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DKral%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DHancock%26aufirst%3DP.%2BJ.%26aulast%3DHaskell%26aufirst%3DK.%2BA.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DRobinson%26aufirst%3DR.%26atitle%3DAllosteric%2520Akt%2520%2528PKB%2529%2520kinase%2520inhibitors.%2520Discovery%2520and%2520SAR%2520of%2520isozyme%2520selective%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D761%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leander, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAvoy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span> </span><span class="NLM_article-title">Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=15713898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlersr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=271-279&author=D.+Defeo-Jonesauthor=S.+F.+Barnettauthor=S.+Fuauthor=P.+J.+Hancockauthor=K.+M.+Haskellauthor=K.+R.+Leanderauthor=E.+McAvoyauthor=C.+W.+Lindsleyauthor=M.+E.+Dugganauthor=G.+D.+Hartmanauthor=H.+E.+Huber&title=Tumor+cell+sensitization+to+apoptotic+stimuli+by+selective+inhibition+of+specific+Akt%2FPKB+family+members"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members</span></div><div class="casAuthors">DeFeo-Jones, Deborah; Barnett, Stanley F.; Fu, Sheng; Hancock, Paula J.; Haskell, Kathleen M.; Leander, Karen R.; McAvoy, Elizabeth; Robinson, Ronald G.; Duggan, Mark E.; Lindsley, Craig W.; Zhao, Zhijian; Huber, Hans E.; Jones, Raymond E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-279</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Recent studies indicate that dysregulation of the Akt/PKB family of serine/threonine kinases is a prominent feature of many human cancers.  The Akt/PKB family is composed of three members termed Akt1/PKBα, Akt2/PKB{szligbeta}, and Akt3/PKBγ.  It is currently not known to what extent there is functional overlap between these family members.  We have recently identified small mol. inhibitors of Akt.  These compds. have pleckstrin homol. domain-dependent, isoenzyme-specific activity.  In this report, we present data showing the relative contribution that inhibition of the different isoenzymes has on the apoptotic response of tumor cells to a variety of chemotherapies.  In multiple cell backgrounds, maximal induction of caspase-3 activity is achieved when both Akt1 and Akt2 are inhibited.  This induction is not reversed by overexpression of functionally active Akt3.  The level of caspase-3 activation achieved under these conditions is equiv. to that obsd. with the phosphatidylinositol-3-kinase inhibitor LY294002.  We also show that in different tumor cell backgrounds inhibition of mammalian target of rapamycin, a downstream substrate of Akt, is less effective in inducing caspase-3 activity than inhibition of Akt1 and Akt2.  This shows that the survival phenotype conferred by Akt can be mediated by signaling pathways independent of mammalian target of rapamycin in some tumor cell backgrounds.  Finally, we show that inhibition of both Akt1 and Akt2 selectively sensitizes tumor cells, but not normal cells, to apoptotic stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdte3IwUcZIrVg90H21EOLACvtfcHk0liQowQdCpDIjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlersr4%253D&md5=20dab10caeb7d4286d8bd4b1ce594a21</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DHancock%26aufirst%3DP.%2BJ.%26aulast%3DHaskell%26aufirst%3DK.%2BM.%26aulast%3DLeander%26aufirst%3DK.%2BR.%26aulast%3DMcAvoy%26aufirst%3DE.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26atitle%3DTumor%2520cell%2520sensitization%2520to%2520apoptotic%2520stimuli%2520by%2520selective%2520inhibition%2520of%2520specific%2520Akt%252FPKB%2520family%2520members%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D271%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAvoy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span> </span><span class="NLM_article-title">Identification and characterization of pleckstin-homology-domain-dependent and isoenzyme-specfic Akt inhibitors</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2005&pages=399-408&author=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=S.+Fuauthor=P.+J.+Hancockauthor=K.+M.+Haskellauthor=R.+E.+Jonesauthor=J.+A.+Kahanaauthor=A.+M.+Kralauthor=K.+Leanderauthor=L.+L.+Leeauthor=J.+Malinowskiauthor=E.+M.+McAvoyauthor=D.+D.+Nahasauthor=R.+G.+Robinsonauthor=H.+E.+Huber&title=Identification+and+characterization+of+pleckstin-homology-domain-dependent+and+isoenzyme-specfic+Akt+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DHancock%26aufirst%3DP.%2BJ.%26aulast%3DHaskell%26aufirst%3DK.%2BM.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DKahana%26aufirst%3DJ.%2BA.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DLeander%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DL.%2BL.%26aulast%3DMalinowski%26aufirst%3DJ.%26aulast%3DMcAvoy%26aufirst%3DE.%2BM.%26aulast%3DNahas%26aufirst%3DD.%2BD.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520pleckstin-homology-domain-dependent%2520and%2520isoenzyme-specfic%2520Akt%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D385%26spage%3D399%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Application of combinatorial chemistry science on modern drug discovery</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc700187t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=345-354&author=J.+P.+Kennedyauthor=L.+Williamsauthor=T.+M.+Bridgesauthor=R.+N.+Danielsauthor=C.+D.+Weaverauthor=C.+W.+Lindsley&title=Application+of+combinatorial+chemistry+science+on+modern+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Combinatorial Chemistry Science on Modern Drug Discovery</span></div><div class="casAuthors">Kennedy, J. Phillip; Williams, Lyndsey; Bridges, Thomas M.; Daniels, R. Nathan; Weaver, David; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-354</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The science that established combinatorial chem. as important new discipline in the 1980s and 1990s, has reemerged and infiltrated every subdiscipline within modern drug discovery and has profound impact.  The application of combinatorial chem. science has revolutionized high-throughput screening paradigms, chem. lead optimization, library purifn. and postpurifn. sample handling, as well as in vitro and in vivo drug metab. and pharmacokinetic assays.  Although no longer in the spotlight and heralded as the savior of the drug industry, combinatorial chem. is alive and well: actually, combinatorial chem. science is more prevalent and widespread than ever before.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_FItqaRFGt7Vg90H21EOLACvtfcHk0lhcWHoU2Jq2eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFShsLo%253D&md5=b97fdb2d165b9b8645d773edf48d44fa</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcc700187t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc700187t%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DApplication%2520of%2520combinatorial%2520chemistry%2520science%2520on%2520modern%2520drug%2520discovery%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2008%26volume%3D10%26spage%3D345%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sootome, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatsuru, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majumder, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, H.</span><span> </span><span class="NLM_article-title">MK-2206, an allosteric Akt inhibitor, enhances tumor efficacy by standard chemotherapetuic agents or molecular targetd drugs in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1956</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1158%2F1535-7163.MCT-09-1012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=20571069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFertbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1956-1967&author=H.+Hiraiauthor=H.+Sootomeauthor=Y.+Nakatsuruauthor=K.+Miyamaauthor=S.+Taguchiauthor=K.+Tsukiokaauthor=Y.+Uenoauthor=H.+Hatchauthor=P.+K.+Majumderauthor=B.-S.+Panauthor=H.+Kotani&title=MK-2206%2C+an+allosteric+Akt+inhibitor%2C+enhances+tumor+efficacy+by+standard+chemotherapetuic+agents+or+molecular+targetd+drugs+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo</span></div><div class="casAuthors">Hirai, Hiroshi; Sootome, Hiroshi; Nakatsuru, Yoko; Miyama, Katsuyoshi; Taguchi, Shunsuke; Tsujioka, Kyoko; Ueno, Yoko; Hatch, Harold; Majumder, Pradip K.; Pan, Bo-Sheng; Kotani, Hidehito</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1956-1967</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The serine/threonine kinase Akt lies at a crit. signaling node downstream of phosphatidylinositol-3-kinase and is important in promoting cell survival and inhibiting apoptosis.  An Akt inhibitor may be particularly useful for cancers in which increased Akt signaling is assocd. with reduced sensitivity to cytotoxic agents or receptor tyrosine kinase inhibitors.  We evaluated the effect of a novel allosteric Akt inhibitor, MK-2206, in combination with several anticancer agents.  In vitro, MK-2206 synergistically inhibited cell proliferation of human cancer cell lines in combination with mol. targeted agents such as erlotinib (an epidermal growth factor receptor inhibitor) or lapatinib (a dual epidermal growth factor receptor/human epidermal growth factor receptor 2 inhibitor).  Complementary inhibition of erlotinib-insensitive Akt phosphorylation by MK-2206 was one mechanism of synergism, and a synergistic effect was found even in erlotinib-insensitive cell lines.  MK-2206 also showed synergistic responses in combination with cytotoxic agents such as topoisomerase inhibitors (doxorubicin, camptothecin), antimetabolites (gemcitabine, 5-fluorouracil), anti-microtubule agents (docetaxel), and DNA cross-linkers (carboplatin) in lung NCI-H460 or ovarian A2780 tumor cells.  The synergy with docetaxel depended on the treatment sequence; a schedule of MK-2206 dosed before docetaxel was not effective.  MK-2206 suppressed the Akt phosphorylation that is induced by carboplatin and gemcitabine.  In vivo, MK-2206 in combination with these agents exerted significantly more potent tumor inhibitory activities than each agent in the monotherapy setting.  These findings suggest that Akt inhibition may augment the efficacy of existing cancer therapeutics; thus, MK-2206 is a promising agent to treat cancer patients who receive these cytotoxic and/or mol. targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPgnWgk1SeALVg90H21EOLACvtfcHk0lhcWHoU2Jq2eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFertbnL&md5=f2d97ab64963cc82d97b35697e49b172</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1012%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DSootome%26aufirst%3DH.%26aulast%3DNakatsuru%26aufirst%3DY.%26aulast%3DMiyama%26aufirst%3DK.%26aulast%3DTaguchi%26aufirst%3DS.%26aulast%3DTsukioka%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DY.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DMajumder%26aufirst%3DP.%2BK.%26aulast%3DPan%26aufirst%3DB.-S.%26aulast%3DKotani%26aufirst%3DH.%26atitle%3DMK-2206%252C%2520an%2520allosteric%2520Akt%2520inhibitor%252C%2520enhances%2520tumor%2520efficacy%2520by%2520standard%2520chemotherapetuic%2520agents%2520or%2520molecular%2520targetd%2520drugs%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1956%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Calleja, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laguerre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larijani, B.</span><span> </span><span class="NLM_article-title">Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=189-200&author=V.+Callejaauthor=M.+Laguerreauthor=B.+Larijani&title=Role+of+a+novel+PH-kinase+domain+interface+in+PKB%2FAkt+regulation%3A+structural+mechanism+for+allosteric+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalleja%26aufirst%3DV.%26aulast%3DLaguerre%26aufirst%3DM.%26aulast%3DLarijani%26aufirst%3DB.%26atitle%3DRole%2520of%2520a%2520novel%2520PH-kinase%2520domain%2520interface%2520in%2520PKB%252FAkt%2520regulation%253A%2520structural%2520mechanism%2520for%2520allosteric%2520inhibition%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D189%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Okuzumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fielder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Inhibitor hijacking of Akt activation</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1038%2Fnchembio.183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=19465931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlarsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=484-493&author=T.+Okuzumiauthor=D.+Fielderauthor=C.+Zhangauthor=D.+C.+Grayauthor=B.+Aizensteinauthor=R.+Hoffmanauthor=K.+M.+Shokat&title=Inhibitor+hijacking+of+Akt+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor hijacking of Akt activation</span></div><div class="casAuthors">Okuzumi, Tatsuya; Fiedler, Dorothea; Zhang, Chao; Gray, Daniel C.; Aizenstein, Brian; Hoffman, Randy; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">484-493</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The kinase Akt plays a central role as a regulator of multiple growth factor input signals, thus making it an attractive anticancer drug target.  A-443654 is an ATP-competitive Akt inhibitor.  Unexpectedly, treatment of cells with A-443654 causes paradoxical hyperphosphorylation of Akt at its two regulatory sites (Thr308 and Ser473).  We explored whether inhibitor-induced hyperphosphorylation of Akt by A-443654 is a consequence of disrupted feedback regulation at a pathway level or whether it is a direct consequence of inhibitor binding to the ATP binding site of Akt.  Catalytically inactive mutants of Akt revealed that binding of an inhibitor to the ATP site of Akt is sufficient to directly cause hyperphosphorylation of the kinase in the absence of any pathway feedback effects.  We conclude that ATP-competitive Akt inhibitors impart regulatory phosphorylation of their target kinase Akt.  These results provide new insights into both natural regulation of Akt activation and Akt inhibitors entering the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWNjUB9YVue7Vg90H21EOLACvtfcHk0lglqg7zXH1vBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlarsrY%253D&md5=4edb5a0457fd9378850102a6414bfdb5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.183%26sid%3Dliteratum%253Aachs%26aulast%3DOkuzumi%26aufirst%3DT.%26aulast%3DFielder%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DGray%26aufirst%3DD.%2BC.%26aulast%3DAizenstein%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DR.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DInhibitor%2520hijacking%2520of%2520Akt%2520activation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D484%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors: physiology, pharmacology and disease</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=295-322&author=C.+M.+Niswenderauthor=P.+J.+Conn&title=Metabotropic+glutamate+receptors%3A+physiology%2C+pharmacology+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DMetabotropic%2520glutamate%2520receptors%253A%2520physiology%252C%2520pharmacology%2520and%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2010%26volume%3D50%26spage%3D295%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Emmittee, K. A.</span><span> </span><span class="NLM_article-title">Recent advances in the design and development of novel negative allosteric modulators of mGlu<sub>5</sub></span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn2000266" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=411-432&author=K.+A.+Emmittee&title=Recent+advances+in+the+design+and+development+of+novel+negative+allosteric+modulators+of+mGlu5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fcn2000266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2000266%26sid%3Dliteratum%253Aachs%26aulast%3DEmmittee%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%2520and%2520development%2520of%2520novel%2520negative%2520allosteric%2520modulators%2520of%2520mGlu5%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D411%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipe, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolkenberg, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theberge, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span> </span><span class="NLM_article-title">Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.2174%2F156802606777057599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=16719816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVahsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=771-785&author=C.+W.+Lindsleyauthor=W.+D.+Shipeauthor=S.+E.+Wolkenbergauthor=C.+R.+Thebergeauthor=D.+L.+Williamsauthor=C.+Surauthor=G.+G.+Kinney&title=Progress+towards+validating+the+NMDA+receptor+hypofunction+hypothesis+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia</span></div><div class="casAuthors">Lindsley, Craig W.; Shipe, William D.; Wolkenberg, Scott E.; Theberge, Cory R.; Williams, David L., Jr.; Sur, Cyrille; Kinney, Gene G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">771-785</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent progress towards validation of the N-methyl-D-aspartate (NMDA) receptor hypofunction hypothesis of schizophrenia in preclin. models.  Schizophrenia, a complex disease characterized by pos., neg. and cognitive symptoms, affects 1% of the world population and requires lifelong, daily maintenance therapy.  For the last several decades, thinking in this field has been dominated by the hypothesis that hyperfunction of dopamine pathways played a key role in schizophrenia.  However, the therapeutic agents developed from this hypothesis have a slow onset of action and tend to improve only the pos. symptoms of the disease.  The NMDA receptor antagonist PCP has been shown to induce the pos., neg. and cognitive symptoms of schizophrenia in healthy patients and cause a resurgence of symptoms in stable patients.  These observations led to the NMDA receptor hypofunction hypothesis as an alternative theory for the underlying cause of schizophrenia.  According to this hypothesis, any agent that can potentiate NMDA receptor currents has the potential to ameliorate the symptoms of schizophrenia.  To date, NMDA receptor currents can be modulated by either direct action on modulatory sites on the NMDA receptor (i.e., the glycine co-agonist binding site) or indirectly by activation of G-protein coupled receptors (GPCRs) known to potentiate NMDA receptor function (i.e., mGluR5).  This review will discuss the NMDA receptor hypofunction hypothesis, the NMDA receptor as an emerging target for the development of novel antipsychotic agents and progress towards in vivo target validation with GlyT1 inhibitors and mGluR5 pos. allosteric modulators.  Other potential targets for modulating NMDA receptor currents (polyamine sites, muscarinic receptors, etc...) will also be addressed briefly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnRBO2B8QD-rVg90H21EOLACvtfcHk0lgYB4ZZMuN7iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVahsLw%253D&md5=4a9e3850e7b34bbb98b5a99ccc6ece07</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F156802606777057599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777057599%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DShipe%26aufirst%3DW.%2BD.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DTheberge%26aufirst%3DC.%2BR.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26atitle%3DProgress%2520towards%2520validating%2520the%2520NMDA%2520receptor%2520hypofunction%2520hypothesis%2520of%2520schizophrenia%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D771%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span> </span><span class="NLM_article-title">A family of highly selectiveallosteric modulators of the metabotropic glutamate receptor subtype 5</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=731-740&author=J.+A.+O%E2%80%99Brienauthor=W.+Lemaireauthor=T.+B.+Chenauthor=R.+S.+L.+Changauthor=M.+A.+Jacobsonauthor=S.+N.+Haauthor=C.+W.+Lindsleyauthor=H.+J.+Schaffhauserauthor=C.+Surauthor=D.+J.+Pettiboneauthor=P.+J.+Connauthor=D.+L.+Williams&title=A+family+of+highly+selectiveallosteric+modulators+of+the+metabotropic+glutamate+receptor+subtype+5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%2BB.%26aulast%3DChang%26aufirst%3DR.%2BS.%2BL.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DHa%26aufirst%3DS.%2BN.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26atitle%3DA%2520family%2520of%2520highly%2520selectiveallosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D731%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4098</span><span class="NLM_x">–</span> <span class="NLM_lpage">5101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1016%2Fj.bmcl.2008.05.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=18550372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslequro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4098-5101&author=S.+Sharmaauthor=A.+L.+Rodriguezauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Synthesis+and+SAR+of+a+mGluR5+allosteric+partial+antagonist+lead%3A+unexpected+modulation+of+pharmacology+with+slight+structural+modifications+to+a+5-%28phenylethynyl%29pyrimidine+scaffold"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: Unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold</span></div><div class="casAuthors">Sharma, Sameer; Rodriguez, Alice L.; Conn, P. Jeffrey; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4098-4101</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This Letter describes the synthesis and SAR, developed through an iterative analog library approach, of a mGluR5 allosteric partial antagonist lead based on a 5-(phenylethynyl)pyrimidine scaffold I (R = H, 3-Me, 3,5-F2, etc.).  With slight structural modifications to the distal Ph ring, analogs demonstrated a range of pharmacol. activities from mGluR5 partial antagonism to full antagonism/neg. allosteric modulation to pos. allosteric modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQBeYocKgYurVg90H21EOLACvtfcHk0liWZTe4IzGb1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslequro%253D&md5=323d229f189185ed5d237e0a6e37e9a8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.091%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520a%2520mGluR5%2520allosteric%2520partial%2520antagonist%2520lead%253A%2520unexpected%2520modulation%2520of%2520pharmacology%2520with%2520slight%2520structural%2520modifications%2520to%2520a%25205-%2528phenylethynyl%2529pyrimidine%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4098%26epage%3D5101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedrowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of molecular switches that modulate modes of mGlu5 pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4103</span><span class="NLM_x">–</span> <span class="NLM_lpage">4106</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900654c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4103-4106&author=S.+Sharmaauthor=J.+Kedrowskiauthor=A.+L.+Rodriguezauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Discovery+of+molecular+switches+that+modulate+modes+of+mGlu5+pharmacology+in+vitro+and+in+vivo+within+a+series+of+functionalized%2C+regioisomeric+2-+and+5-%28phenylethynyl%29pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm900654c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900654c%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKedrowski%26aufirst%3DJ.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520molecular%2520switches%2520that%2520modulate%2520modes%2520of%2520mGlu5%2520pharmacology%2520in%2520vitro%2520and%2520in%2520vivo%2520within%2520a%2520series%2520of%2520functionalized%252C%2520regioisomeric%25202-%2520and%25205-%2528phenylethynyl%2529pyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4103%26epage%3D4106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">“Molecular Switches” on mGluR allosteric ligands that modulate modes of pharmacology</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2403</span><span class="NLM_x">–</span> <span class="NLM_lpage">2410</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi200129s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=2403-2410&author=M.+R.+Woodauthor=C.+R.+Hopkinsauthor=J.+T.+Broganauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=%E2%80%9CMolecular+Switches%E2%80%9D+on+mGluR+allosteric+ligands+that+modulate+modes+of+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fbi200129s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200129s%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DBrogan%26aufirst%3DJ.%2BT.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3D%25E2%2580%259CMolecular%2520Switches%25E2%2580%259D%2520on%2520mGluR%2520allosteric%2520ligands%2520that%2520modulate%2520modes%2520of%2520pharmacology%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D2403%26epage%3D2410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1124%2Fjpet.103.061747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=14747613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1yhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=568-577&author=J.+A.+O%E2%80%99Brienauthor=W.+Lemaireauthor=M.+Wittmannauthor=M.+A.+Jacobsonauthor=S.+N.+Haauthor=D.+D.+Wisnoskiauthor=C.+W.+Lindsleyauthor=H.+J.+Schaffhauserauthor=B.+Roweauthor=C.+Surauthor=D.+L.+Williamsauthor=P.+J.+Conn&title=A+novel+selective+allosteric+modulator+potentiates+the+activity+of+native+metabotropic+glutamate+receptor+subtype+5+in+rat+forebrain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain</span></div><div class="casAuthors">O'Brien, Julie A.; Wei, Lemaire; Wittmann, Marion; Jacobson, Marlene A.; Ha, Sookhee N.; Wisnoski, David D.; Lindsley, Craig W.; Schaffhauser, Herve J.; Rowe, Blake; Sur, Cyrille; Duggan, Mark E.; Pettibone, Douglas J.; Conn, P. Jeffrey; Williams, David L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">568-577</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We found that N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl) methyl]phenyl}-2-hydroxybenzamide (CPPHA), is a potent and selective pos. allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5).  CPPHA alone had no agonist activity and acted as a selective pos. allosteric modulator of human and rat mGluR5.  CPPHA potentiated threshold responses to glutamate in fluorometric Ca2+ assays 7- to 8-fold with EC50 values in the 400 to 800 nM range, and at 10 μM shifted mGluR5 agonist concn.-response curves to glutamate, quisqualate, and (R,S)-3,5-dihydroxyphenylglycine (DHPG) 4- to 7-fold to the left.  The only effect of CPPHA on other mGluRs was weak inhibition of mGluR4 and 8.  Neither CPPHA nor the previously described 3,3'-difluorobenzaldazine (DFB) affected [3H]quisqualate binding to mGluR5, but although DFB partially competed for [3H]3-methoxy-5-(2-pyridinylethynyl)pyridine binding, CPPHA had no effect on the binding of this 2-methyl-6-(phenylethynyl)pyridine analog to mGluR5.  Although the binding sites for the two classes of allosteric modulators seem to be different, these different allosteric sites can modulate functionally and mechanistically similar allosteric effects.  In electrophysiol. studies of brain slice prepns., it had been previously shown that activation of mGluR5 receptors by agonists increased N-methyl-D-aspartate (NMDA) receptor currents in the CA1 region of hippocampal slices.  We found that CPPHA (10 μM) potentiated NMDA receptor currents in hippocampal slices induced by threshold levels of DHPG, whereas having no effect on these currents by itself.  Similarly, 10 μM CPPHA also potentiated mGluR5-mediated DHPG-induced depolarization of rat subthalamic nucleus neurons.  These results demonstrate that allosteric potentiation of mGluR5 increases the effect of threshold agonist concns. in native systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobhO_ZGYafZbVg90H21EOLACvtfcHk0lg9jlMRQNOkbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1yhur0%253D&md5=7240162e8c2a4f9da3e010b2bbe2142a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.061747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.061747%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DHa%26aufirst%3DS.%2BN.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DRowe%26aufirst%3DB.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520novel%2520selective%2520allosteric%2520modulator%2520potentiates%2520the%2520activity%2520of%2520native%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520in%2520rat%2520forebrain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D568%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1386</span><span class="NLM_x">–</span> <span class="NLM_lpage">1391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1386-1391&author=Z.+Zhaoauthor=D.+D.+Wisnoskiauthor=W.+Lemaireauthor=J.+A.+O%E2%80%99Brienauthor=D.+L.+Williamsauthor=M.+A.+Jacobsonauthor=C.+W.+Lindsley&title=Challenges+in+the+development+of+mGluR5+positive+allosteric+modulators%3A+the+discovery+of+CPPHA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DChallenges%2520in%2520the%2520development%2520of%2520mGluR5%2520positive%2520allosteric%2520modulators%253A%2520the%2520discovery%2520of%2520CPPHA%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1386%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 (mGluR5) that potentiate receptor function in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5825</span><span class="NLM_x">–</span> <span class="NLM_lpage">5828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049400d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5825-5828&author=C.+W.+Lindsleyauthor=D.+D.+Wisnoskiauthor=M.+E.+Dugganauthor=W.+H.+Leisterauthor=G.+D.+Hartmanauthor=J.+R.+Huffauthor=D.+L.+Williamsauthor=J.+A.+O%E2%80%99Brienauthor=W.+Lemaireauthor=C.+Surauthor=G.+G.+Kinneyauthor=P.+J.+Connauthor=M.+E.+Duggan&title=Discovery+of+positive+allosteric+modulators+for+the+metabotropic+glutamate+receptor+subtype+5+%28mGluR5%29+that+potentiate+receptor+function+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm049400d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049400d%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520positive%2520allosteric%2520modulators%2520for%2520the%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520%2528mGluR5%2529%2520that%2520potentiate%2520receptor%2520function%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5825%26epage%3D5828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Kinney, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span> </span><span class="NLM_article-title">A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1124%2Fjpet.104.079244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=15608073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=199-206&author=G.+G.+Kinneyauthor=J.+A.+O%E2%80%99Brienauthor=W.+Lemaireauthor=M.+Burnoauthor=D.+J.+Bickelauthor=M.+K.+Clementsauthor=T.+B.+Chenauthor=D.+D.+Wisnoskiauthor=C.+W.+Lindsleyauthor=P.+R.+Tillerauthor=P.+J.+Connauthor=D.+L.+Williams&title=A+novel+selective+positive+allosteric+modulator+of+metabotropic+glutamate+receptor+subtype+5+has+in+vivo+activity+and+antipsychotic-like+effects+in+rat+behavioral+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models</span></div><div class="casAuthors">Kinney, Gene G.; O'Brien, Julie A.; Lemaire, Wei; Burno, Maryann; Bickel, Denise J.; Clements, Michelle K.; Chen, Tsing-Bau; Wisnoski, David D.; Lindsley, Craig W.; Tiller, Philip R.; Smith, Sheri; Jacobson, Marlene A.; Sur, Cyrille; Duggan, Mark E.; Pettibone, Douglas J.; Conn, P. Jeffrey; Williams, David L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We found that 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) is a potent and selective pos. allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5).  In Chinese hamster ovary cells expressing human mGluR5, CDPPB potentiated threshold responses to glutamate in fluorometric Ca2+ assays more than 7-fold with an EC50 value of approx. 27 nM.  At 1 μM, CDPPB shifted mGluR5 agonist concn. response curves to glutamate, quisqualate, and (R,S)-3,5-dihydroxyphenylglycine 3- to 9-fold to the left.  At higher concns., CDPPB exhibited agonist-like activity on cells expressing mGluR5.  No other activity was obsd. on any other mGluR or cell type at concns. up to 10 μM.  CDPPB had no effect on [3H]quisqualate binding to mGluR5 but did compete for binding of [3H]methoxyPEPy, an analog of the selective mGluR5 neg. allosteric modulator MPEP.  CDPPB was found to be brain penetrant and reversed amphetamine-induced locomotor activity and amphetamine-induced deficits in prepulse inhibition in rats, two models sensitive to antipsychotic drug treatment.  These results demonstrate that pos. allosteric modulation of mGluR5 produces behavioral effects, suggesting that such modulation serves as a viable approach to increasing mGluR5 activity in vivo.  These effects are consistent with the hypothesis that allosteric potentiation of mGluR5 may provide a novel approach for development of antipsychotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5MND_DZkDL7Vg90H21EOLACvtfcHk0ljbHsKqwISEnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLg%253D&md5=371bb91ca8ac48cdf8b38c95634385da</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.079244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.079244%26sid%3Dliteratum%253Aachs%26aulast%3DKinney%26aufirst%3DG.%2BG.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DChen%26aufirst%3DT.%2BB.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DTiller%26aufirst%3DP.%2BR.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26atitle%3DA%2520novel%2520selective%2520positive%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520has%2520in%2520vivo%2520activity%2520and%2520antipsychotic-like%2520effects%2520in%2520rat%2520behavioral%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Stauffer, S. R.</span><span> </span><span class="NLM_article-title">Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGlu<sub>5</sub>)</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn2000519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFCmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=450-470&author=S.+R.+Stauffer&title=Progress+toward+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+subtype+5+%28mGlu5%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5)</span></div><div class="casAuthors">Stauffer, Shaun R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">450-470</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Review describes recent trends in the development of small mol. mGlu5 pos. allosteric modulators (PAMs).  A large body of pharmacol., genetic, electrophysiol., and in vivo behavioral evidence has accumulated over the past decade which continues to support the hypothesis and rationale for the activation of the metabotropic glutamate receptor subtype 5 (mGlu5) as a viable and promising target for the development of novel antipsychotics.  Until recently, functionally efficacious and potent mGlu5 PAMs have been somewhat structurally limited in scope and slow to emerge.  This Review will discuss efforts since late 2008 which have provided novel mGlu5 PAM chemotypes, offering ligands with a diverse range of pharmacol., physicochem., and DMPK properties that were previously unavailable.  In addn., significant biol. studies of importance in the past few years using the well established PAMs known as DFB, CPPHA, CDPPB, and ADX-47273 will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHnCTYtdTjz7Vg90H21EOLACvtfcHk0lj_3380Id-ryw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFCmsbY%253D&md5=496ce47a9c3efefdd078844493b8011e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fcn2000519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2000519%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26atitle%3DProgress%2520toward%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520%2528mGlu5%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D450%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Parmentier-Batteur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forest, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tynebor, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauré, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosahl, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span> </span><span class="NLM_article-title">Mechanism based neurotoxicity of mGlu5 positive allosteric modulators: development challenges for a promising novel antipsychotic target</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=161-173&author=S.+Parmentier-Batteurauthor=P.+H.+Hutsonauthor=K.+Menzelauthor=J.+M.+Uslanerauthor=B.+A.+Mattsonauthor=J.+A.+O%E2%80%99Brienauthor=B.+C.+Magliaroauthor=T.+Forestauthor=C.+A.+Stumpauthor=R.+M.+Tyneborauthor=N.+J.+Anthonyauthor=T.+J.+Tuckerauthor=X.+F.+Zhangauthor=R.+Gomezauthor=S.+L.+Huszarauthor=N.+Lambengauthor=H.+Faur%C3%A9author=E.+Le+Poulauthor=S.+Poliauthor=T.+W.+Rosahlauthor=J.+P.+Rocherauthor=R.+Hargreavesauthor=T.+M.+Williams&title=Mechanism+based+neurotoxicity+of+mGlu5+positive+allosteric+modulators%3A+development+challenges+for+a+promising+novel+antipsychotic+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParmentier-Batteur%26aufirst%3DS.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DMenzel%26aufirst%3DK.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DForest%26aufirst%3DT.%26aulast%3DStump%26aufirst%3DC.%2BA.%26aulast%3DTynebor%26aufirst%3DR.%2BM.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DTucker%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%2BF.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DLambeng%26aufirst%3DN.%26aulast%3DFaur%25C3%25A9%26aufirst%3DH.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DRosahl%26aufirst%3DT.%2BW.%26aulast%3DRocher%26aufirst%3DJ.%2BP.%26aulast%3DHargreaves%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26atitle%3DMechanism%2520based%2520neurotoxicity%2520of%2520mGlu5%2520positive%2520allosteric%2520modulators%253A%2520development%2520challenges%2520for%2520a%2520promising%2520novel%2520antipsychotic%2520target%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D82%26spage%3D161%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogliotti, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span> </span><span class="NLM_article-title">Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanism</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1714</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=1703-1714&author=T.+M.+Bridgesauthor=J.+R.+Rookauthor=M.+J.+Noetzelauthor=R.+D.+Morrisonauthor=Y.+Zhouauthor=R.+D.+Gogliottiauthor=P.+N.+Vinsonauthor=Z.+Xiangauthor=C.+K.+Jonesauthor=C.+M.+Niswenderauthor=C.+W.+Lindsleyauthor=S.+R.+Staufferauthor=P.+J.+Connauthor=S.+J.+Daniels&title=Biotransformation+of+a+novel+positive+allosteric+modulator+of+metabotropic+glutamate+receptor+subtype+5+contributes+to+seizure-like+adverse+events+in+rats+involving+a+receptor+agonism-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DRook%26aufirst%3DJ.%2BR.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26atitle%3DBiotransformation%2520of%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520contributes%2520to%2520seizure-like%2520adverse%2520events%2520in%2520rats%2520involving%2520a%2520receptor%2520agonism-dependent%2520mechanism%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D1703%26epage%3D1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouliot, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Unique signaling profiles of positive allosteric modulators of metabotropic mlutamate receptor subtype 5 determine differences in in vivo activity</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1016%2Fj.biopsych.2012.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=23140665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GktLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=501-509&author=J.+M.+Rookauthor=M.+J.+Noetzelauthor=W.+A.+Pouliotauthor=T.+M.+Bridgesauthor=P.+N.+Vinsonauthor=H.+P.+Choauthor=Y.+Zhouauthor=S.+R.+Staufferauthor=C.+M.+Niswenderauthor=S.+J.+Danielsauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Unique+signaling+profiles+of+positive+allosteric+modulators+of+metabotropic+mlutamate+receptor+subtype+5+determine+differences+in+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Unique Signaling Profiles of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Determine Differences in In Vivo Activity</span></div><div class="casAuthors">Rook, Jerri M.; Noetzel, Meredith J.; Pouliot, Wendy A.; Bridges, Thomas M.; Vinson, Paige N.; Cho, Hyekyung P.; Zhou, Ya; Gogliotti, Rocco D.; Manka, Jason T.; Gregory, Karen J.; Stauffer, Shaun R.; Dudek, F. Edward; Xiang, Zixiu; Niswender, Colleen M.; Daniels, J. Scott; Jones, Carrie K.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">501-509</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Metabotropic glutamate receptor subtype 5 (mGlu5) activators have emerged as a novel approach to the treatment of schizophrenia.  Pos. allosteric modulators (PAMs) of mGlu5 have generated tremendous excitement and fueled major drug discovery efforts.  Although mGlu5 PAMs have robust efficacy in preclin. models of schizophrenia, preliminary reports suggest that these compds. may induce seizure activity.  Prototypical mGlu5 PAMs do not activate mGlu5 directly but selectively potentiate activation of mGlu5 by glutamate.  This mechanism may be crit. to maintaining normal activity-dependence of mGlu5 activation and achieving optimal in vivo effects.Using specially engineered mGlu5 cell lines incorporating point mutations within the allosteric and orthosteric binding sites, as well as brain slice electrophysiol. and in vivo electroencephalog. and behavioral pharmacol., we found that some mGlu5 PAMs have intrinsic allosteric agonist activity in the absence of glutamate.  Both in vitro mutagenesis and in vivo pharmacol. studies demonstrate that VU0422465 is an agonist PAM that induces epileptiform activity and behavioral convulsions in rodents.  In contrast, VU0361747, an mGlu5 PAMs optimized to eliminate allosteric agonist activity, has robust in vivo efficacy and does not induce adverse effects at doses that yield high brain concns.Loss of the abs. dependence of mGlu5 PAMs on glutamate release for their activity can lead to severe adverse effects.  The finding that closely related mGlu5 PAMs can differ in their intrinsic agonist activity provides crit. new insights that is essential for advancing these mols. through clin. development for treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEnfOyxRj5nrVg90H21EOLACvtfcHk0ljbqr2AcFnUWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GktLrM&md5=f8aba766e4ddf4fb28b3e3166ce8cd8c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DPouliot%26aufirst%3DW.%2BA.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DUnique%2520signaling%2520profiles%2520of%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520mlutamate%2520receptor%2520subtype%25205%2520determine%2520differences%2520in%2520in%2520vivo%2520activity%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D73%26spage%3D501%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Schann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frauli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuville, P.</span><span> </span><span class="NLM_article-title">Chemical switch of a metabotropic glutamate receptor 2 silent sllosteric modulator into dual metabotropic glutamate receptor 2/3 negative/positive allosteric modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8775</span><span class="NLM_x">–</span> <span class="NLM_lpage">8779</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101069m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8775-8779&author=S.+Schannauthor=S.+Mayerauthor=C.+Franchetauthor=M.+Frauliauthor=E.+Steinbergauthor=M.+Thomasauthor=L.+Baronauthor=P.+Neuville&title=Chemical+switch+of+a+metabotropic+glutamate+receptor+2+silent+sllosteric+modulator+into+dual+metabotropic+glutamate+receptor+2%2F3+negative%2Fpositive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm101069m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101069m%26sid%3Dliteratum%253Aachs%26aulast%3DSchann%26aufirst%3DS.%26aulast%3DMayer%26aufirst%3DS.%26aulast%3DFranchet%26aufirst%3DC.%26aulast%3DFrauli%26aufirst%3DM.%26aulast%3DSteinberg%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DBaron%26aufirst%3DL.%26aulast%3DNeuville%26aufirst%3DP.%26atitle%3DChemical%2520switch%2520of%2520a%2520metabotropic%2520glutamate%2520receptor%25202%2520silent%2520sllosteric%2520modulator%2520into%2520dual%2520metabotropic%2520glutamate%2520receptor%25202%252F3%2520negative%252Fpositive%2520allosteric%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8775%26epage%3D8779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Utley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddenham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salovich, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamorano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: unexpected “molecular switch” from a closely related mGlu4 positive allosteric modulator</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6955</span><span class="NLM_x">–</span> <span class="NLM_lpage">6959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6955-6959&author=T.+Utleyauthor=D.+Haddenhamauthor=J.+M.+Salovichauthor=R.+Zamoranoauthor=P.+N.+Vinsonauthor=C.+W.+Lindsleyauthor=C.+R.+Hopkinsauthor=C.+M.+Niswender&title=Synthesis+and+SAR+of+a+novel+metabotropic+glutamate+receptor+4+%28mGlu4%29+antagonist%3A+unexpected+%E2%80%9Cmolecular+switch%E2%80%9D+from+a+closely+related+mGlu4+positive+allosteric+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUtley%26aufirst%3DT.%26aulast%3DHaddenham%26aufirst%3DD.%26aulast%3DSalovich%26aufirst%3DJ.%2BM.%26aulast%3DZamorano%26aufirst%3DR.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520a%2520novel%2520metabotropic%2520glutamate%2520receptor%25204%2520%2528mGlu4%2529%2520antagonist%253A%2520unexpected%2520%25E2%2580%259Cmolecular%2520switch%25E2%2580%259D%2520from%2520a%2520closely%2520related%2520mGlu4%2520positive%2520allosteric%2520modulator%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6955%26epage%3D6959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Digby, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamsal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebois, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding mode</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn300103e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWru7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1025-1036&author=G.+J.+Digbyauthor=T.+J.+Utleyauthor=A.+Lamsalauthor=C.+Sevelauthor=D.+J.+Shefflerauthor=E.+P.+Leboisauthor=T.+M.+Bridgesauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Chemical+modification+of+the+M%281%29+agonist+VU0364572+reveals+molecular+switches+in+pharmacology+and+a+bitopic+binding+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Modification of the M1 Agonist VU0364572 Reveals Molecular Switches in Pharmacology and a Bitopic Binding Mode</span></div><div class="casAuthors">Digby, Gregory J.; Utley, Thomas J.; Lamsal, Atin; Sevel, Christian; Sheffler, Douglas J.; Lebois, Evan P.; Bridges, Thomas M.; Wood, Michael R.; Niswender, Colleen M.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1025-1036</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously reported the discovery of VU0364572 and VU0357017 as M1-selective agonists that appear to activate M1 through actions at an allosteric site.  Previous studies have revealed that chem. scaffolds for many allosteric modulators contain mol. switches that allow discovery of allosteric antagonists and allosteric agonists or pos. allosteric modulators (PAMs) based on a single chem. scaffold.  Based on this, we initiated a series of studies to develop selective M1 allosteric antagonists based on the VU0364572 scaffold.  Interestingly, two lead antagonists identified in this series, VU0409774 and VU0409775, inhibited ACh-induced Ca2+ responses at rat M1-5 receptor subtypes, suggesting they are nonselective muscarinic antagonists.  VU0409774 and VU0409775 also completely displaced binding of the nonselective radioligand [3H]-NMS at M1 and M3 mAChRs with affinities similar to their functional IC50 values.  Finally, Schild anal. revealed that these compds. inhibit M1 responses through a fully competitive interaction at the orthosteric binding site.  This surprising finding prompted further studies to det. whether agonist activity of VU0364572 and VU0357017 may also engage in previously unappreciated actions at the orthosteric site on M1.  Surprisingly, both VU0364572 and VU0357017 completely displaced [3H]-NMS binding to the orthosteric site of M1-M5 receptors at high concns.  Furthermore, evaluation of agonist activity in systems with varying levels of receptor reserve and Furchgott anal. using a cell line expressing M1 under control of an inducible promotor was consistent with an action of these compds. as weak orthosteric partial agonists of M1.  However, consistent with previous studies suggesting actions at a site that is distinct from the orthosteric binding site, VU0364572 or VU0357017 slowed the rate of [3H]-NMS dissocn. from CHO-rM1 membranes.  Together, these results suggest that VU0364572 and VU0357017 act as bitopic ligands and that novel antagonists in this series act as competitive orthosteric site antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8v_k1NUXafLVg90H21EOLACvtfcHk0ligbBPzsCpHRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWru7fI&md5=16540c6580d192252e09013a9ffffb17</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fcn300103e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300103e%26sid%3Dliteratum%253Aachs%26aulast%3DDigby%26aufirst%3DG.%2BJ.%26aulast%3DUtley%26aufirst%3DT.%2BJ.%26aulast%3DLamsal%26aufirst%3DA.%26aulast%3DSevel%26aufirst%3DC.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DLebois%26aufirst%3DE.%2BP.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DChemical%2520modification%2520of%2520the%2520M%25281%2529%2520agonist%2520VU0364572%2520reveals%2520molecular%2520switches%2520in%2520pharmacology%2520and%2520a%2520bitopic%2520binding%2520mode%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D1025%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Luker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sargent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paine, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairaudeau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougall, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millichip, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInally, T.</span><span> </span><span class="NLM_article-title">Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acids</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3616</span><span class="NLM_x">–</span> <span class="NLM_lpage">3621</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3616-3621&author=T.+Lukerauthor=R.+Bonnertauthor=R.+Schmidtauthor=C.+Sargentauthor=S.+W.+Paineauthor=S.+Thomauthor=G.+Pairaudeauauthor=A.+Patelauthor=R.+Mohammedauthor=E.+Akamauthor=I.+Dougallauthor=A.+M.+Davisauthor=S.+Abbottauthor=I.+Millichipauthor=T.+McInally&title=Switching+between+agonists+and+antagonists+at+CRTh2+in+a+series+of+highly+potent+and+selective+biaryl+phenoxyacetic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuker%26aufirst%3DT.%26aulast%3DBonnert%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DSargent%26aufirst%3DC.%26aulast%3DPaine%26aufirst%3DS.%2BW.%26aulast%3DThom%26aufirst%3DS.%26aulast%3DPairaudeau%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DMohammed%26aufirst%3DR.%26aulast%3DAkam%26aufirst%3DE.%26aulast%3DDougall%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DAbbott%26aufirst%3DS.%26aulast%3DMillichip%26aufirst%3DI.%26aulast%3DMcInally%26aufirst%3DT.%26atitle%3DSwitching%2520between%2520agonists%2520and%2520antagonists%2520at%2520CRTh2%2520in%2520a%2520series%2520of%2520highly%2520potent%2520and%2520selective%2520biaryl%2520phenoxyacetic%2520acids%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3616%26epage%3D3621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Cheung, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haibo, Yu.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiping, Xu.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beiyan, Zou</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span> </span><span class="NLM_article-title">Discovery of a series of 2-phenyl-<i>N</i>-(2-(pyrrolidin-1-yl) phenyl) acetamides as novel molecular switches that modulate modes of Kv7. 2 (KCNQ2) channel</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6975</span><span class="NLM_x">–</span> <span class="NLM_lpage">6979</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300700v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6975-6979&author=Y.+Y.+Cheungauthor=Yu.+Haiboauthor=Xu.+Kaipingauthor=Zou+Beiyanauthor=C.+W.+Lindsleyauthor=M.+Liauthor=C.+R.+Hopkins&title=Discovery+of+a+series+of+2-phenyl-N-%282-%28pyrrolidin-1-yl%29+phenyl%29+acetamides+as+novel+molecular+switches+that+modulate+modes+of+Kv7.+2+%28KCNQ2%29+channel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm300700v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300700v%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DY.%2BY.%26aulast%3DHaibo%26aufirst%3DYu.%26aulast%3DKaiping%26aufirst%3DXu.%26aulast%3DBeiyan%26aufirst%3DZou%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%25202-phenyl-N-%25282-%2528pyrrolidin-1-yl%2529%2520phenyl%2529%2520acetamides%2520as%2520novel%2520molecular%2520switches%2520that%2520modulate%2520modes%2520of%2520Kv7.%25202%2520%2528KCNQ2%2529%2520channel%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6975%26epage%3D6979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure–function studies and structure–activity relationships</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=860-875&author=K.+J.+Gregoryauthor=M.+J.+Noetzelauthor=J.+M.+Rookauthor=P.+N.+Vinsonauthor=S.+R.+Staufferauthor=A.+L.+Rodriguezauthor=K.+A.+Emmitteauthor=C.+M.+Niswenderauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Investigating+metabotropic+glutamate+receptor+5+allosteric+modulator+cooperativity%2C+affinity%2C+and+agonism%3A+enriching+structure%E2%80%93function+studies+and+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DInvestigating%2520metabotropic%2520glutamate%2520receptor%25205%2520allosteric%2520modulator%2520cooperativity%252C%2520affinity%252C%2520and%2520agonism%253A%2520enriching%2520structure%25E2%2580%2593function%2520studies%2520and%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D860%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenthur, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruner, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrington, S. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogi, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vamos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu<sub>3</sub>) NAM probe (ML289) derived from a closely related mGlu<sub>5</sub> PAM</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3921</span><span class="NLM_x">–</span> <span class="NLM_lpage">3925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3921-3925&author=D.+J.+Shefflerauthor=C.+R.+Wenthurauthor=J.+A.+Brunerauthor=S.+J.+S.+Carringtonauthor=P.+N.+Vinsonauthor=K.+K.+Gogiauthor=A.+L.+Blobaumauthor=R.+D.+Morrisonauthor=M.+Vamosauthor=N.+D.+P.+Cosfordauthor=S.+R.+Staufferauthor=S.+J.+Danielsauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Development+of+a+novel%2C+CNS-penetrant%2C+metabotropic+glutamate+receptor+3+%28mGlu3%29+NAM+probe+%28ML289%29+derived+from+a+closely+related+mGlu5+PAM"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DWenthur%26aufirst%3DC.%2BR.%26aulast%3DBruner%26aufirst%3DJ.%2BA.%26aulast%3DCarrington%26aufirst%3DS.%2BJ.%2BS.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DGogi%26aufirst%3DK.%2BK.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DVamos%26aufirst%3DM.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDevelopment%2520of%2520a%2520novel%252C%2520CNS-penetrant%252C%2520metabotropic%2520glutamate%2520receptor%25203%2520%2528mGlu3%2529%2520NAM%2520probe%2520%2528ML289%2529%2520derived%2520from%2520a%2520closely%2520related%2520mGlu5%2520PAM%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3921%26epage%3D3925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Wenthur, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engers, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byers, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-(2-fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-hydroxypiperidin-1-yl)methanone (ML337), an mGlu<sub>3</sub> selective and CNS penetrant negative allosteric modulator (NAM)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5308</span><span class="NLM_x">–</span> <span class="NLM_lpage">5212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5308-5212&author=C.+J.+Wenthurauthor=R.+Morrisonauthor=A.+S.+Feltsauthor=K.+A.+Smithauthor=J.+L.+Engersauthor=F.+W.+Byersauthor=J.+S.+Danielsauthor=K.+A.+Emmitteauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Discovery+of+%28R%29-%282-fluoro-4-%28%28-4-methoxyphenyl%29ethynyl%29phenyl%29+%283-hydroxypiperidin-1-yl%29methanone+%28ML337%29%2C+an+mGlu3+selective+and+CNS+penetrant+negative+allosteric+modulator+%28NAM%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWenthur%26aufirst%3DC.%2BJ.%26aulast%3DMorrison%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DSmith%26aufirst%3DK.%2BA.%26aulast%3DEngers%26aufirst%3DJ.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520%2528R%2529-%25282-fluoro-4-%2528%2528-4-methoxyphenyl%2529ethynyl%2529phenyl%2529%2520%25283-hydroxypiperidin-1-yl%2529methanone%2520%2528ML337%2529%252C%2520an%2520mGlu3%2520selective%2520and%2520CNS%2520penetrant%2520negative%2520allosteric%2520modulator%2520%2528NAM%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5308%26epage%3D5212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Notartomaso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappulla, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagioni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarselli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lionetto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmaco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battaglia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Signore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span> </span><span class="NLM_article-title">Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1</span> <span class="citation_source-journal">Mol. Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1650</span><span class="NLM_x">–</span> <span class="NLM_lpage">1666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1650-1666&author=S.+Notartomasoauthor=C.+Zappullaauthor=F.+Biagioniauthor=M.+Cannellaauthor=D.+Bucciauthor=G.+Mascioauthor=P.+Scarselliauthor=F.+Fazioauthor=F.+Weiszauthor=L.+Lionettoauthor=M.+Simmacoauthor=R.+Gradiniauthor=G.+Battagliaauthor=M.+Signoreauthor=A.+Pulitiauthor=F.+Nicoletti&title=Pharmacological+enhancement+of+mGlu1+metabotropic+glutamate+receptors+causes+a+prolonged+symptomatic+benefit+in+a+mouse+model+of+spinocerebellar+ataxia+type+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNotartomaso%26aufirst%3DS.%26aulast%3DZappulla%26aufirst%3DC.%26aulast%3DBiagioni%26aufirst%3DF.%26aulast%3DCannella%26aufirst%3DM.%26aulast%3DBucci%26aufirst%3DD.%26aulast%3DMascio%26aufirst%3DG.%26aulast%3DScarselli%26aufirst%3DP.%26aulast%3DFazio%26aufirst%3DF.%26aulast%3DWeisz%26aufirst%3DF.%26aulast%3DLionetto%26aufirst%3DL.%26aulast%3DSimmaco%26aufirst%3DM.%26aulast%3DGradini%26aufirst%3DR.%26aulast%3DBattaglia%26aufirst%3DG.%26aulast%3DSignore%26aufirst%3DM.%26aulast%3DPuliti%26aufirst%3DA.%26aulast%3DNicoletti%26aufirst%3DF.%26atitle%3DPharmacological%2520enhancement%2520of%2520mGlu1%2520metabotropic%2520glutamate%2520receptors%2520causes%2520a%2520prolonged%2520symptomatic%2520benefit%2520in%2520a%2520mouse%2520model%2520of%2520spinocerebellar%2520ataxia%2520type%25201%26jtitle%3DMol.%2520Brain%26date%3D2013%26volume%3D19%26spage%3D1650%26epage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span> </span><span class="NLM_article-title">Re-exploration of the PHCCC scaffold: discovery of improved positive allosteric modulators of mGlu4</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn9000318" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivVOgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=411-419&author=R.+Williamsauthor=Y.+Zhouauthor=C.+M.+Niswenderauthor=Q.+Luoauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+R.+Hopkins&title=Re-exploration+of+the+PHCCC+scaffold%3A+discovery+of+improved+positive+allosteric+modulators+of+mGlu4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Re-exploration of the PHCCC Scaffold: Discovery of Improved Positive Allosteric Modulators of mGluR4</span></div><div class="casAuthors">Williams, Richard; Zhou, Ya; Niswender, Colleen M.; Luo, Qingwei; Conn, P. Jeffrey; Lindsley, Craig W.; Hopkins, Corey R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">411-419</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes a detailed structure-activity relation (SAR) anal. of the metabotropic glutamate receptor 4 (mGluR4) pos. allosteric modulator, (-)-N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide (PHCCC).  The authors have now developed compds. with improved potency and efficacy; in addn., compds. are presented that show selectivity for mGluR4 vs. the other mGluR subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK2WcP_RojsbVg90H21EOLACvtfcHk0liTnvSiUyIUIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivVOgu70%253D&md5=e2d43eefe332164e71002af710ba1fd8</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fcn9000318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn9000318%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DRe-exploration%2520of%2520the%2520PHCCC%2520scaffold%253A%2520discovery%2520of%2520improved%2520positive%2520allosteric%2520modulators%2520of%2520mGlu4%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D411%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engers, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogliotti, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamorano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrsion, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span> </span><span class="NLM_article-title">Discovery, synthesis, and structure–activity relationship development of a series of <i>N</i>-4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu<sub>4</sub>) with oral efficacy in an antiparkinsonian animal model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7639</span><span class="NLM_x">–</span> <span class="NLM_lpage">7647</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200956q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7639-7647&author=C.+K.+Jonesauthor=D.+W.+Engersauthor=A.+D.+Thompsonauthor=J.+R.+Fieldauthor=A.+L.+Blobaumauthor=S.+R.+Lindsleyauthor=Y.+Zhouauthor=R.+D.+Gogliottiauthor=S.+Jadhavauthor=R.+Zamoranoauthor=Y.+Smithauthor=R.+Morrsionauthor=S.+J.+Danielsauthor=C.+D.+Weaverauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+M.+Niswenderauthor=C.+R.+Hopkins&title=Discovery%2C+synthesis%2C+and+structure%E2%80%93activity+relationship+development+of+a+series+of+N-4-%282%2C5-dioxopyrrolidin-1-yl%29phenylpicolinamides+%28VU0400195%2C+ML182%29%3A+characterization+of+a+novel+positive+allosteric+modulator+of+the+metabotropic+glutamate+receptor+4+%28mGlu4%29+with+oral+efficacy+in+an+antiparkinsonian+animal+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm200956q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200956q%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DEngers%26aufirst%3DD.%2BW.%26aulast%3DThompson%26aufirst%3DA.%2BD.%26aulast%3DField%26aufirst%3DJ.%2BR.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DLindsley%26aufirst%3DS.%2BR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DJadhav%26aufirst%3DS.%26aulast%3DZamorano%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DY.%26aulast%3DMorrsion%26aufirst%3DR.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520development%2520of%2520a%2520series%2520of%2520N-4-%25282%252C5-dioxopyrrolidin-1-yl%2529phenylpicolinamides%2520%2528VU0400195%252C%2520ML182%2529%253A%2520characterization%2520of%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25204%2520%2528mGlu4%2529%2520with%2520oral%2520efficacy%2520in%2520an%2520antiparkinsonian%2520animal%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7639%26epage%3D7647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engers, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span> </span><span class="NLM_article-title">A novel class of succinimide-derived negative allosteric modulators of metabotropic glutamate receptor subtype 1 provides insight into a disconnect in activity between the rat and human receptors</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn5000343" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlKmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=597-610&author=H.+P.+Choauthor=D.+W.+Engersauthor=D.+F.+Venableauthor=C.+M.+Niswenderauthor=C.+W.+Lindsleyauthor=P.+J.+Connauthor=K.+A.+Emmitteauthor=A.+L.+Rodriguez&title=A+novel+class+of+succinimide-derived+negative+allosteric+modulators+of+metabotropic+glutamate+receptor+subtype+1+provides+insight+into+a+disconnect+in+activity+between+the+rat+and+human+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Class of Succinimide-Derived Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Provides Insight into a Disconnect in Activity between the Rat and Human Receptors</span></div><div class="casAuthors">Cho, Hyekyung P.; Engers, Darren W.; Venable, Daryl F.; Niswender, Colleen M.; Lindsley, Craig W.; Conn, P. Jeffrey; Emmitte, Kyle A.; Rodriguez, Alice L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">597-610</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent progress in the discovery of mGlu1 allosteric modulators has suggested the modulation of mGlu1 could offer possible treatment for a no. of central nervous system disorders; however, the available chemotypes are inadequate to fully investigate the therapeutic potential of mGlu1 modulation.  To address this issue, we used a fluorescence-based high-throughput screening assay to screen an allosteric modulator-biased library of compds. to generate structurally diverse mGlu1 neg. allosteric modulator hits for chem. optimization.  Herein, we describe the discovery and characterization of a novel mGlu1 chemotype.  This series of succinimide neg. allosteric modulators, exemplified by VU0410425 (I), exhibited potent inhibitory activity at rat mGlu1 but was, surprisingly, inactive at human mGlu1.  VU0410425 and a set of chem. diverse mGlu1 neg. allosteric modulators previously reported in the literature were utilized to examine this species disconnect between rat and human mGlu1 activity.  Mutation of the key transmembrane domain residue 757 and functional screening of VU0410425 and the literature compds. suggests that amino acid 757 plays a role in the activity of these compds., but the contribution of the residue is scaffold specific, ranging from crit. to minor.  The operational model of allosterism was used to est. the binding affinities of each compd. to compare to functional data.  This novel series of mGlu1 neg. allosteric modulators provides valuable insight into the pharmacol. underlying the disconnect between rat and human mGlu1 activity, an issue that must be understood to progress the therapeutic potential of allosteric modulators of mGlu1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprK6LSEGOtMrVg90H21EOLACvtfcHk0ljpk3UMSlNb-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlKmu7k%253D&md5=54af5fcfaeb7393c3a175751dde74264</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fcn5000343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn5000343%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DEngers%26aufirst%3DD.%2BW.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26atitle%3DA%2520novel%2520class%2520of%2520succinimide-derived%2520negative%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25201%2520provides%2520insight%2520into%2520a%2520disconnect%2520in%2520activity%2520between%2520the%2520rat%2520and%2520human%2520receptors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D597%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barrantes, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morriosn, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Chemical modulation of mutant mGlu1receptors derived from deleterious GRM1 mutations found in schizophrenics: development of novel mGlu1 PAMs via a “double molecular switch” of an mGlu4 PAM chemotype</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/cb500560h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500560h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.+P.+Choauthor=P.+M.+Garcia-Barrantesauthor=J.+T.+Broganauthor=C.+R.+Hopkinsauthor=C.+M.+Niswenderauthor=A.+L.+Rodriguezauthor=D.+Venableauthor=R.+D.+Morriosnauthor=M.+Bubserauthor=S.+J.+Danielsauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Chemical+modulation+of+mutant+mGlu1receptors+derived+from+deleterious+GRM1+mutations+found+in+schizophrenics%3A+development+of+novel+mGlu1+PAMs+via+a+%E2%80%9Cdouble+molecular+switch%E2%80%9D+of+an+mGlu4+PAM+chemotype&doi=10.1021%2Fcb500560h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fcb500560h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500560h%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DGarcia-Barrantes%26aufirst%3DP.%2BM.%26aulast%3DBrogan%26aufirst%3DJ.%2BT.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DVenable%26aufirst%3DD.%26aulast%3DMorriosn%26aufirst%3DR.%2BD.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DChemical%2520modulation%2520of%2520mutant%2520mGlu1receptors%2520derived%2520from%2520deleterious%2520GRM1%2520mutations%2520found%2520in%2520schizophrenics%253A%2520development%2520of%2520novel%2520mGlu1%2520PAMs%2520via%2520a%2520%25E2%2580%259Cdouble%2520molecular%2520switch%25E2%2580%259D%2520of%2520an%2520mGlu4%2520PAM%2520chemotype%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26doi%3D10.1021%2Fcb500560h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlo, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahhav, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy <i>N</i>-benzyl isatins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3445</span><span class="NLM_x">–</span> <span class="NLM_lpage">3448</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900286j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3445-3448&author=T.+M.+Bridgesauthor=J.+E.+Marloauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=S.+B.+Jahhavauthor=P.+R.+Gentryauthor=H.+P.+Choauthor=C.+D.+Weaverauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Discovery+of+the+first+highly+M5-preferring+muscarinic+acetylcholine+receptor+ligand%2C+an+M5+positive+allosteric+modulator+derived+from+a+series+of+5-trifluoromethoxy+N-benzyl+isatins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm900286j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900286j%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DMarlo%26aufirst%3DJ.%2BE.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DJahhav%26aufirst%3DS.%2BB.%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520first%2520highly%2520M5-preferring%2520muscarinic%2520acetylcholine%2520receptor%2520ligand%252C%2520an%2520M5%2520positive%2520allosteric%2520modulator%2520derived%2520from%2520a%2520series%2520of%25205-trifluoromethoxy%2520N-benzyl%2520isatins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3445%26epage%3D3448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breininger, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Chemical lead optimization of a Ppan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: Development of a potent and highly selective M1 PAM</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1972</span><span class="NLM_x">–</span> <span class="NLM_lpage">1975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1972-1975&author=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=M.+J.+Noetzelauthor=M.+L.+Breiningerauthor=P.+R.+Gentryauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Chemical+lead+optimization+of+a+Ppan+Gq+mAChR+M1%2C+M3%2C+M5+positive+allosteric+modulator+%28PAM%29+lead.+Part+II%3A+Development+of+a+potent+and+highly+selective+M1+PAM"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DBreininger%26aufirst%3DM.%2BL.%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DChemical%2520lead%2520optimization%2520of%2520a%2520Ppan%2520Gq%2520mAChR%2520M1%252C%2520M3%252C%2520M5%2520positive%2520allosteric%2520modulator%2520%2528PAM%2529%2520lead.%2520Part%2520II%253A%2520Development%2520of%2520a%2520potent%2520and%2520highly%2520selective%2520M1%2520PAM%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1972%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Mirza, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparks, R. G.</span><span> </span><span class="NLM_article-title">Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1111%2Fj.1527-3458.2003.tb00247.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=12847557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsl2qt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=159-186&author=N.+R.+Mirzaauthor=D.+Petersauthor=R.+G.+Sparks&title=Xanomeline+and+the+antipsychotic+potential+of+muscarinic+receptor+subtype+selective+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists</span></div><div class="casAuthors">Mirza, Naheed R.; Peters, Dan; Sparks, Robin G.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drug Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-186</span>CODEN:
                <span class="NLM_cas:coden">CDREFB</span>;
        ISSN:<span class="NLM_cas:issn">1080-563X</span>.
    
            (<span class="NLM_cas:orgname">Neva Press</span>)
        </div><div class="casAbstract">A review.  Binding studies initially suggested that the muscarinic agonist, xanomeline, was a subtype selective muscarinic M1 receptor agonist, and a potential new treatment for Alzheimer's disease.  However, later in vitro and in vivo functional studies suggest that this compd. is probably better described as a subtype selective M1/M4 muscarinic receptor agonist.  This subtype selectivity profile has been claimed to explain the limited classical cholinomimetic side effects, particularly gastrointestinal, seen with xanomeline in animals.  However, in both healthy volunteers and Alzheimer's patients many of these side effects have been reported for xanomeline and in the patient population this led to a >50% discontinuation rate.  Clearly, the preclin. studies have not been able to predict this adverse profile of xanomeline, and this suggests that either xanomeline is not as subtype selective as predicted from preclin. research or that there are differences between humans and animals with regard to muscarinic receptors.  Nevertheless, in Alzheimer's patients xanomeline dose-dependently improves aspects of behavioral disturbance and social behavior including a redn. in hallucinations, agitation, delusions, vocal outbursts and suspiciousness.  The effects on cognition are not as robust and mainly seen at the highest doses tested.  These effects in Alzheimer's patients have given impetus to the suggestion that muscarinic agonists have potential antipsychotic effects.  The current review assesses the antipsychotic profile of xanomeline within the framework of the limited clin. studies with cholinergic agents in man, and the preclin. research on xanomeline using various models commonly used for the assessment of new antipsychotic drugs.  In general, xanomeline has an antipsychotic-like profile in various dopamine models of psychosis and this agrees with the known interactions between the cholinergic and dopaminergic systems in the brain.  Moreover, current data suggests that the actions of xanomeline at the M4 muscarinic receptor subtype might mediate its antidopaminergic effects.  Particularly intriguing are studies showing that xanomeline, even after acute administration, selectively inhibits the firing of mesolimbic dopamine cells relative to dopamine cell bodies projecting to the striatum.  This data suggest that xanomeline would have a faster onset of action compared to current antipsychotics and would not induce extrapyramidal side effects.  The preclin. data on the whole are promising for an antipsychotic-like profile.  If in a new formulation (i.e., transdermal) xanomeline has less adverse effects, this drug may be valuable in the treatment of patients with psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvVnKMP2LfgbVg90H21EOLACvtfcHk0ljP0hicic-rJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsl2qt7o%253D&md5=cf96dec926979e17599b2673a49f11c2</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2003.tb00247.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2003.tb00247.x%26sid%3Dliteratum%253Aachs%26aulast%3DMirza%26aufirst%3DN.%2BR.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DSparks%26aufirst%3DR.%2BG.%26atitle%3DXanomeline%2520and%2520the%2520antipsychotic%2520potential%2520of%2520muscarinic%2520receptor%2520subtype%2520selective%2520agonists%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2003%26volume%3D9%26spage%3D159%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawawy, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lah, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Novel selective allosteric activator of the M<sub>1</sub> muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">10422</span><span class="NLM_x">–</span> <span class="NLM_lpage">10433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1523%2FJNEUROSCI.1850-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=18842902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=10422-10433&author=C.+K.+Jonesauthor=A.+E.+Bradyauthor=A.+A.+Davisauthor=Z.+Xiangauthor=M.+Bubserauthor=M.+N.+Tawawyauthor=A.+S.+Kaneauthor=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=S.+R.+Bradleyauthor=T.+E.+Petersonauthor=M.+S.+Ansariauthor=R.+M.+Baldwinauthor=R.+M.+Kesslerauthor=A.+Y.+Deutchauthor=J.+L.+Lahauthor=A.+I.+Leveyauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Novel+selective+allosteric+activator+of+the+M1+muscarinic+acetylcholine+receptor+regulates+amyloid+processing+and+produces+antipsychotic-like+activity+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span></div><div class="casAuthors">Jones, Carrie K.; Brady, Ashley E.; Davis, Albert A.; Xiang, Zixiu; Bubser, Michael; Tantawy, Mohammed Noor; Kane, Alexander S.; Bridges, Thomas M.; Kennedy, J. Phillip; Bradley, Stefania R.; Peterson, Todd E.; Ansari, M. Sib; Baldwin, Ronald M.; Kessler, Robert M.; Deutch, Ariel Y.; Lah, James J.; Levey, Allan I.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10422-10433</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies suggest that subtype-selective activators of M1/M4 muscarinic acetylcholine receptors (mAChRs) may offer a novel approach for the treatment of psychotic symptoms assocd. with schizophrenia and Alzheimer's disease.  Previously developed muscarinic agonists have provided clin. data in support of this hypothesis, but failed in clin. development because of a lack of true subtype specificity and adverse effects assocd. with activation of other mAChR subtypes.  We now report characterization of a novel highly selective agonist for the M1 receptor with no agonist activity at any of the other mAChR subtypes, termed TBPB [1-((1'-2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one].  Mutagenesis and mol. pharmacol. studies revealed that TBPB activates M1 through an allosteric site rather than the orthosteric acetylcholine binding site, which is likely crit. for its unprecedented selectivity.  Whole-cell patch-clamp recordings demonstrated that activation of M1 by TBPB potentiates NMDA receptor currents in hippocampal pyramidal cells but does not alter excitatory or inhibitory synaptic transmission, responses thought to be mediated by M2 and M4.  TBPB was efficacious in models predictive of antipsychotic-like activity in rats at doses that did not produce catalepsy or peripheral adverse effects of other mAChR agonists.  Finally, TBPB had effects on the processing of the amyloid precursor protein toward the non-amyloidogenic pathway and decreased Aβ prodn. in vitro.  Together, these data suggest that selective activation of M1 may provide a novel approach for the treatment of symptoms assocd. with schizophrenia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5LP3cEBPDvbVg90H21EOLACvtfcHk0lgEZIKlNrLhcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF&md5=25b306eb2aa00bdce1c08ad24bd59b35</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1850-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1850-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DTawawy%26aufirst%3DM.%2BN.%26aulast%3DKane%26aufirst%3DA.%2BS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DBradley%26aufirst%3DS.%2BR.%26aulast%3DPeterson%26aufirst%3DT.%2BE.%26aulast%3DAnsari%26aufirst%3DM.%2BS.%26aulast%3DBaldwin%26aufirst%3DR.%2BM.%26aulast%3DKessler%26aufirst%3DR.%2BM.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26aulast%3DLah%26aufirst%3DJ.%2BL.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520selective%2520allosteric%2520activator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520regulates%2520amyloid%2520processing%2520and%2520produces%2520antipsychotic-like%2520activity%2520in%2520rats%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D10422%26epage%3D10433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Lebois, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meiler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M<sub>1</sub> receptor function in the central nervous system</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn900003h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKms7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=104-121&author=E.+P.+Leboisauthor=T.+M.+Bridgesauthor=M.+L.+Lewisauthor=E.+S.+Dawsonauthor=A.+S.+Kaneauthor=Z.+Xiangauthor=S.+B.+Jadhavauthor=H.+Yinauthor=J.+P.+Kennedyauthor=J.+Meilerauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+D.+Weaverauthor=C.+W.+Lindsley&title=Discovery+and+characterization+of+novel+subtype-selective+allosteric+agonists+for+the+investigation+of+M1+receptor+function+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of Novel Subtype-Selective Allosteric Agonists for the Investigation of M1 Receptor Function in the Central Nervous System</span></div><div class="casAuthors">Lebois, Evan P.; Bridges, Thomas M.; Lewis, L. Michelle; Dawson, Eric S.; Kane, Alexander S.; Xiang, Zixiu; Jadhav, Satyawan B.; Yin, Huiyong; Kennedy, J. Phillip; Meiler, Jens; Niswender, Colleen M.; Jones, Carrie K.; Conn, P. Jeffrey; Weaver, C. David; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">104-121</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cholinergic transmission in the forebrain is mediated primarily by five subtypes of muscarinic acetylcholine receptors (mAChRs), termed M1-M5.  Of the mAChR subtypes, M1 is among the most heavily expressed in regions that are crit. for learning and memory and has been viewed as the most crit. mAChR subtype for memory and attention mechanisms.  Unfortunately, it has been difficult to develop selective activators of M1 and other individual mAChR subtypes, which has prevented detailed studies of the functional roles of selective activation of M1.  Using a functional high-throughput screening and subsequent diversity-oriented synthesis approach, the authors have discovered a novel series of highly selective M1 allosteric agonists.  These compds. activate M1 with EC50 values in the 150-500 nM range and have unprecedented, clean ancillary pharmacol. (no substantial activity at 10 μM across a large panel of targets).  Targeted mutagenesis revealed a potentially novel allosteric binding site in the third extracellular loop of the M1 receptor for these allosteric agonists.  Optimized compds., such as VU0357017, provide excellent brain exposure after systemic dosing and have robust in vivo efficacy in reversing scopolamine-induced deficits in a rodent model of contextual fear conditioning.  This series of selective M1 allosteric agonists provides crit. research tools to allow dissection of M1-mediated effects in the CNS and potential leads for novel treatments for Alzheimer's disease and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoobcQ3CSd337Vg90H21EOLACvtfcHk0lgEZIKlNrLhcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKms7vJ&md5=7395771d4a98649d299da7530d807b9e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fcn900003h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn900003h%26sid%3Dliteratum%253Aachs%26aulast%3DLebois%26aufirst%3DE.%2BP.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DLewis%26aufirst%3DM.%2BL.%26aulast%3DDawson%26aufirst%3DE.%2BS.%26aulast%3DKane%26aufirst%3DA.%2BS.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DJadhav%26aufirst%3DS.%2BB.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520novel%2520subtype-selective%2520allosteric%2520agonists%2520for%2520the%2520investigation%2520of%2520M1%2520receptor%2520function%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D104%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarr, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrington, S. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digby, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisewnder, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Further exploration of M<sub>1</sub> allosteric agonists: subtle structural changes abolish M<sub>1</sub> allosteric agonism and result in pan-mAChR orthosteric antagonism</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=223-227&author=D.+J.+Shefflerauthor=C.+Sevelauthor=U.+Leauthor=K.+M.+Lovellauthor=J.+C.+Tarrauthor=S.+J.+S.+Carringtonauthor=H.+P.+Choauthor=G.+J.+Digbyauthor=C.+M.+Nisewnderauthor=P.+J.+Connauthor=C.+R.+Hopkinsauthor=M.+R.+Woodauthor=C.+W.+Lindsley&title=Further+exploration+of+M1+allosteric+agonists%3A+subtle+structural+changes+abolish+M1+allosteric+agonism+and+result+in+pan-mAChR+orthosteric+antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DSevel%26aufirst%3DC.%26aulast%3DLe%26aufirst%3DU.%26aulast%3DLovell%26aufirst%3DK.%2BM.%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DCarrington%26aufirst%3DS.%2BJ.%2BS.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DDigby%26aufirst%3DG.%2BJ.%26aulast%3DNisewnder%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DFurther%2520exploration%2520of%2520M1%2520allosteric%2520agonists%253A%2520subtle%2520structural%2520changes%2520abolish%2520M1%2520allosteric%2520agonism%2520and%2520result%2520in%2520pan-mAChR%2520orthosteric%2520antagonism%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D223%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Digby, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebois, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemirovsky, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennenga, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bimonte-Nelson, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Italiano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrsion, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olive, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Novel allosteric agonists of M<sub>1</sub> muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">8532</span><span class="NLM_x">–</span> <span class="NLM_lpage">8544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1523%2FJNEUROSCI.0337-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=22723693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2iu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=8532-8544&author=G.+J.+Digbyauthor=M.+J.+Noetzelauthor=M.+Bubserauthor=T.+J.+Utleyauthor=A.+G.+Walkerauthor=N.+E.+Byunauthor=E.+P.+Leboisauthor=Z.+Xiangauthor=D.+J.+Shefflerauthor=H.+P.+Choauthor=A.+A.+Davisauthor=N.+E.+Nemirovskyauthor=S.+E.+Mennengaauthor=B.+W.+Campauthor=H.+A.+Bimonte-Nelsonauthor=J.+Bodeauthor=K.+Italianoauthor=R.+Morrsionauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=M.+F.+Oliveauthor=C.+W.+Lindsleyauthor=C.+K.+Jonesauthor=P.+J.+Conn&title=Novel+allosteric+agonists+of+M1+muscarinic+acetylcholine+receptors+induce+brain+region-specific+responses+that+correspond+with+behavioral+effects+in+animal+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models</span></div><div class="casAuthors">Digby, Gregory J.; Noetzel, Meredith J.; Bubser, Michael; Utley, Thomas J.; Walker, Adam G.; Byun, Nellie E.; Lebois, Evan P.; Xiang, Zixiu; Sheffler, Douglas J.; Cho, Hyekyung P.; Davis, Albert A.; Nemirovsky, Natali E.; Mennenga, Sarah E.; Camp, Bryan W.; Bimonte-Nelson, Heather A.; Bode, Jacob; Italiano, Kimberly; Morrison, Ryan; Daniels, J. Scott; Niswender, Colleen M.; Olive, M. Foster; Lindsley, Craig W.; Jones, Carrie K.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8532-8544</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">M1 muscarinic acetylcholine receptors (mAChRs) represent a viable target for treatment of multiple disorders of the central nervous system (CNS) including Alzheimer's disease and schizophrenia.  The recent discovery of highly selective allosteric agonists of M1 receptors has provided a major breakthrough in developing a viable approach for the discovery of novel therapeutic agents that target these receptors.  Here we describe the characterization of two novel M1 allosteric agonists, VU0357017 and VU0364572, that display profound differences in their efficacy in activating M1 coupling to different signaling pathways including Ca2+ and β-arrestin responses.  Interestingly, the ability of these agents to differentially activate coupling of M1 to specific signaling pathways leads to selective actions on some but not all M1-mediated responses in brain circuits.  These novel M1 allosteric agonists induced robust electrophysiol. effects in rat hippocampal slices, but showed lower efficacy in striatum and no measureable effects on M1-mediated responses in medial prefrontal cortical pyramidal cells in mice.  Consistent with these actions, both M1 agonists enhanced acquisition of hippocampal-dependent cognitive function but did not reverse amphetamine-induced hyperlocomotion in rats.  Together, these data reveal that M1 allosteric agonists can differentially regulate coupling of M1 to different signaling pathways, and this can dramatically alter the actions of these compds. on specific brain circuits important for learning and memory and psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh138Eac3vNrVg90H21EOLACvtfcHk0lgWcDC-29LfFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2iu7w%253D&md5=6278ee1366f8e159729c23ef8ecc880d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0337-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0337-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DDigby%26aufirst%3DG.%2BJ.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DUtley%26aufirst%3DT.%2BJ.%26aulast%3DWalker%26aufirst%3DA.%2BG.%26aulast%3DByun%26aufirst%3DN.%2BE.%26aulast%3DLebois%26aufirst%3DE.%2BP.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DNemirovsky%26aufirst%3DN.%2BE.%26aulast%3DMennenga%26aufirst%3DS.%2BE.%26aulast%3DCamp%26aufirst%3DB.%2BW.%26aulast%3DBimonte-Nelson%26aufirst%3DH.%2BA.%26aulast%3DBode%26aufirst%3DJ.%26aulast%3DItaliano%26aufirst%3DK.%26aulast%3DMorrsion%26aufirst%3DR.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DOlive%26aufirst%3DM.%2BF.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520allosteric%2520agonists%2520of%2520M1%2520muscarinic%2520acetylcholine%2520receptors%2520induce%2520brain%2520region-specific%2520responses%2520that%2520correspond%2520with%2520behavioral%2520effects%2520in%2520animal%2520models%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D8532%26epage%3D8544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graufelds, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCampbell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shughrue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danziger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascarella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span> </span><span class="NLM_article-title">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">15950</span><span class="NLM_x">–</span> <span class="NLM_lpage">15955</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1073%2Fpnas.0900903106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=19717450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15950-15955&author=L.+Maauthor=M.+A.+Seagerauthor=M.+Wittmannauthor=M.+Jacobsonauthor=D.+Bickelauthor=M.+Burnoauthor=K.+Jonesauthor=V.+K.+Graufeldsauthor=G.+Xuauthor=M.+Pearsonauthor=A.+McCampbellauthor=R.+Gasparauthor=P.+Shughrueauthor=A.+Danzigerauthor=C.+Reganauthor=R.+Flickauthor=D.+Pascarellaauthor=S.+Garsonauthor=S.+Doranauthor=C.+Kreatsoulasauthor=L.+Vengauthor=C.+W.+Lindsleyauthor=W.+Shipeauthor=S.+Kudukauthor=C.+Surauthor=G.+Kinneyauthor=G.+R.+Seabrookauthor=W.+J.+Ray&title=Selective+activation+of+the+M1+muscarinic+acetylcholine+receptor+achieved+by+allosteric+potentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span></div><div class="casAuthors">Ma, Lei; Seager, Matthew; Wittmann, Marion; Jacobson, Marlene; Bickel, Denise; Burno, Maryann; Jones, Keith; Graufelds, Valerie Kuzmick; Xu, Guangping; Pearson, Michelle; McCampbell, Alexander; Gaspar, Renee; Shughrue, Paul; Danziger, Andrew; Regan, Christopher; Flick, Rose; Pascarella, Danette; Garson, Susan; Doran, Scott; Kreatsoulas, Constantine; Veng, Lone; Lindsley, Craig W.; Shipe, William; Kuduk, Scott; Sur, Cyrille; Kinney, Gene; Seabrook, Guy R.; Ray, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">15950-15955, S15950/1-S15950/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The forebrain cholinergic system promotes higher brain function in part by signaling through the M, muscarinic acetylcholine receptor (mAChR).  During Alzheimer's disease (AD), these cholinergic neurons degenerate, therefore selectively activating M1 receptors could improve cognitive function in these patients while avoiding unwanted peripheral responses assocd. with non-selective muscarinic agonists.  We describe here benzyl quinolone carboxylic acid (BQCA), a highly selective allosteric potentiator of the M1 mAChR.  BQCA reduces the concn. of ACh required to activate M1 up to 129-fold with an inflection point value of 845 nM.  No potentiation, agonism, or antagonism activity on other mAChRs is obsd. up to 100 ArM.  Furthermore studies in M1-/- mice demonstrates that BQCA requires M1 to promote inositol phosphate turnover in primary neurons and to increase c-fos and arc RNA expression and ERK phosphorylation in the brain.  Radioligand-binding assays, mol. modeling, and site-directed mutagenesis expts. indicate that BQCA acts at an allosteric site involving residues Y179 and W400.  BQCA reverses scopolamine-induced memory deficits in contextual fear conditioning, increases blood flow to the cerebral cortex, and increases wakefulness while reducing delta sleep.  In contrast to M1 allosteric agonists, which do not improve memory in scopolamine-challenged mice in contextual fear conditioning, BQCA induces 13-arrestin recruitment to M1, suggesting a role for this signal transduction mechanism in the cholinergic modulation of memory.  In summary, BQCA exploits an allosteric potentiation mechanism to provide selectivity for the M1 receptor and represents a promising therapeutic strategy for cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0SGRL-coGErVg90H21EOLACvtfcHk0lh6GbPJ0QzL1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL&md5=4470732fd762f761a18d2bc96220dcb1</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900903106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900903106%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DGraufelds%26aufirst%3DV.%2BK.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcCampbell%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DDanziger%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DFlick%26aufirst%3DR.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DShipe%26aufirst%3DW.%26aulast%3DKuduk%26aufirst%3DS.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520achieved%2520by%2520allosteric%2520potentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D15950%26epage%3D15955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Tarr, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turlington, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pancani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Targeting selective activation of M<sub>1</sub> for the treatment of Alzheimer’s disease: further chemical optimization and pharmacological characterization of the M<sub>1</sub> positive allosteric modulator ML169</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn300068s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=884-895&author=J.+C.+Tarrauthor=M.+L.+Turlingtonauthor=P.+R.+Reidauthor=T.+J.+Utleyauthor=D.+J.+Shefflerauthor=H.+P.+Choauthor=R.+Klarauthor=T.+Pancaniauthor=M.+T.+Kleinauthor=T.+M.+Bridgesauthor=R.+D.+Morrisonauthor=A.+L.+Blobaumauthor=Z.+Xiangauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=M.+R.+Woodauthor=C.+W.+Lindsley&title=Targeting+selective+activation+of+M1+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+further+chemical+optimization+and+pharmacological+characterization+of+the+M1+positive+allosteric+modulator+ML169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Selective Activation of M1 for the Treatment of Alzheimer's Disease: Further Chemical Optimization and Pharmacological Characterization of the M1 Positive Allosteric Modulator ML169</span></div><div class="casAuthors">Tarr, James C.; Turlington, Mark L.; Reid, Paul R.; Utley, Thomas J.; Sheffler, Douglas J.; Cho, Hyekyung P.; Klar, Rebecca; Pancani, Tristano; Klein, Michael T.; Bridges, Thomas M.; Morrison, Ryan D.; Blobaum, Anna L.; Xiang, Zixui; Daniels, J. Scott; Niswender, Colleen M.; Conn, P. Jeffrey; Wood, Michael R.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">884-895</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The M1 muscarinic acetylcholine receptor is thought to play an important role in memory and cognition, making it a potential target for the treatment of Alzheimer's disease (AD) and schizophrenia.  Moreover, M1 interacts with BACE1 and regulates its proteasomal degrdn., suggesting selective M1 activation could afford both palliative cognitive benefit as well as disease modification in AD.  A key challenge in targeting the muscarinic acetylcholine receptors is achieving mAChR subtype selectivity.  Our lab has previously reported the M1 selective pos. allosteric modulator ML169.  Herein we describe our efforts to further optimize this lead compd. by prepg. analog libraries and probing novel scaffolds.  We were able to identify several analogs that possessed submicromolar potency, with our best example displaying an EC50 of 310 nM.  The new compds. maintained complete selectivity for the M1 receptor over the other subtypes (M2-M5), displayed improved DMPK profiles, and potentiated the carbachol (CCh)-induced excitation in striatal MSNs.  Selected analogs were able to potentiate CCh-mediated non-amyloidogenic APPα release, further strengthening the concept that M1 PAMs may afford a disease-modifying role in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1gJudWdQ8i7Vg90H21EOLACvtfcHk0lh6GbPJ0QzL1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7jI&md5=dd85b45664febaaa063a2c53d5379c50</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fcn300068s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300068s%26sid%3Dliteratum%253Aachs%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DTurlington%26aufirst%3DM.%2BL.%26aulast%3DReid%26aufirst%3DP.%2BR.%26aulast%3DUtley%26aufirst%3DT.%2BJ.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DKlar%26aufirst%3DR.%26aulast%3DPancani%26aufirst%3DT.%26aulast%3DKlein%26aufirst%3DM.%2BT.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DTargeting%2520selective%2520activation%2520of%2520M1%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520further%2520chemical%2520optimization%2520and%2520pharmacological%2520characterization%2520of%2520the%2520M1%2520positive%2520allosteric%2520modulator%2520ML169%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D884%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Byun, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grannan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosanelli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowrishankar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelm, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melancon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarr, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1578</span><span class="NLM_x">–</span> <span class="NLM_lpage">1593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=1578-1593&author=N.+E.+Byunauthor=M.+Grannanauthor=M.+Bubserauthor=R.+L.+Barryauthor=A.+Thompsonauthor=J.+Rosanelliauthor=R.+Gowrishankarauthor=N.+D.+Kelmauthor=S.+Damonauthor=T.+M.+Bridgesauthor=B.+J.+Melanconauthor=J.+C.+Tarrauthor=J.+T.+Broganauthor=M.+J.+Avisonauthor=A.+Y.+Deutchauthor=J.+Wessauthor=M.+R.+Woodauthor=C.+W.+Lindsleyauthor=J.+C.+Goreauthor=P.+J.+Connauthor=C.+K.+Jones&title=Antipsychotic+drug-like+effects+of+the+selective+M4+muscarinic+acetylcholine+receptor+positive+allosteric+modulator+VU0152100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DByun%26aufirst%3DN.%2BE.%26aulast%3DGrannan%26aufirst%3DM.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DBarry%26aufirst%3DR.%2BL.%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DRosanelli%26aufirst%3DJ.%26aulast%3DGowrishankar%26aufirst%3DR.%26aulast%3DKelm%26aufirst%3DN.%2BD.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DBrogan%26aufirst%3DJ.%2BT.%26aulast%3DAvison%26aufirst%3DM.%2BJ.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DGore%26aufirst%3DJ.%2BC.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DAntipsychotic%2520drug-like%2520effects%2520of%2520the%2520selective%2520M4%2520muscarinic%2520acetylcholine%2520receptor%2520positive%2520allosteric%2520modulator%2520VU0152100%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D1578%26epage%3D1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dencker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grannan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/cn500128b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500128b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Bubserauthor=T.+M.+Bridgesauthor=D.+Denckerauthor=R.+W.+Gouldauthor=M.+D.+Grannanauthor=J.+Wesauthor=M.+E.+Dugganauthor=J.+Dunlopauthor=M.+R.+Woodauthor=C.+W.+Lindsleyauthor=P.+J.+Connauthor=C.+K.+Jones&title=Selective+activation+of+M4+muscarinic+acetylcholine+receptors+reverses+MK-801-induced+behavioral+impairments+and+enhances+associative+learning+in+rodents&doi=10.1021%2Fcn500128b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fcn500128b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500128b%26sid%3Dliteratum%253Aachs%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DDencker%26aufirst%3DD.%26aulast%3DGould%26aufirst%3DR.%2BW.%26aulast%3DGrannan%26aufirst%3DM.%2BD.%26aulast%3DWes%26aufirst%3DJ.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DSelective%2520activation%2520of%2520M4%2520muscarinic%2520acetylcholine%2520receptors%2520reverses%2520MK-801-induced%2520behavioral%2520impairments%2520and%2520enhances%2520associative%2520learning%2520in%2520rodents%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26doi%3D10.1021%2Fcn500128b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Dore, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okrasa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Vega, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazayeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiggin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span> </span><span class="NLM_article-title">Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">511</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1038%2Fnature13396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=25042998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ChurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2014&pages=557-562&author=A.+S.+Doreauthor=K.+Okrasaauthor=J.+C.+Patelauthor=M.+Serrano-Vegaauthor=K.+Bennettauthor=R.+M.+Cookeauthor=J.+C.+Erreyauthor=A.+Jazayeriauthor=S.+Khanauthor=B.+Tehanauthor=M.+Weirauthor=G.+R.+Wigginauthor=F.+H.+Marshall&title=Structure+of+class+C+GPCR+metabotropic+glutamate+receptor+5+transmembrane+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain</span></div><div class="casAuthors">Dore, Andrew S.; Okrasa, Krzysztof; Patel, Jayesh C.; Serrano-Vega, Maria; Bennett, Kirstie; Cooke, Robert M.; Errey, James C.; Jazayeri, Ali; Khan, Samir; Tehan, Ben; Weir, Malcolm; Wiggin, Giselle R.; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">7511</span>),
    <span class="NLM_cas:pages">557-562</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metabotropic glutamate receptors are class C G-protein-coupled receptors which respond to the neurotransmitter glutamate.  Structural studies have been restricted to the amino-terminal extracellular domain, providing little understanding of the membrane-spanning signal transduction domain.  Metabotropic glutamate receptor 5 (mGlu5 receptor) is of considerable interest as a drug target in the treatment of fragile X syndrome, autism, depression, anxiety, addiction and movement disorders.  Here we report the crystal structure of the transmembrane domain of the human receptor in complex with the neg. allosteric modulator, mavoglurant.  The structure provides detailed insight into the architecture of the transmembrane domain of class C receptors including the precise location of the allosteric binding site within the transmembrane domain and key micro-switches which regulate receptor signaling.  This structure also provides a model for all class C G-protein-coupled receptors and may aid in the design of new small-mol. drugs for the treatment of brain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4LiHVA8klWLVg90H21EOLACvtfcHk0lgUV0ndlU91jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ChurnK&md5=43a1f0b72a923044fa718729f97c075d</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnature13396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13396%26sid%3Dliteratum%253Aachs%26aulast%3DDore%26aufirst%3DA.%2BS.%26aulast%3DOkrasa%26aufirst%3DK.%26aulast%3DPatel%26aufirst%3DJ.%2BC.%26aulast%3DSerrano-Vega%26aufirst%3DM.%26aulast%3DBennett%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DR.%2BM.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DJazayeri%26aufirst%3DA.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DWiggin%26aufirst%3DG.%2BR.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DStructure%2520of%2520class%2520C%2520GPCR%2520metabotropic%2520glutamate%2520receptor%25205%2520transmembrane%2520domain%26jtitle%3DNature%26date%3D2014%26volume%3D511%26spage%3D557%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Selvy, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavieri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span> </span><span class="NLM_article-title">Phospholipase D: enzymology, signaling, and chemical modulation</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">6064</span><span class="NLM_x">–</span> <span class="NLM_lpage">6119</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr200296t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=6064-6119&author=P.+E.+Selvyauthor=R.+Lavieriauthor=C.+W.+Lindsleyauthor=H.+A.+Brown&title=Phospholipase+D%3A+enzymology%2C+signaling%2C+and+chemical+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fcr200296t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200296t%26sid%3Dliteratum%253Aachs%26aulast%3DSelvy%26aufirst%3DP.%2BE.%26aulast%3DLavieri%26aufirst%3DR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26atitle%3DPhospholipase%2520D%253A%2520enzymology%252C%2520signaling%252C%2520and%2520chemical%2520modulation%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D6064%26epage%3D6119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Monovich, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugrage, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toscano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommasi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaSala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P.</span><span> </span><span class="NLM_article-title">Optimization of halopemide for phospholipase D2 inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2310</span><span class="NLM_x">–</span> <span class="NLM_lpage">2311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2310-2311&author=L.+Monovichauthor=B.+Mugrageauthor=E.+Quadrosauthor=K.+Toscanoauthor=R.+Tommasiauthor=S.+LaVoieauthor=E.+Liuauthor=Z.+M.+Duauthor=D.+LaSalaauthor=W.+Boyarauthor=P.+Steed&title=Optimization+of+halopemide+for+phospholipase+D2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonovich%26aufirst%3DL.%26aulast%3DMugrage%26aufirst%3DB.%26aulast%3DQuadros%26aufirst%3DE.%26aulast%3DToscano%26aufirst%3DK.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DLaVoie%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DDu%26aufirst%3DZ.%2BM.%26aulast%3DLaSala%26aufirst%3DD.%26aulast%3DBoyar%26aufirst%3DW.%26aulast%3DSteed%26aufirst%3DP.%26atitle%3DOptimization%2520of%2520halopemide%2520for%2520phospholipase%2520D2%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2310%26epage%3D2311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">De Cuyper, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstraeten, D.</span><span> </span><span class="NLM_article-title">The clinical significance of halpemide, a dopamine-blocker related to butyrphenones</span> <span class="citation_source-journal">Neuropsychobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1984&pages=211-216&author=H.+De+Cuyperauthor=D.+Verstraeten&title=The+clinical+significance+of+halpemide%2C+a+dopamine-blocker+related+to+butyrphenones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BCuyper%26aufirst%3DH.%26aulast%3DVerstraeten%26aufirst%3DD.%26atitle%3DThe%2520clinical%2520significance%2520of%2520halpemide%252C%2520a%2520dopamine-blocker%2520related%2520to%2520butyrphenones%26jtitle%3DNeuropsychobiology%26date%3D1984%26volume%3D12%26spage%3D211%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Scott, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvy, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criswell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span> </span><span class="NLM_article-title">Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1038%2Fnchembio.140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=19136975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktValtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=108-117&author=S.+A.+Scottauthor=P.+E.+Selvyauthor=J.+Buckauthor=H.+P.+Choauthor=T.+L.+Criswellauthor=A.+L.+Thomasauthor=M.+D.+Armstrongauthor=C.+Arteagaauthor=C.+W.+Lindsleyauthor=H.+A.+Brown&title=Design+of+isoform-selective+phospholipase+D+inhibitors+that+modulate+cancer+cell+invasiveness"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness</span></div><div class="casAuthors">Scott, Sarah A.; Selvy, Paige E.; Buck, Jason R.; Cho, Hyekyung P.; Criswell, Tracy L.; Thomas, Ashley L.; Armstrong, Michelle D.; Arteaga, Carlos L.; Lindsley, Craig W.; Brown, H. Alex</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">108-117</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phospholipase D (PLD) is an essential enzyme responsible for the prodn. of the lipid second messenger phosphatidic acid.  Phosphatidic acid participates in both G protein-coupled receptor and receptor tyrosine kinase signal transduction networks.  The lack of potent and isoform-selective inhibitors has limited progress in defining the cellular roles of PLD.  We used a diversity-oriented synthetic approach and developed a library of PLD inhibitors with considerable pharmacol. characterization.  Here we report the rigorous evaluation of that library, which contains highly potent inhibitors, including the first isoform-selective PLD inhibitors.  Specific members of this series inhibit isoforms with >100-fold selectivity both in vitro and in cells.  A subset of inhibitors was shown to block invasiveness in metastatic breast cancer models.  These findings demonstrate the power of diversity-oriented synthesis combined with biochem. assays and mass spectrometric lipid profiling of cellular responses to develop the first isoform-selective PLD inhibitors-a new class of antimetastatic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeuImMQ0J3KLVg90H21EOLACvtfcHk0liSdVn0qkHj6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktValtA%253D%253D&md5=52aed3879c88eecc13d60a6b611fa2a9</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.140%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DS.%2BA.%26aulast%3DSelvy%26aufirst%3DP.%2BE.%26aulast%3DBuck%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DCriswell%26aufirst%3DT.%2BL.%26aulast%3DThomas%26aufirst%3DA.%2BL.%26aulast%3DArmstrong%26aufirst%3DM.%2BD.%26aulast%3DArteaga%26aufirst%3DC.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26atitle%3DDesign%2520of%2520isoform-selective%2520phospholipase%2520D%2520inhibitors%2520that%2520modulate%2520cancer%2520cell%2520invasiveness%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D108%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Lewis, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavieri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvy, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoops, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures on PLD1 specificity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1919</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1916-1919&author=J.+A.+Lewisauthor=S.+A.+Scottauthor=R.+Lavieriauthor=J.+R.+Buckauthor=P.+E.+Selvyauthor=S.+L.+Stoopsauthor=M.+D.+Armstrongauthor=H.+A.+Brownauthor=C.+W.+Lindsley&title=Design+and+synthesis+of+isoform-selective+phospholipase+D+%28PLD%29+inhibitors.+Part+I%3A+Impact+of+alternative+halogenated+privileged+structures+on+PLD1+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%2BA.%26aulast%3DScott%26aufirst%3DS.%2BA.%26aulast%3DLavieri%26aufirst%3DR.%26aulast%3DBuck%26aufirst%3DJ.%2BR.%26aulast%3DSelvy%26aufirst%3DP.%2BE.%26aulast%3DStoops%26aufirst%3DS.%2BL.%26aulast%3DArmstrong%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520isoform-selective%2520phospholipase%2520D%2520%2528PLD%2529%2520inhibitors.%2520Part%2520I%253A%2520Impact%2520of%2520alternative%2520halogenated%2520privileged%2520structures%2520on%2520PLD1%2520specificity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1916%26epage%3D1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Lavieri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvy, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of halogenated <i>N</i>-(2-(4-oxo-1-phenyl-1,3,8-triazasprio[4.5]decan-8-yl)ethylbenzamides: discovery of an isoform selective small-molecule phospholipase D2 (PLD2) inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6706</span><span class="NLM_x">–</span> <span class="NLM_lpage">6719</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100814g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6706-6719&author=R.+Lavieriauthor=S.+A.+Scottauthor=P.+E.+Selvyauthor=H.+A.+Brownauthor=C.+W.+Lindsley&title=Design%2C+synthesis+and+biological+evaluation+of+halogenated+N-%282-%284-oxo-1-phenyl-1%2C3%2C8-triazasprio%5B4.5%5Ddecan-8-yl%29ethylbenzamides%3A+discovery+of+an+isoform+selective+small-molecule+phospholipase+D2+%28PLD2%29+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm100814g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100814g%26sid%3Dliteratum%253Aachs%26aulast%3DLavieri%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DS.%2BA.%26aulast%3DSelvy%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520halogenated%2520N-%25282-%25284-oxo-1-phenyl-1%252C3%252C8-triazasprio%255B4.5%255Ddecan-8-yl%2529ethylbenzamides%253A%2520discovery%2520of%2520an%2520isoform%2520selective%2520small-molecule%2520phospholipase%2520D2%2520%2528PLD2%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6706%26epage%3D6719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">O’Reilly, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oquin, T. H.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Development of dual PLD1/2 and PLD2 selective inhibitors from a common 1,3,8-triazaspiro[4.5]decane core; discovery of ML298 and ML299 that decrease invasive migration in U87-MG glioblastoma cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2695</span><span class="NLM_x">–</span> <span class="NLM_lpage">2699</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301782e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2695-2699&author=M.+C.+O%E2%80%99Reillyauthor=S.+A.+Scottauthor=K.+A.+Brownauthor=T.+H.+Oquinauthor=P.+G.+Thomasauthor=J.+S.+Danielsauthor=R.+Morrisonauthor=H.+A.+Brownauthor=C.+W.+Lindsley&title=Development+of+dual+PLD1%2F2+and+PLD2+selective+inhibitors+from+a+common+1%2C3%2C8-triazaspiro%5B4.5%5Ddecane+core%3B+discovery+of+ML298+and+ML299+that+decrease+invasive+migration+in+U87-MG+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fjm301782e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301782e%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%2BC.%26aulast%3DScott%26aufirst%3DS.%2BA.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26aulast%3DOquin%26aufirst%3DT.%2BH.%26aulast%3DThomas%26aufirst%3DP.%2BG.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DMorrison%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDevelopment%2520of%2520dual%2520PLD1%252F2%2520and%2520PLD2%2520selective%2520inhibitors%2520from%2520a%2520common%25201%252C3%252C8-triazaspiro%255B4.5%255Ddecane%2520core%253B%2520discovery%2520of%2520ML298%2520and%2520ML299%2520that%2520decrease%2520invasive%2520migration%2520in%2520U87-MG%2520glioblastoma%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2695%26epage%3D2699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Brunz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span> </span><span class="NLM_article-title">Phospholipase D<sub>2</sub> mediates survival signaling through direct regulation of Akt in glioblastoma cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=600-616&author=R.+Brunzauthor=H.+E.+Taylorauthor=C.+W.+Lindsleyauthor=H.+A.+Brown&title=Phospholipase+D2+mediates+survival+signaling+through+direct+regulation+of+Akt+in+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunz%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DH.%2BE.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26atitle%3DPhospholipase%2520D2%2520mediates%2520survival%2520signaling%2520through%2520direct%2520regulation%2520of%2520Akt%2520in%2520glioblastoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D600%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Oguin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span> </span><span class="NLM_article-title">Phospholipase D facilitates efficient entry of influenza virus allowing escape from innate mmune inhibition</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1074/jbc.M114.558817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1074%2Fjbc.M114.558817" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+Oguinauthor=S.+Sharmaauthor=A.+D.+Stuartauthor=C.+K.+Jonesauthor=J.+S.+Danielsauthor=C.+W.+Lindsleyauthor=P.+G.+Thomasauthor=H.+A.+Brown&title=Phospholipase+D+facilitates+efficient+entry+of+influenza+virus+allowing+escape+from+innate+mmune+inhibition&doi=10.1074%2Fjbc.M114.558817"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.558817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.558817%26sid%3Dliteratum%253Aachs%26aulast%3DOguin%26aufirst%3DT.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DStuart%26aufirst%3DA.%2BD.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DThomas%26aufirst%3DP.%2BG.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26atitle%3DPhospholipase%2520D%2520facilitates%2520efficient%2520entry%2520of%2520influenza%2520virus%2520allowing%2520escape%2520from%2520innate%2520mmune%2520inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26doi%3D10.1074%2Fjbc.M114.558817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Christopher
C. Presley, Charles K. Perry, Elizabeth S. Childress, Matthew J. Mulder, Vincent B. Luscombe, Alice L. Rodriguez, Colleen M. Niswender, P. Jeffrey Conn, <span class="NLM_string-name hlFld-ContribAuthor">Craig W. Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Synthetic Cytochrome P450-Mimetic Metalloporphyrins To Facilitate “Biomimetic” Biotransformation of a Series of mGlu5 Allosteric Ligands. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (7)
                                     , 12782-12789. <a href="https://doi.org/10.1021/acsomega.9b02017" title="DOI URL">https://doi.org/10.1021/acsomega.9b02017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b02017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b02017%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DEvaluation%252Bof%252BSynthetic%252BCytochrome%252BP450-Mimetic%252BMetalloporphyrins%252BTo%252BFacilitate%252B%2525E2%252580%25259CBiomimetic%2525E2%252580%25259D%252BBiotransformation%252Bof%252Ba%252BSeries%252Bof%252BmGlu5%252BAllosteric%252BLigands%26aulast%3DPresley%26aufirst%3DChristopher%2BC.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02072019%26date%3D17072019%26volume%3D4%26issue%3D7%26spage%3D12782%26epage%3D12789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jose M.  Arencibia</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Fröhner</span>, <span class="hlFld-ContribAuthor ">Magdalena  Krupa</span>, <span class="hlFld-ContribAuthor ">Daniel  Pastor-Flores</span>, <span class="hlFld-ContribAuthor ">Piotr  Merker</span>, <span class="hlFld-ContribAuthor ">Thomas  Oellerich</span>, <span class="hlFld-ContribAuthor ">Sonja  Neimanis</span>, <span class="hlFld-ContribAuthor ">Christian  Schmithals</span>, <span class="hlFld-ContribAuthor ">Verena  Köberle</span>, <span class="hlFld-ContribAuthor ">Evelyn  Süß</span>, <span class="hlFld-ContribAuthor ">Stefan  Zeuzem</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Albrecht  Piiper</span>, <span class="hlFld-ContribAuthor ">Dalibor  Odadzic</span>, <span class="hlFld-ContribAuthor ">Jörg O.  Schulze</span>, and <span class="hlFld-ContribAuthor ">Ricardo M.  Biondi</span>  . </span><span class="cited-content_cbyCitation_article-title">An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (2)
                                     , 564-573. <a href="https://doi.org/10.1021/acschembio.6b00827" title="DOI URL">https://doi.org/10.1021/acschembio.6b00827</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.6b00827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.6b00827%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DAn%252BAllosteric%252BInhibitor%252BScaffold%252BTargeting%252Bthe%252BPIF-Pocket%252Bof%252BAtypical%252BProtein%252BKinase%252BC%252BIsoforms%26aulast%3DArencibia%26aufirst%3DJose%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D20092016%26date%3D03012017%26date%3D13012017%26date%3D17022017%26date%3D03012017%26volume%3D12%26issue%3D2%26spage%3D564%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Cheeseman</span>, <span class="hlFld-ContribAuthor ">Nicola E. A.  Chessum</span>, <span class="hlFld-ContribAuthor ">Carl S.  Rye</span>, <span class="hlFld-ContribAuthor ">A. Elisa  Pasqua</span>, <span class="hlFld-ContribAuthor ">Michael J.  Tucker</span>, <span class="hlFld-ContribAuthor ">Birgit  Wilding</span>, <span class="hlFld-ContribAuthor ">Lindsay E.  Evans</span>, <span class="hlFld-ContribAuthor ">Susan  Lepri</span>, <span class="hlFld-ContribAuthor ">Meirion  Richards</span>, <span class="hlFld-ContribAuthor ">Swee Y.  Sharp</span>, <span class="hlFld-ContribAuthor ">Salyha  Ali</span>, <span class="hlFld-ContribAuthor ">Martin  Rowlands</span>, <span class="hlFld-ContribAuthor ">Lisa  O’Fee</span>, <span class="hlFld-ContribAuthor ">Asadh  Miah</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Alan T.  Henley</span>, <span class="hlFld-ContribAuthor ">Marissa  Powers</span>, <span class="hlFld-ContribAuthor ">Robert  te Poele</span>, <span class="hlFld-ContribAuthor ">Emmanuel  De Billy</span>, <span class="hlFld-ContribAuthor ">Loredana  Pellegrino</span>, <span class="hlFld-ContribAuthor ">Florence  Raynaud</span>, <span class="hlFld-ContribAuthor ">Rosemary  Burke</span>, <span class="hlFld-ContribAuthor ">Rob L. M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, and <span class="hlFld-ContribAuthor ">Keith  Jones</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (1)
                                     , 180-201. <a href="https://doi.org/10.1021/acs.jmedchem.6b01055" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BChemical%252BProbe%252BBisamide%252B%252528CCT251236%252529%25253A%252BAn%252BOrally%252BBioavailable%252BEfficacious%252BPirin%252BLigand%252Bfrom%252Ba%252BHeat%252BShock%252BTranscription%252BFactor%252B1%252B%252528HSF1%252529%252BPhenotypic%252BScreen%26aulast%3DCheeseman%26aufirst%3DMatthew%2BD.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D15072016%26date%3D22122016%26date%3D12012017%26date%3D23112016%26volume%3D60%26issue%3D1%26spage%3D180%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marino  Convertino</span>, <span class="hlFld-ContribAuthor ">Jhuma  Das</span>, and <span class="hlFld-ContribAuthor ">Nikolay V.  Dokholyan</span>  . </span><span class="cited-content_cbyCitation_article-title">Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (6)
                                     , 1471-1489. <a href="https://doi.org/10.1021/acschembio.6b00195" title="DOI URL">https://doi.org/10.1021/acschembio.6b00195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.6b00195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.6b00195%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DPharmacological%252BChaperones%25253A%252BDesign%252Band%252BDevelopment%252Bof%252BNew%252BTherapeutic%252BStrategies%252Bfor%252Bthe%252BTreatment%252Bof%252BConformational%252BDiseases%26aulast%3DConvertino%26aufirst%3DMarino%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01032016%26date%3D20042016%26date%3D28042016%26date%3D17062016%26date%3D20042016%26volume%3D11%26issue%3D6%26spage%3D1471%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolay V.  Dokholyan</span>  . </span><span class="cited-content_cbyCitation_article-title">Controlling Allosteric Networks in Proteins. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (11)
                                     , 6463-6487. <a href="https://doi.org/10.1021/acs.chemrev.5b00544" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00544%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DControlling%252BAllosteric%252BNetworks%252Bin%252BProteins%26aulast%3DDokholyan%26aufirst%3DNikolay%2BV.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D15092015%26date%3D19022016%26date%3D08062016%26volume%3D116%26issue%3D11%26spage%3D6463%26epage%3D6487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>, <span class="hlFld-ContribAuthor ">Corey R.  Hopkins</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">Karen J.  Gregory</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, and <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>  . </span><span class="cited-content_cbyCitation_article-title">Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (11)
                                     , 6707-6741. <a href="https://doi.org/10.1021/acs.chemrev.5b00656" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00656%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DPractical%252BStrategies%252Band%252BConcepts%252Bin%252BGPCR%252BAllosteric%252BModulator%252BDiscovery%25253A%252BRecent%252BAdvances%252Bwith%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DLindsley%26aufirst%3DCraig%2BW.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06112015%26date%3D16022016%26date%3D08062016%26volume%3D116%26issue%3D11%26spage%3D6707%26epage%3D6741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro M.  Garcia-Barrantes</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Frank W.  Byers</span>, <span class="hlFld-ContribAuthor ">Charles W.  Locuson</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Zixiu  Xiang</span>, <span class="hlFld-ContribAuthor ">Jerri M.  Rook</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, and <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu1), Based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and Mutant mGlu1 Receptors Found in Schizophrenics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (20)
                                     , 7959-7971. <a href="https://doi.org/10.1021/acs.jmedchem.5b00727" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00727%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BNovel%25252C%252BCNS%252BPenetrant%252BPositive%252BAllosteric%252BModulators%252Bfor%252Bthe%252BMetabotropic%252BGlutamate%252BReceptor%252BSubtype%252B1%252B%252528mGlu1%252529%25252C%252BBased%252Bon%252Ban%252BN-%2525283-Chloro-4-%2525281%25252C3-dioxoisoindolin-2-yl%252529phenyl%252529-3-methylfuran-2-carboxamide%252BScaffold%25252C%252BThat%252BPotentiate%252BWild%252BType%252Band%252BMutant%252BmGlu1%252BReceptors%252BFound%252Bin%252BSchizophrenics%26aulast%3DGarcia-Barrantes%26aufirst%3DPedro%2BM.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D11052015%26date%3D08102015%26date%3D22102015%26date%3D01102015%26volume%3D58%26issue%3D20%26spage%3D7959%26epage%3D7971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paraskevi  Gkeka</span>, <span class="hlFld-ContribAuthor ">Alexandra  Papafotika</span>, <span class="hlFld-ContribAuthor ">Savvas  Christoforidis</span>, and <span class="hlFld-ContribAuthor ">Zoe  Cournia</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploring a Non-ATP Pocket for Potential Allosteric Modulation of PI3Kα. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2015,</strong> <em>119 </em>
                                    (3)
                                     , 1002-1016. <a href="https://doi.org/10.1021/jp506423e" title="DOI URL">https://doi.org/10.1021/jp506423e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jp506423e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjp506423e%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DExploring%252Ba%252BNon-ATP%252BPocket%252Bfor%252BPotential%252BAllosteric%252BModulation%252Bof%252BPI3K%2525CE%2525B1%26aulast%3DGkeka%26aufirst%3DParaskevi%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D27062014%26date%3D03102014%26date%3D03122014%26date%3D22012015%26date%3D09102014%26volume%3D119%26issue%3D3%26spage%3D1002%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Harish  Vashisth</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Pathways Originating at Cysteine Residues in Regulators of G-Protein Signaling Proteins. </span><span class="cited-content_cbyCitation_journal-name">Biophysical Journal</span><span> <strong>2021,</strong> <em>120 </em>
                                    (3)
                                     , 517-526. <a href="https://doi.org/10.1016/j.bpj.2020.12.010" title="DOI URL">https://doi.org/10.1016/j.bpj.2020.12.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bpj.2020.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bpj.2020.12.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBiophysical%2520Journal%26atitle%3DAllosteric%252BPathways%252BOriginating%252Bat%252BCysteine%252BResidues%252Bin%252BRegulators%252Bof%252BG-Protein%252BSignaling%252BProteins%26aulast%3DLiu%26aufirst%3DYong%26date%3D2021%26volume%3D120%26issue%3D3%26spage%3D517%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoltán  Orgován</span>, <span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Molecular Switches in Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     , 81-93. <a href="https://doi.org/10.1002/cmdc.202000444" title="DOI URL">https://doi.org/10.1002/cmdc.202000444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000444%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAllosteric%252BMolecular%252BSwitches%252Bin%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DOrgov%25C3%25A1n%26aufirst%3DZolt%25C3%25A1n%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D81%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dario  Doller</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00057-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00057-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00057-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00057-8%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252BModulation%26aulast%3DDoller%26aufirst%3DDario%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francis S.  Willard</span>, <span class="hlFld-ContribAuthor ">David B.  Wainscott</span>. </span><span class="cited-content_cbyCitation_article-title">G protein-coupled receptor allosteric modulators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 271-282. <a href="https://doi.org/10.1016/B978-0-12-816228-6.00014-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-816228-6.00014-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816228-6.00014-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816228-6.00014-3%26sid%3Dliteratum%253Aachs%26atitle%3DG%252Bprotein-coupled%252Breceptor%252Ballosteric%252Bmodulators%26aulast%3DWillard%26aufirst%3DFrancis%2BS.%26date%3D2020%26spage%3D271%26epage%3D282%26pub%3DElsevier%26atitle%3DGPCRs%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice E.  Berizzi</span>, <span class="hlFld-ContribAuthor ">Cyril  Goudet</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies and considerations of G-protein-coupled receptor photopharmacology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 143-172. <a href="https://doi.org/10.1016/bs.apha.2019.12.001" title="DOI URL">https://doi.org/10.1016/bs.apha.2019.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apha.2019.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apha.2019.12.001%26sid%3Dliteratum%253Aachs%26atitle%3DStrategies%252Band%252Bconsiderations%252Bof%252BG-protein-coupled%252Breceptor%252Bphotopharmacology%26aulast%3DBerizzi%26aufirst%3DAlice%2BE.%26date%3D2020%26spage%3D143%26epage%3D172%26pub%3DElsevier%26atitle%3DFrom%252BStructure%252Bto%252BClinical%252BDevelopment%25253A%252BAllosteric%252BModulation%252Bof%252BG%252BProtein-Coupled%252BReceptors%26date%3D2020%26volume%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro E.  Leroux</span>, <span class="hlFld-ContribAuthor ">Jörg O.  Schulze</span>, <span class="hlFld-ContribAuthor ">Ricardo M.  Biondi</span>. </span><span class="cited-content_cbyCitation_article-title">AGC kinases, mechanisms of regulation ‎and innovative drug development. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2018,</strong> <em>48 </em>, 1-17. <a href="https://doi.org/10.1016/j.semcancer.2017.05.011" title="DOI URL">https://doi.org/10.1016/j.semcancer.2017.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2017.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2017.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DAGC%252Bkinases%25252C%252Bmechanisms%252Bof%252Bregulation%252B%2525E2%252580%25258Eand%252Binnovative%252Bdrug%252Bdevelopment%26aulast%3DLeroux%26aufirst%3DAlejandro%2BE.%26date%3D2018%26volume%3D48%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas K.  David</span>, <span class="hlFld-ContribAuthor ">Nayak K.  Prashanth</span>, <span class="hlFld-ContribAuthor ">M.  Rajendraswami</span>, <span class="hlFld-ContribAuthor ">Devendrareddy  Pallalu</span>, <span class="hlFld-ContribAuthor ">Arlindo L.  Castelhano</span>, <span class="hlFld-ContribAuthor ">Michael J.  Kates</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">Development and kilogram-scale synthesis of mGlu5 negative allosteric modulator VU0424238 (auglurant). </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (36)
                                     , 3554-3558. <a href="https://doi.org/10.1016/j.tetlet.2017.07.100" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.07.100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.07.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.07.100%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDevelopment%252Band%252Bkilogram-scale%252Bsynthesis%252Bof%252BmGlu5%252Bnegative%252Ballosteric%252Bmodulator%252BVU0424238%252B%252528auglurant%252529%26aulast%3DDavid%26aufirst%3DThomas%2BK.%26date%3D2017%26volume%3D58%26issue%3D36%26spage%3D3554%26epage%3D3558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shawn  Johnstone</span>, <span class="hlFld-ContribAuthor ">Jeffrey S.  Albert</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2239-2258. <a href="https://doi.org/10.1016/j.bmcl.2017.03.084" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.084%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPharmacological%252Bproperty%252Boptimization%252Bfor%252Ballosteric%252Bligands%25253A%252BA%252Bmedicinal%252Bchemistry%252Bperspective%26aulast%3DJohnstone%26aufirst%3DShawn%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2239%26epage%3D2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marko  Novinec</span>, <span class="hlFld-ContribAuthor ">Mateja  Rebernik</span>, <span class="hlFld-ContribAuthor ">Brigita  Lenarčič</span>. </span><span class="cited-content_cbyCitation_article-title">An allosteric site enables fine-tuning of cathepsin K by diverse effectors. </span><span class="cited-content_cbyCitation_journal-name">FEBS Letters</span><span> <strong>2016,</strong> <em>590 </em>
                                    (24)
                                     , 4507-4518. <a href="https://doi.org/10.1002/1873-3468.12495" title="DOI URL">https://doi.org/10.1002/1873-3468.12495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/1873-3468.12495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F1873-3468.12495%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Letters%26atitle%3DAn%252Ballosteric%252Bsite%252Benables%252Bfine-tuning%252Bof%252Bcathepsin%252BK%252Bby%252Bdiverse%252Beffectors%26aulast%3DNovinec%26aufirst%3DMarko%26date%3D2016%26date%3D2016%26volume%3D590%26issue%3D24%26spage%3D4507%26epage%3D4518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edwin  Kroon</span>, <span class="hlFld-ContribAuthor ">Jörg O.  Schulze</span>, <span class="hlFld-ContribAuthor ">Evelyn  Süß</span>, <span class="hlFld-ContribAuthor ">Carlos J.  Camacho</span>, <span class="hlFld-ContribAuthor ">Ricardo M.  Biondi</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (47)
                                     , 14139-14142. <a href="https://doi.org/10.1002/ange.201506310" title="DOI URL">https://doi.org/10.1002/ange.201506310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201506310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201506310%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BAllosteric%252BKinase%252BModulator%252Bby%252BCombining%252BComputational%252Band%252BSynthetic%252BMethods%26aulast%3DKroon%26aufirst%3DEdwin%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D47%26spage%3D14139%26epage%3D14142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edwin  Kroon</span>, <span class="hlFld-ContribAuthor ">Jörg O.  Schulze</span>, <span class="hlFld-ContribAuthor ">Evelyn  Süß</span>, <span class="hlFld-ContribAuthor ">Carlos J.  Camacho</span>, <span class="hlFld-ContribAuthor ">Ricardo M.  Biondi</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (47)
                                     , 13933-13936. <a href="https://doi.org/10.1002/anie.201506310" title="DOI URL">https://doi.org/10.1002/anie.201506310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201506310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201506310%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BAllosteric%252BKinase%252BModulator%252Bby%252BCombining%252BComputational%252Band%252BSynthetic%252BMethods%26aulast%3DKroon%26aufirst%3DEdwin%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D47%26spage%3D13933%26epage%3D13936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karen J.  Gregory</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2015,</strong> <em>88 </em>
                                    (1)
                                     , 188-202. <a href="https://doi.org/10.1124/mol.114.097220" title="DOI URL">https://doi.org/10.1124/mol.114.097220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.114.097220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.114.097220%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DMolecular%252BInsights%252Binto%252BMetabotropic%252BGlutamate%252BReceptor%252BAllosteric%252BModulation%26aulast%3DGregory%26aufirst%3DKaren%2BJ.%26date%3D2015%26date%3D2015%26volume%3D88%26issue%3D1%26spage%3D188%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haruto  Kurata</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Gentry</span>, <span class="hlFld-ContribAuthor ">Masaya  Kokubo</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Frank W.  Byers</span>, <span class="hlFld-ContribAuthor ">Michael R.  Wood</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">Further optimization of the M5 NAM MLPCN probe ML375: Tactics and challenges. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (3)
                                     , 690-694. <a href="https://doi.org/10.1016/j.bmcl.2014.11.082" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.11.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.11.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.11.082%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFurther%252Boptimization%252Bof%252Bthe%252BM5%252BNAM%252BMLPCN%252Bprobe%252BML375%25253A%252BTactics%252Band%252Bchallenges%26aulast%3DKurata%26aufirst%3DHaruto%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D690%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The first allosteric modulators with clinical success were benzodiazepines (BZDs), GABA<sub>A</sub> PAMs. The generic BZD core <b>1</b> and important medications <b>2</b> (Valium) and the tricylic analog <b>3</b> (Xanax) are shown. Also shown are structures of the two marketed GPCR allosteric modulators: cinacalcet (<b>4</b>), a calcium sensing receptor PAM, and maraviroc (<b>5</b>), a CCR<sub>5</sub> NAM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of adenosine triphosphate (ATP) <b>6</b>, the prototypical ATP-competitive, pan-kinase inhibitor staurosporine <b>7</b>, and a PIP lipid analog <b>8</b>. In 2001, <b>6</b> and <b>7</b> were examples of known Akt inhibitors, but neither were selective versus the kinome or other PH-domain containing proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Akt biology and allosteric inhibitors. (A) Loss of function mutations or deletions in PTEN leads to high levels of PIP3 which recruits Akt from the cytoplasm, where it exists in an inactive, PH-in conformation to the plasma membrane, where the PH domains binds to PIP3 leading to a PH-out conformation exposing T308 and Ser473 for phosphorylation by PDK1 and mTORC2, and active Akt. Inset: a model by which an allosteric inhibitor could stabilize the PH-in conformation, thus blocking both the activity and activation of Akt. Detailed mutagenesis, biochemical, and later X-ray studies confirmed that allosteric Akt inhibitors <b>9</b>–<b>13</b> adhere to this model of inhibition. (B) HTS lead <b>9</b> was found to be the first allosteric inhibitor of Akt. An iterative parallel synthesis and MAOS approach (TES) delivered key tool compounds with unprecedented selectivity for Akt1 (<b>10</b>), Akt2 (<b>11</b>), or both Akt1 and Akt2 (<b>12</b>). Subsequent intense medicinal chemistry provided MK-2206 (<b>13</b>) an orally bioavailable pan-allosteric Akt inhibitor that advanced into clinical trials and displayed efficacy against solid tumors in phase II.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0012.jpeg" id="rightTab-GRAPHIC-d3314e664-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cartoon of the metabotropic glutamate receptor subtype 5 (mGlu<sub>5</sub>) showing the structure and binding site of the endogenous agonist glutamate (<b>14</b>) in the extracellular Venus fly trap domain and the prototypical allosteric ligand, MPEP (<b>15</b>) an mGlu<sub>5</sub> NAM, that binds within the transmembrane domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. The first mGlu<sub>5</sub> PAMs <b>16</b> and <b>20</b> and the subsequent optimization that led to the discovery of two distinct allosteric sites on mGlu<sub>5</sub> that can potentiate receptor function and the key in vivo proof of concept mGlu<sub>5</sub> PAM <b>21</b> that validated the mechanism and pharmacological approach for treatment of multiple symptom clusters of schizophrenia.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. “Molecular switches” within MPEP site mGlu<sub>5</sub> allosteric ligands. Subtle structural modifications modulate the mode of pharmacology. <b>24</b> proved to be a potent PAM with in vivo activity in antipsychotic models, demonstrating the mode of pharmacology “switch” in vitro was mirrored in vivo.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. mGlu<sub>5</sub> PAMs and ago-PAMs leading to seizure liability and neurotoxicity. Pure PAM <b>27</b> also induced seizures, but studies found that a CYP-mediated “molecular switch” afforded a racemic secondary alcohol metabolite <b>28</b> that modulated the mode of pharmacology from pure PAM to allosteric agonist and gave rise to the adverse effect liability and not the parent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Beneficial “molecular switches”. (A) Delivery of the first highly selective mGlu<sub>3</sub> NAM <b>31</b> by virtue of a 4-OMe “molecular switch” on an mGlu<sub>5</sub> PAM scaffold. Subsequent optimization and “fluorine walk” provided <b>32</b>, which was further optimized for DMPK properties by deuterium incorporation, as in <b>33</b>, to overcome “flat” SAR. (B) The allosteric sites on mGlu<sub>4</sub> and mGlu<sub>1</sub> historically cross-talk, and taking advantage of a “double molecular switch”, an mGlu<sub>1</sub> PAM with properties suitable for in vivo studies resulted. (C) An M<sub>1</sub> HTS identified <b>37</b> as an M<sub>1</sub>, M<sub>3</sub>, M<sub>5</sub> PAM. A “molecular switch” in the form of a 5-OCF<sub>3</sub> group engendered selectivity for M<sub>5</sub>, while addition of small heterocycles to replace the 4-Br moiety afforded selective M<sub>1</sub> PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. In pursuit of a better xanomeline. Shown are structures of xanomeline (<b>40</b>) and subsequent M<sub>1</sub> allosteric agonists <b>41</b>–<b>44</b>, which demonstrated that all were bitopic with receptor reserve-dependent pharmacology (e.g., brain region-specific activity) and thus not tractable as a therapeutic approach. PAMs of either M<sub>1</sub> (<b>45</b> and <b>46</b>) or M<sub>4</sub> (<b>47</b> or <b>48</b>) have emerged as important in vivo tools to demonstrate that this mode of pharmacology is superior to allosteric agonism with true mAChR selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/medium/jm-2014-011786_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Development of allosteric, isoform selective PLD inhibitors <b>51</b>–<b>54</b>, utilizing DOS, iterative parallel synthesis, the “fluorine walk” and “molecular switches”, all of which were borrowed from the allosteric GPCR field.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-18/jm5011786/20150902/images/large/jm-2014-011786_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5011786&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i10">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 91 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Adventures in allosteric drug discovery</span>. Presented at the 246th National Meeting of the American Chemical Society, Indianapolis, IN, September 10,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>The 2013 Portoghese Lectureship.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+W.+Lindsley&title=Adventures+in+allosteric+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAdventures%2520in%2520allosteric%2520drug%2520discovery%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. J.</span><span> </span><span class="NLM_article-title">Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1124%2Fpr.108.000992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=20392808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=265-304&author=T.+Kenakinauthor=L.+J.+Miller&title=Seven+transmembrane+receptors+as+shapeshifting+proteins%3A+the+impact+of+allosteric+modulation+and+functional+selectivity+on+new+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery</span></div><div class="casAuthors">Kenakin, Terry; Miller, Laurence J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">265-304</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  It is useful to consider seven transmembrane receptors (7TMRs) as disordered proteins able to allosterically respond to a no. of binding partners.  Considering 7TMRs as allosteric systems, affinity and efficacy can be thought of in terms of energy flow between a modulator, conduit (the receptor protein), and a no. of guests.  These guests can be other mols., receptors, membrane-bound proteins, or signaling proteins in the cytosol.  These vectorial flows of energy can yield std. canonical guest allostery (allosteric modification of drug effect), effects along the plane of the cell membrane (receptor oligomerization), or effects directed into the cytosol (differential signaling as functional selectivity).  This review discusses these apparently diverse pharmacol. effects in terms of mol. dynamics and protein ensemble theory, which tends to unify 7TMR behavior toward cells.  Special consideration will be given to functional selectivity (biased agonism and biased antagonism) in terms of mechanism of action and potential therapeutic application.  The explosion of technol. that has enabled observation of diverse 7TMR behavior has also shown how drugs can have multiple (pluridimensional) efficacies and how this can cause paradoxical drug classification and nomenclatures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3xCdUTrHggbVg90H21EOLACvtfcHk0ljwfOn_v6NAKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbM&md5=fa2394cfb3ae2ecdde09775b50b45b8b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.108.000992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.108.000992%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26atitle%3DSeven%2520transmembrane%2520receptors%2520as%2520shapeshifting%2520proteins%253A%2520the%2520impact%2520of%2520allosteric%2520modulation%2520and%2520functional%2520selectivity%2520on%2520new%2520drug%2520discovery%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D265%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Fenton, A. W.</span><span> </span><span class="NLM_article-title">Allostery: an illustrated definition for the “second secret of life”</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=420-425&author=A.+W.+Fenton&title=Allostery%3A+an+illustrated+definition+for+the+%E2%80%9Csecond+secret+of+life%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFenton%26aufirst%3DA.%2BW.%26atitle%3DAllostery%253A%2520an%2520illustrated%2520definition%2520for%2520the%2520%25E2%2580%259Csecond%2520secret%2520of%2520life%25E2%2580%259D%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2008%26volume%3D33%26spage%3D420%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopolous, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Allosteric modulators of GPCRs as a novel approach to treatment of CNS disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=41-54&author=P.+J.+Connauthor=A.+Christopolousauthor=C.+W.+Lindsley&title=Allosteric+modulators+of+GPCRs+as+a+novel+approach+to+treatment+of+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DChristopolous%26aufirst%3DA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulators%2520of%2520GPCRs%2520as%2520a%2520novel%2520approach%2520to%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D41%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">G-protein coupled receptors: from classical modes of modulation to allosteric mechanisms</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb800116f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=530-542&author=T.+M.+Bridgesauthor=C.+W.+Lindsley&title=G-protein+coupled+receptors%3A+from+classical+modes+of+modulation+to+allosteric+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fcb800116f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb800116f%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DG-protein%2520coupled%2520receptors%253A%2520from%2520classical%2520modes%2520of%2520modulation%2520to%2520allosteric%2520mechanisms%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2008%26volume%3D3%26spage%3D530%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">G protein-coupled receptors allosterism and complexing</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=323-374&author=A.+Christopoulosauthor=T.+Kenakin&title=G+protein-coupled+receptors+allosterism+and+complexing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DG%2520protein-coupled%2520receptors%2520allosterism%2520and%2520complexing%26jtitle%3DPharmacol.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D323%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric binding sites on cell surface receptors: novel targets for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=198-210&author=A.+Christopoulos&title=Allosteric+binding+sites+on+cell+surface+receptors%3A+novel+targets+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520binding%2520sites%2520on%2520cell%2520surface%2520receptors%253A%2520novel%2520targets%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D198%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kenakin, T. P.</span><span> </span><span class="NLM_article-title">7TM receptor allostery: putting numbers to shapeshifting proteins</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=460-469&author=T.+P.+Kenakin&title=7TM+receptor+allostery%3A+putting+numbers+to+shapeshifting+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26atitle%3D7TM%2520receptor%2520allostery%253A%2520putting%2520numbers%2520to%2520shapeshifting%2520proteins%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D460%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Lane, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdul-Ridha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span> </span><span class="NLM_article-title">Regulation of G protein-coupled receptors by allosteric ligands</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn400005t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1yhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=527-534&author=R.+J.+Laneauthor=A.+Abdul-Ridhaauthor=M.+Canals&title=Regulation+of+G+protein-coupled+receptors+by+allosteric+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of G Protein-Coupled Receptors by Allosteric Ligands</span></div><div class="casAuthors">Lane, J. Robert; Abdul-Ridha, Alaa; Canals, Meritxell</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-534</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topog. distinct, druggable, allosteric sites may be present on all G protein-coupled receptors (GPCRs).  As such, targeting these sites with synthetic small mols. offers an attractive approach to develop receptor-subtype selective chem. leads for the development of novel therapies.  A crucial part of drug development is to understand the acute and chronic effects of such allosteric modulators at their corresponding GPCR target.  Key regulatory processes including cell-surface delivery, endocytosis, recycling, and down-regulation tightly control the no. of receptors at the surface of the cell.  As many GPCR therapeutics will be administered chronically, understanding how such ligands modulate these regulatory pathways forms an essential part of the characterization of novel GPCR ligands.  This is true for both orthosteric and allosteric ligands.  In this Review, we summarize our current understanding of GPCR regulatory processes with a particular focus on the effects and implications of allosteric targeting of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKrOeC3g251bVg90H21EOLACvtfcHk0lhOh29wWHkLpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1yhtrY%253D&md5=e95af61d6cdc720069c9d9dd8de8ff5c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcn400005t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400005t%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DR.%2BJ.%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DCanals%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520G%2520protein-coupled%2520receptors%2520by%2520allosteric%2520ligands%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D527%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Monod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J.-P.</span><span> </span><span class="NLM_article-title">On the nature of allosteric transitions: a plausible model</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1956&pages=88-118&author=J.+Monodauthor=J.+Wymanauthor=J.-P.+Changeux&title=On+the+nature+of+allosteric+transitions%3A+a+plausible+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonod%26aufirst%3DJ.%26aulast%3DWyman%26aufirst%3DJ.%26aulast%3DChangeux%26aufirst%3DJ.-P.%26atitle%3DOn%2520the%2520nature%2520of%2520allosteric%2520transitions%253A%2520a%2520plausible%2520model%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1956%26spage%3D88%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Melancon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Allosteric modulation of 7 transmembrane spanning receptors: theory, practice and opportunities for CNS drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1445</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201139r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1445-1464&author=B.+J.+Melanconauthor=C.+R.+Hopkinsauthor=M.+R.+Woodauthor=K.+A.+Emmitteauthor=C.+M.+Niswenderauthor=A.+Christopoulosauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Allosteric+modulation+of+7+transmembrane+spanning+receptors%3A+theory%2C+practice+and+opportunities+for+CNS+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm201139r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201139r%26sid%3Dliteratum%253Aachs%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulation%2520of%25207%2520transmembrane%2520spanning%2520receptors%253A%2520theory%252C%2520practice%2520and%2520opportunities%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1445%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meiler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span> </span><span class="NLM_article-title">Opportunities and challenges in discovery of allosteric modulators of GPCRs for treatment of CNS disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=692-708&author=P.+J.+Connauthor=C.+W.+Lindsleyauthor=J.+Meilerauthor=C.+M.+Niswender&title=Opportunities+and+challenges+in+discovery+of+allosteric+modulators+of+GPCRs+for+treatment+of+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26atitle%3DOpportunities%2520and%2520challenges%2520in%2520discovery%2520of%2520allosteric%2520modulators%2520of%2520GPCRs%2520for%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D692%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Mohler, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritschy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, U.</span><span> </span><span class="NLM_article-title">A new benzodiazepine pharmacology</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2002&pages=2-8&author=H.+F.+Mohlerauthor=J.+M.+Fritschyauthor=U.+Rudolph&title=A+new+benzodiazepine+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DH.%2BF.%26aulast%3DFritschy%26aufirst%3DJ.%2BM.%26aulast%3DRudolph%26aufirst%3DU.%26atitle%3DA%2520new%2520benzodiazepine%2520pharmacology%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D300%26spage%3D2%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wenthur, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Drugs for allosteric sites on receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1146%2Fannurev-pharmtox-010611-134525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=24111540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVSqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=165-184&author=C.+J.+Wenthurauthor=P.+R.+Gentryauthor=T.+P.+Matthewsauthor=C.+W.+Lindsley&title=Drugs+for+allosteric+sites+on+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs for allosteric sites on receptors</span></div><div class="casAuthors">Wenthur, Cody J.; Gentry, Patrick R.; Mathews, Thomas P.; Lindlsye, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">165-184</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The presence of druggable, topog. distinct allosteric sites on a wide range of receptor families has offered new paradigms for small mols. to modulate receptor function.  Moreover, ligands that target allosteric sites offer significant advantages over the corresponding orthosteric ligands in terms of selectivity, including subtype selectivity within receptor families, and can also impart improved physicochem. properties.  However, allosteric ligands are not a panacea.  Many chem. issues (e.g., flat structure-activity relationships) and pharmacol. issues (e.g., ligand-biased signaling) that are allosteric centric have emerged.  Notably, the fact that allosteric sites are less evolutionarily conserved leads to improved selectivity; however, this can also lead to species differences that can hinder safety assessment.  Many allosteric ligands possess mol. switches, wherein a small structural change (chem. or metabolic) can modulate the mode of pharmacol. or receptor subtype selectivity.  As the field has matured, as described here, key principles and strategies have emerged for the design of ligands/drugs for allosteric sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx6zv9s5vbLLVg90H21EOLACvtfcHk0ljxyIO3Uu82TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVSqtrs%253D&md5=56aff98cecab954cbabac96c94f25f47</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-010611-134525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-010611-134525%26sid%3Dliteratum%253Aachs%26aulast%3DWenthur%26aufirst%3DC.%2BJ.%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDrugs%2520for%2520allosteric%2520sites%2520on%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D54%26spage%3D165%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wagenen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colloton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbon, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shatzen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scully, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D.</span><span> </span><span class="NLM_article-title">Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1124%2Fjpet.103.057273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=14593085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlSqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2004&pages=627-635&author=E.+F.+Nemethauthor=W.+H.+Heatonauthor=M.+Millerauthor=J.+Foxauthor=M.+F.+Balandrinauthor=B.+C.+Van+Wagenenauthor=M.+Collotonauthor=W.+Karbonauthor=J.+Scherrerauthor=E.+Shatzenauthor=G.+Rishtonauthor=S.+Scullyauthor=M.+Qiauthor=R.+Harrisauthor=D.+Laceyauthor=D.+Martin&title=Pharmacodynamics+of+the+type+II+calcimimetic+compound+cinacalcet+HCl"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl</span></div><div class="casAuthors">Nemeth, Edward F.; Heaton, William H.; Miller, Michael; Fox, John; Balandrin, Manuel F.; Van Wagenen, Bradford C.; Colloton, Mathew; Karbon, William; Scherrer, Jon; Shatzen, Edward; Rishton, Gilbert; Scully, Sheila; Qi, Meiying; Harris, Robert; Lacey, David; Martin, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">627-635</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Calcimimetic compds., which activate the parathyroid cell Ca2+ receptor (CaR) and inhibit parathyroid hormone (PTH) secretion, are under exptl. study as a treatment for hyperparathyroidism.  This report describes the salient pharmacodynamic properties, using several test systems, of a new calcimimetic compd., cinacalcet HCl.  Cinacalcet HCl increased the concn. of cytoplasmic Ca2+ ([Ca2+]i) in human embryonic kidney 293 cells expressing the human parathyroid CaR.  Cinacalcet HCl (EC50 = 51 nM) in the presence of 0.5 mM extracellular Ca2+ elicited increases in [Ca2+]i in a dose- and calcium-dependent manner.  Similarly, in the presence of 0.5 mM extracellular Ca2+, cinacalcet HCl (IC50 = 28 nM) produced a concn.-dependent decrease in PTH secretion from cultured bovine parathyroid cells.  Using rat medullary thyroid carcinoma 6-23 cells expressing the CaR, cinacalcet HCl (EC50 = 34 nM) produced a concn.-dependent increase in calcitonin secretion.  In vivo studies in rats demonstrated cinacalcet HCl is orally bioavailable and displays approx. linear pharmacokinetics over the dose range of 1 to 36 mg/kg.  Furthermore, this compd. suppressed serum PTH and blood-ionized Ca2+ levels and increased serum calcitonin levels in a dose-dependent manner.  Cinacalcet was about 30-fold more potent at lowering serum levels of PTH than it was at increasing serum calcitonin levels.  The S-enantiomer of cinacalcet (S-AMG 073) was at least 75-fold less active in these assay systems.  The present findings provide compelling evidence that cinacalcet HCl is a potent and stereoselective activator of the parathyroid CaR and, as such, might be beneficial in the treatment of hyperparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJiwFjyTkZmbVg90H21EOLACvtfcHk0lgzpouk2MEH8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlSqurg%253D&md5=c31bff7be63a9455622b387668b1cde5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.057273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.057273%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DHeaton%26aufirst%3DW.%2BH.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DVan%2BWagenen%26aufirst%3DB.%2BC.%26aulast%3DColloton%26aufirst%3DM.%26aulast%3DKarbon%26aufirst%3DW.%26aulast%3DScherrer%26aufirst%3DJ.%26aulast%3DShatzen%26aufirst%3DE.%26aulast%3DRishton%26aufirst%3DG.%26aulast%3DScully%26aufirst%3DS.%26aulast%3DQi%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DLacey%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DD.%26atitle%3DPharmacodynamics%2520of%2520the%2520type%2520II%2520calcimimetic%2520compound%2520cinacalcet%2520HCl%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D308%26spage%3D627%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span> </span><span class="NLM_article-title">Maraviroc, a chemokine CCR5 receptor antagonist for the treatment of HIV infection and AIDS</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=669-681&author=N.+A.+Meanwellauthor=J.+F.+Kadow&title=Maraviroc%2C+a+chemokine+CCR5+receptor+antagonist+for+the+treatment+of+HIV+infection+and+AIDS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DMaraviroc%252C%2520a%2520chemokine%2520CCR5%2520receptor%2520antagonist%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%2520and%2520AIDS%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D669%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span>For information on the VCNDD, see the following: <a href="http://www.vcndd.com/" class="extLink">http://www.vcndd.com/</a> (accessed August 1,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+information+on+the+VCNDD%2C+see+the+following%3A+http%3A%2F%2Fwww.vcndd.com%2F+%28accessed+August+1%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span>For information on the MLPCN and available probe compounds, see the following: <a href="https://mli.nih.gov/mli/mlpcn/" class="extLink">https://mli.nih.gov/mli/mlpcn/</a> (accessed August 1,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+information+on+the+MLPCN+and+available+probe+compounds%2C+see+the+following%3A+https%3A%2F%2Fmli.nih.gov%2Fmli%2Fmlpcn%2F+%28accessed+August+1%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. J.</span><span> </span><span class="NLM_article-title">Structural basis for control by phosphorylation</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">2209</span><span class="NLM_x">–</span> <span class="NLM_lpage">2242</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr000225s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVSis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=2209-2242&author=L.+N.+Johnsonauthor=R.+J.+Lewis&title=Structural+basis+for+control+by+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Control by Phosphorylation</span></div><div class="casAuthors">Johnson, Louise N.; Lewis, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2209-2242</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 178 refs.  Topics discussed include eukaryotic protein phosphorylation, phospho-signaling and protein/protein assocn., phosphorylation signaling order/disorder transitions and protein/protein dissocn., evolution of control of phosphorylases by phosphorylation, and prokaryotic signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJI8Pig56m7bVg90H21EOLACvtfcHk0lhiDTv57QtAiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVSis74%253D&md5=f4423d804035acc474d4f309cf3af966</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcr000225s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr000225s%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520control%2520by%2520phosphorylation%26jtitle%3DChem.%2520Rev.%26date%3D2001%26volume%3D101%26spage%3D2209%26epage%3D2242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span> </span><span class="NLM_article-title">Protein phosphorylation in signaling</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2005&pages=286-290&author=T.+Pawsonauthor=J.+D.+Scott&title=Protein+phosphorylation+in+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26atitle%3DProtein%2520phosphorylation%2520in%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2005%26volume%3D30%26spage%3D286%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Protein kinases—the major drug targets of the twenty-first century?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%E2%80%94the+major+drug+targets+of+the+twenty-first+century%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases%25E2%2580%2594the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xuong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowadski, J. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2154</span><span class="NLM_x">–</span> <span class="NLM_lpage">2161</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00060a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=2154-2161&author=J.+Zhengauthor=L.+Eyckauthor=R.+Karlssonauthor=N.+Xuongauthor=S.+S.+Taylorauthor=J.+M.+Sowadski&title=Crystal+structure+of+the+catalytic+subunit+of+cAMP-dependent+protein+kinase+complexed+with+MgATP+and+peptide+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi00060a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00060a005%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DEyck%26aufirst%3DL.%26aulast%3DKarlsson%26aufirst%3DR.%26aulast%3DXuong%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DSowadski%26aufirst%3DJ.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520catalytic%2520subunit%2520of%2520cAMP-dependent%2520protein%2520kinase%2520complexed%2520with%2520MgATP%2520and%2520peptide%2520inhibitor%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D2154%26epage%3D2161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hantschel, O.</span><span> </span><span class="NLM_article-title">Structure, regulation, signaling, and targeting of Abl kinases in cancer</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1177%2F1947601912458584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=23226581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSktr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=436-446&author=O.+Hantschel&title=Structure%2C+regulation%2C+signaling%2C+and+targeting+of+Abl+kinases+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, regulation, signaling, and targeting of abl kinases in cancer</span></div><div class="casAuthors">Hantschel, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">436-446, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Abl kinases are prototypic cytoplasmic tyrosine kinases and are involved in a variety of chromosomal aberrations in different cancers.  This causes the expression of Abl fusion proteins, such as Bcr-Abl, that are constitutively activated and drivers of tumorigenesis.  Over the past decades, biochem. and functional studies on the mol. mechanisms of Abl regulation have gone hand in hand with progression of our structural understanding of autoinhibited and active Abl conformations.  In parallel, Abl oncoproteins have become prime mol. targets for cancer therapy, using ATP (ATP)-competitive kinase inhibitors, such as imatinib.  Abl-targeting drugs serve as a paradigm for our understanding of kinase inhibitor action, specificity, and resistance development.  In this review article, I will review the mol. mechanisms that are responsible for the regulation of Abl kinase activity and how oncogenic Abl fusions signal.  Furthermore, past and ongoing efforts to target Abl oncoproteins using ATP-competitive and allosteric inhibitors, as well as future possibilities using combination therapy, will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfQtqXVsETdrVg90H21EOLACvtfcHk0lhiDTv57QtAiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSktr7E&md5=f3b1114eb39b1f79d8d00a287d2b9a89</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1177%2F1947601912458584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601912458584%26sid%3Dliteratum%253Aachs%26aulast%3DHantschel%26aufirst%3DO.%26atitle%3DStructure%252C%2520regulation%252C%2520signaling%252C%2520and%2520targeting%2520of%2520Abl%2520kinases%2520in%2520cancer%26jtitle%3DGenes%2520Cancer%26date%3D2012%26volume%3D3%26spage%3D436%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Palmieri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giulio, R.</span><span> </span><span class="NLM_article-title">αC Helix displacement as a general approach for allosteric modulation of protein kinases</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=1-8&author=L.+Palmieriauthor=R.+Giulio&title=%CE%B1C+Helix+displacement+as+a+general+approach+for+allosteric+modulation+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmieri%26aufirst%3DL.%26aulast%3DGiulio%26aufirst%3DR.%26atitle%3D%25CE%25B1C%2520Helix%2520displacement%2520as%2520a%2520general%2520approach%2520for%2520allosteric%2520modulation%2520of%2520protein%2520kinases%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Betzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riazul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubbers, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakkaraj, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schönbrunn, E.</span><span> </span><span class="NLM_article-title">Discovery of a potential allosteric ligand binding site in CDK2</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb100410m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Gisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=492-501&author=S.+Betziauthor=A.+Riazulauthor=M.+Mathewauthor=D.+J.+Lubbersauthor=H.+Hanauthor=S.+R.+Jakkarajauthor=G.+I.+Georgauthor=E.+Sch%C3%B6nbrunn&title=Discovery+of+a+potential+allosteric+ligand+binding+site+in+CDK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potential Allosteric Ligand Binding Site in CDK2</span></div><div class="casAuthors">Betzi, Stephane; Alam, Riazul; Martin, Mathew; Lubbers, Donna J.; Han, Huijong; Jakkaraj, Sudhakar R.; Georg, Gunda I.; Schonbrunn, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">492-501</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) are key regulatory enzymes in cell cycle progression and transcription.  Aberrant activity of CDKs has been implicated in a no. of medical conditions, and numerous small mol. CDK inhibitors have been reported as potential drug leads.  However, these inhibitors exclusively bind to the ATP site, which is largely conserved among protein kinases, and clin. trials have not resulted in viable drug candidates, attributed in part to the lack of target selectivity.  CDKs are unique among protein kinases, as their functionality strictly depends on assocn. with their partner proteins, the cyclins.  In an effort to identify potential target sites for disruption of the CDK-cyclin interaction, we probed the extrinsic fluorophore 8-anilino-1-naphthalene sulfonate (ANS) with human CDK2 and cyclin A using fluorescence spectroscopy and protein crystallog.  ANS interacts with free CDK2 in a satn.-dependent manner with an apparent Kd of 37 μM, and cyclin A displaced ANS from CDK2 with an EC50 value of 0.6 μM.  Co-crystal structures with ANS alone and in ternary complex with ATP site-directed inhibitors revealed two ANS mols. bound adjacent to one another, away from the ATP site, in a large pocket that extends from the DFG region above the C-helix.  Binding of ANS is accompanied by substantial structural changes in CDK2, resulting in a C-helix conformation that is incompatible for cyclin A assocn.  These findings indicate the potential of the ANS binding pocket as a new target site for allosteric inhibitors disrupting the interaction of CDKs and cyclins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGlhg8YO4Yl7Vg90H21EOLACvtfcHk0lgN7MRsXGrvTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Gisb4%253D&md5=893aed13b1638f7626fbb4851014fe6e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcb100410m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100410m%26sid%3Dliteratum%253Aachs%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DRiazul%26aufirst%3DA.%26aulast%3DMathew%26aufirst%3DM.%26aulast%3DLubbers%26aufirst%3DD.%2BJ.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DJakkaraj%26aufirst%3DS.%2BR.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DSch%25C3%25B6nbrunn%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520a%2520potential%2520allosteric%2520ligand%2520binding%2520site%2520in%2520CDK2%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D492%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Busschots, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Garcia, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piiper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzari, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neimanis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arencibia, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, R. M.</span><span> </span><span class="NLM_article-title">Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1016%2Fj.chembiol.2012.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=22999883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2ksbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1152-1163&author=K.+Busschotsauthor=L.+A.+Lopez-Garciaauthor=C.+Lammiauthor=A.+Strobaauthor=S.+Zeuzemauthor=A.+Piiperauthor=P.+M.+Alzariauthor=S.+Neimanisauthor=J.+M.+Arencibiaauthor=M.+Engelauthor=J.+O.+Schulzeauthor=R.+M.+Biondi&title=Substrate-selective+inhibition+of+protein+kinase+PDK1+by+small+compounds+that+bind+to+the+PIF-pocket+allosteric+docking+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site</span></div><div class="casAuthors">Busschots, Katrien; Lopez-Garcia, Laura A.; Lammi, Carmen; Stroba, Adriana; Zeuzem, Stefan; Piiper, Albrecht; Alzari, Pedro M.; Neimanis, Sonja; Arencibia, Jose M.; Engel, Matthias; Schulze, Joerg O.; Biondi, Ricardo M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1152-1163</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The PIF-pocket of AGC protein kinases participates in the physiol. mechanism of regulation by acting as a docking site for substrates and as a switch for the transduction of the conformational changes needed for activation or inhibition.  We describe the effects of compds. that bind to the PIF-pocket of PDK1.  In vitro, PS210 is a potent activator of PDK1, and the crystal structure of the PDK1-ATP-PS210 complex shows that PS210 stimulates the closure of the kinase domain.  However, in cells, the prodrug of PS210 (PS423) acts as a substrate-selective inhibitor of PDK1, inhibiting the phosphorylation and activation of S6K, which requires docking to the PIF-pocket, but not affecting PKB/Akt.  This work describes a tool to study the dynamics of PDK1 activity and a potential approach for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCik10255dpLVg90H21EOLACvtfcHk0lgN7MRsXGrvTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2ksbvO&md5=8efdcf836d5d910e979a2640709c1d4e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DBusschots%26aufirst%3DK.%26aulast%3DLopez-Garcia%26aufirst%3DL.%2BA.%26aulast%3DLammi%26aufirst%3DC.%26aulast%3DStroba%26aufirst%3DA.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DPiiper%26aufirst%3DA.%26aulast%3DAlzari%26aufirst%3DP.%2BM.%26aulast%3DNeimanis%26aufirst%3DS.%26aulast%3DArencibia%26aufirst%3DJ.%2BM.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DSchulze%26aufirst%3DJ.%2BO.%26aulast%3DBiondi%26aufirst%3DR.%2BM.%26atitle%3DSubstrate-selective%2520inhibition%2520of%2520protein%2520kinase%2520PDK1%2520by%2520small%2520compounds%2520that%2520bind%2520to%2520the%2520PIF-pocket%2520allosteric%2520docking%2520site%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D1152%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Lopez-Garcia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fröhner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Süss, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navratil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindie, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, T. J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzari, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, R. M.</span><span> </span><span class="NLM_article-title">Allosteric regulation of protein kinase PKCζ by the N-terminal C1 domain and small compounds to the PIF-pocket</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1016%2Fj.chembiol.2011.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=22118680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeqs7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1463-1473&author=L.+Lopez-Garciaauthor=J.+O.+Schulzeauthor=W.+Fr%C3%B6hnerauthor=H.+Zhangauthor=E.+S%C3%BCssauthor=N.+Weberauthor=J.+Navratilauthor=S.+Amonauthor=V.+Hindieauthor=S.+Zeuzemauthor=T.+J.+D.+Jorgensenauthor=P.+M.+Alzariauthor=M.+Engelauthor=R.+M.+Biondi&title=Allosteric+regulation+of+protein+kinase+PKC%CE%B6+by+the+N-terminal+C1+domain+and+small+compounds+to+the+PIF-pocket"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Regulation of Protein Kinase PKCζ by the N-Terminal C1 Domain and Small Compounds to the PIF-Pocket</span></div><div class="casAuthors">Lopez-Garcia, Laura A.; Schulze, Joerg O.; Froehner, Wolfgang; Zhang, Hua; Suess, Evelyn; Weber, Nadja; Navratil, Jeanette; Amon, Sabine; Hindie, Valerie; Zeuzem, Stefan; Jorgensen, Thomas J. D.; Alzari, Pedro M.; Neimanis, Sonja; Engel, Matthias; Biondi, Ricardo M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1463-1473</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Protein kinases are key mediators of cellular signaling, and therefore, their activities are tightly controlled.  AGC kinases are regulated by phosphorylation and by N- and C-terminal regions.  Here, the mol. mechanism of inhibition of atypical PKCζ was studied and it was found that the inhibition by the N-terminal region cannot be explained by a simple pseudosubstrate inhibitory mechanism.  Notably, it was found that the C1 domain allosterically inhibits PKCζ activity and verified an allosteric communication between the PIF-pocket of atypical PKCs and the binding site of the C1 domain.  Finally, low-mol.-wt. compds. were developed that bind to the PIF-pocket and allosterically inhibit PKCζ activity.  This work establishes a central role for the PIF-pocket on the regulation of PKCζ and allows one to envisage development of drugs targeting the PIF-pocket that can either activate or inhibit AGC kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe4nR0hoXIfbVg90H21EOLACvtfcHk0ljsioHKJXObvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeqs7nF&md5=fb2fef02f710e6cd2084d5cf1bd3c6d2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Garcia%26aufirst%3DL.%26aulast%3DSchulze%26aufirst%3DJ.%2BO.%26aulast%3DFr%25C3%25B6hner%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DS%25C3%25BCss%26aufirst%3DE.%26aulast%3DWeber%26aufirst%3DN.%26aulast%3DNavratil%26aufirst%3DJ.%26aulast%3DAmon%26aufirst%3DS.%26aulast%3DHindie%26aufirst%3DV.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DJorgensen%26aufirst%3DT.%2BJ.%2BD.%26aulast%3DAlzari%26aufirst%3DP.%2BM.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DBiondi%26aufirst%3DR.%2BM.%26atitle%3DAllosteric%2520regulation%2520of%2520protein%2520kinase%2520PKC%25CE%25B6%2520by%2520the%2520N-terminal%2520C1%2520domain%2520and%2520small%2520compounds%2520to%2520the%2520PIF-pocket%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D1463%26epage%3D1473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Fischmann, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhood, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannarino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V. S.</span><span> </span><span class="NLM_article-title">Crystal structures of MEK1 binary and ternary complexes with nucleotides and inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2661</span><span class="NLM_x">–</span> <span class="NLM_lpage">2674</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi801898e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=2661-2674&author=T.+O.+Fischmannauthor=C.+K.+Smithauthor=T.+W.+Mayhoodauthor=J.+E.+Myersauthor=P.+Reichertauthor=A.+Mannarinoauthor=D.+Carrauthor=H.+Zhuauthor=J.+Wongauthor=R.-S.+Yangauthor=H.+V.+Leauthor=V.+S.+Madison&title=Crystal+structures+of+MEK1+binary+and+ternary+complexes+with+nucleotides+and+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fbi801898e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801898e%26sid%3Dliteratum%253Aachs%26aulast%3DFischmann%26aufirst%3DT.%2BO.%26aulast%3DSmith%26aufirst%3DC.%2BK.%26aulast%3DMayhood%26aufirst%3DT.%2BW.%26aulast%3DMyers%26aufirst%3DJ.%2BE.%26aulast%3DReichert%26aufirst%3DP.%26aulast%3DMannarino%26aufirst%3DA.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DR.-S.%26aulast%3DLe%26aufirst%3DH.%2BV.%26aulast%3DMadison%26aufirst%3DV.%2BS.%26atitle%3DCrystal%2520structures%2520of%2520MEK1%2520binary%2520and%2520ternary%2520complexes%2520with%2520nucleotides%2520and%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D2661%26epage%3D2674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, R.</span><span> </span><span class="NLM_article-title">Strategies for the selective regulation of kinases with allosteric modulators: exploiting exclusive structural features</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb300663j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCls7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=58-70&author=Z.+Fangauthor=G.+Christianauthor=R.+Daniel&title=Strategies+for+the+selective+regulation+of+kinases+with+allosteric+modulators%3A+exploiting+exclusive+structural+features"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural Features</span></div><div class="casAuthors">Fang, Zhizhou; Gruetter, Christian; Rauh, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-70</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The modulation of kinase function has become an important goal in modern drug discovery and chem. biol. research.  In cancer-targeted therapies, kinase inhibitors have been experiencing an upsurge, which can be measured by the increasing no. of kinase inhibitors approved by the FDA in recent years.  However, lack of efficacy, limited selectivity, and the emergence of acquired drug resistance still represent major bottlenecks in the clinic and challenge inhibitor development.  Most known kinase inhibitors target the active kinase and are ATP competitive.  A second class of small org. mols., which address remote sites of the kinase and stabilize enzymically inactive conformations, is rapidly moving to the forefront of kinase inhibitor research.  Such allosteric modulators bind to sites that are less conserved across the kinome and only accessible upon conformational changes.  These mols. are therefore thought to provide various advantages such as higher selectivity and extended drug target residence times.  This review highlights various strategies that have been developed to utilizing exclusive structural features of kinases and thereby modulating their activity allosterically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSjxxztmczXrVg90H21EOLACvtfcHk0lj1lih0eaPyTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCls7bN&md5=50864096bf66229ff74482a9b56847d6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcb300663j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300663j%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DChristian%26aufirst%3DG.%26aulast%3DDaniel%26aufirst%3DR.%26atitle%3DStrategies%2520for%2520the%2520selective%2520regulation%2520of%2520kinases%2520with%2520allosteric%2520modulators%253A%2520exploiting%2520exclusive%2520structural%2520features%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D58%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Hennessy, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Exploiting the PI3K/AKT pathway for cancer drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1038%2Fnrd1902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=16341064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=988-1004&author=B.+T.+Hennessyauthor=D.+L.+Smithauthor=P.+T.+Ramauthor=Y.+Luauthor=G.+B.+Mills&title=Exploiting+the+PI3K%2FAKT+pathway+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery</span></div><div class="casAuthors">Hennessy, Bryan T.; Smith, Debra L.; Ram, Prahlad T.; Lu, Yiling; Mills, Gordon B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">988-1004</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Evolving studies with several different targeted therapeutic agents are demonstrating that patients with genomic alterations of the target, including amplification, translocation and mutation, are more likely to respond to the therapy.  Recent studies indicate that numerous components of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway are targeted by amplification, mutation and translocation more frequently than any other pathway in cancer patients, with resultant activation of the pathway.  This warrants exploiting the PI3K/AKT pathway for cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq40Fg-hLrrMbVg90H21EOLACvtfcHk0lj1lih0eaPyTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI&md5=faecabc3a6799137d133afb37d139ceb</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd1902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1902%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DB.%2BT.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRam%26aufirst%3DP.%2BT.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DExploiting%2520the%2520PI3K%252FAKT%2520pathway%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D988%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.2174%2F1568026053507714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=15853641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=109-125&author=S.+F.+Barnettauthor=M.+T.+Bilodeauauthor=C.+W.+Lindsley&title=The+Akt%2FPKB+family+of+protein+kinases%3A+a+review+of+small+molecule+inhibitors+and+progress+towards+target+validation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation</span></div><div class="casAuthors">Barnett, Stanley F.; Bilodeau, Mark T.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-125</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent advances in the development and biol. evaluation of small mol. inhibitors for the serine/threonine kinase Akt (PKB).  Akt plays a pivotal role in cell survival and proliferation through a no. of downstream effectors.  Recent studies indicate that unregulated activation of the PI3K/Akt pathway is a prominent feature of many human cancers and Akt is over-expressed or activated in all major cancers.  Akt is considered an attractive target for chemotherapy and it was postulated that inhibition of Akt alone or in combination with std. cancer chemotherapeutics will reduce the apoptotic threshold and preferentially kill cancer cells.  The development of specific and potent inhibitors will allow this hypothesis to be tested in animals.  The majority of small mol. inhibitors in this nascent field are classic ATP-competitive inhibitors which provide little specificity.  Phosphatidylinositol (PI) analogs were reported to inhibit Akt, but these inhibitors may also have specificity problems with respect to other PH domain contg. proteins and may have poor bioavailability.  None of the inhibitors in these classes were reported to have Akt isoenzyme specificity.  Recently, novel allosteric inhibitors were reported which are pleckstrin homol. domain dependent and exhibit Akt isoenzyme selectivity.  Inhibitors in this class may have sufficient potency and specificity to test for tumor efficacy in animal models and recently reported preliminary expts. are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLzMZqnXaA5bVg90H21EOLACvtfcHk0lj1lih0eaPyTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLY%253D&md5=44734cf0124197d3c4d5d9be5f7499ca</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1568026053507714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507714%26sid%3Dliteratum%253Aachs%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DThe%2520Akt%252FPKB%2520family%2520of%2520protein%2520kinases%253A%2520a%2520review%2520of%2520small%2520molecule%2520inhibitors%2520and%2520progress%2520towards%2520target%2520validation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D109%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.2174%2F156802610790980602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=20180757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFKnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=458-477&author=C.+W.+Lindsley&title=The+Akt%2FPKB+family+of+protein+kinases%3A+a+review+of+small+molecule+inhibitors+and+progress+towards+target+validation%3A+a+2009+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update</span></div><div class="casAuthors">Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-477</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent advances in the development and biol. evaluation of small mol. inhibitors for the serine/threonine kinase Akt (PKB) as a reprise of our 2005 review with new data from the 2006-2009 time period.  Akt plays a pivotal role in cell survival and proliferation through a no. of downstream effectors.  Recent studies indicate that unregulated activation of the PI3K/Akt pathway is a prominent feature of many human cancers and Akt is over-expressed or activated in all major cancers.  Akt is considered an attractive target for cancer therapy and inhibition of Akt alone or in combination with std. cancer chemotherapeutics has been postulated to reduce the apoptotic threshold and preferentially kill cancer cells.  Recently, several series of small mol., ATP-competitive inhibitors have been reported with a range of Akt potencies and selectivities.  Phosphatidylinositol (PI) analogs have been reported to inhibit Akt, but these inhibitors may also have specificity problems with respect to other pleckstrin homol. (PH) domain contg. proteins and may have poor bioavailability.  In addn., novel allosteric inhibitors have been reported which are PH domain dependent, exhibit selectivity for the individual Akt isoenzymes and inhibit the activity and the activation of Akt.  Compds. within these classes Akt inhibitors have sufficient potency and specificity which have culminated in recent reports of efficacy in tumor xenograft models.  Moreover, Merck just disclosed pos. Phase I data with an oral allosteric Akt inhibitor (MK-2206).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsF3tzEhRty7Vg90H21EOLACvtfcHk0lhbws46Nuyv-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFKnsr0%253D&md5=ea76a6057c31b029d0308f74dd293051</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F156802610790980602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790980602%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DThe%2520Akt%252FPKB%2520family%2520of%2520protein%2520kinases%253A%2520a%2520review%2520of%2520small%2520molecule%2520inhibitors%2520and%2520progress%2520towards%2520target%2520validation%253A%2520a%25202009%2520update%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D458%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kumar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">AKT crystal structure and AKT-specific inhibitors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">7493</span><span class="NLM_x">–</span> <span class="NLM_lpage">7501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=7493-7501&author=C.+Kumarauthor=V.+Madison&title=AKT+crystal+structure+and+AKT-specific+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DC.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DAKT%2520crystal%2520structure%2520and%2520AKT-specific%2520inhibitors%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D7493%26epage%3D7501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Cheng, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicosia, S. V.</span><span> </span><span class="NLM_article-title">The Akt/PKB pathway: molecular target for cancer drug discovery</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">7482</span><span class="NLM_x">–</span> <span class="NLM_lpage">7492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=7482-7492&author=J.+Q.+Chengauthor=C.+W.+Lindsleyauthor=G.+Z.+Chengauthor=H.+Yangauthor=S.+V.+Nicosia&title=The+Akt%2FPKB+pathway%3A+molecular+target+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DCheng%26aufirst%3DG.%2BZ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DNicosia%26aufirst%3DS.%2BV.%26atitle%3DThe%2520Akt%252FPKB%2520pathway%253A%2520molecular%2520target%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D7482%26epage%3D7492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. Q.</span><span> </span><span class="NLM_article-title">Targeting phosphatidylinositol-3 kinase/Akt pathway for cancer therapy</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1250</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1250-1258&author=D.+Kimauthor=G.+Z.+Chengauthor=C.+W.+Lindsleyauthor=H.+Yangauthor=J.+Q.+Cheng&title=Targeting+phosphatidylinositol-3+kinase%2FAkt+pathway+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DG.%2BZ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26atitle%3DTargeting%2520phosphatidylinositol-3%2520kinase%252FAkt%2520pathway%2520for%2520cancer%2520therapy%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D6%26spage%3D1250%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R.</span><span> </span><span class="NLM_article-title">Allosteric Akt (PKB) kinase inhibitors. Discovery and SAR of isozyme selective inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=761-764&author=C.+W.+Lindsleyauthor=Z.+Zhaoauthor=M.+E.+Dugganauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=H.+E.+Huberauthor=J.+R.+Huffauthor=G.+D.+Hartmanauthor=W.+Leisterauthor=A.+Kralauthor=S.+Fuauthor=P.+J.+Hancockauthor=K.+A.+Haskellauthor=R.+E.+Jonesauthor=R.+Robinson&title=Allosteric+Akt+%28PKB%29+kinase+inhibitors.+Discovery+and+SAR+of+isozyme+selective+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DKral%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DHancock%26aufirst%3DP.%2BJ.%26aulast%3DHaskell%26aufirst%3DK.%2BA.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DRobinson%26aufirst%3DR.%26atitle%3DAllosteric%2520Akt%2520%2528PKB%2529%2520kinase%2520inhibitors.%2520Discovery%2520and%2520SAR%2520of%2520isozyme%2520selective%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D761%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leander, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAvoy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span> </span><span class="NLM_article-title">Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=15713898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlersr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=271-279&author=D.+Defeo-Jonesauthor=S.+F.+Barnettauthor=S.+Fuauthor=P.+J.+Hancockauthor=K.+M.+Haskellauthor=K.+R.+Leanderauthor=E.+McAvoyauthor=C.+W.+Lindsleyauthor=M.+E.+Dugganauthor=G.+D.+Hartmanauthor=H.+E.+Huber&title=Tumor+cell+sensitization+to+apoptotic+stimuli+by+selective+inhibition+of+specific+Akt%2FPKB+family+members"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members</span></div><div class="casAuthors">DeFeo-Jones, Deborah; Barnett, Stanley F.; Fu, Sheng; Hancock, Paula J.; Haskell, Kathleen M.; Leander, Karen R.; McAvoy, Elizabeth; Robinson, Ronald G.; Duggan, Mark E.; Lindsley, Craig W.; Zhao, Zhijian; Huber, Hans E.; Jones, Raymond E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-279</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Recent studies indicate that dysregulation of the Akt/PKB family of serine/threonine kinases is a prominent feature of many human cancers.  The Akt/PKB family is composed of three members termed Akt1/PKBα, Akt2/PKB{szligbeta}, and Akt3/PKBγ.  It is currently not known to what extent there is functional overlap between these family members.  We have recently identified small mol. inhibitors of Akt.  These compds. have pleckstrin homol. domain-dependent, isoenzyme-specific activity.  In this report, we present data showing the relative contribution that inhibition of the different isoenzymes has on the apoptotic response of tumor cells to a variety of chemotherapies.  In multiple cell backgrounds, maximal induction of caspase-3 activity is achieved when both Akt1 and Akt2 are inhibited.  This induction is not reversed by overexpression of functionally active Akt3.  The level of caspase-3 activation achieved under these conditions is equiv. to that obsd. with the phosphatidylinositol-3-kinase inhibitor LY294002.  We also show that in different tumor cell backgrounds inhibition of mammalian target of rapamycin, a downstream substrate of Akt, is less effective in inducing caspase-3 activity than inhibition of Akt1 and Akt2.  This shows that the survival phenotype conferred by Akt can be mediated by signaling pathways independent of mammalian target of rapamycin in some tumor cell backgrounds.  Finally, we show that inhibition of both Akt1 and Akt2 selectively sensitizes tumor cells, but not normal cells, to apoptotic stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdte3IwUcZIrVg90H21EOLACvtfcHk0lh3QmX7ONclLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlersr4%253D&md5=20dab10caeb7d4286d8bd4b1ce594a21</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DHancock%26aufirst%3DP.%2BJ.%26aulast%3DHaskell%26aufirst%3DK.%2BM.%26aulast%3DLeander%26aufirst%3DK.%2BR.%26aulast%3DMcAvoy%26aufirst%3DE.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26atitle%3DTumor%2520cell%2520sensitization%2520to%2520apoptotic%2520stimuli%2520by%2520selective%2520inhibition%2520of%2520specific%2520Akt%252FPKB%2520family%2520members%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D271%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAvoy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span> </span><span class="NLM_article-title">Identification and characterization of pleckstin-homology-domain-dependent and isoenzyme-specfic Akt inhibitors</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2005&pages=399-408&author=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=S.+Fuauthor=P.+J.+Hancockauthor=K.+M.+Haskellauthor=R.+E.+Jonesauthor=J.+A.+Kahanaauthor=A.+M.+Kralauthor=K.+Leanderauthor=L.+L.+Leeauthor=J.+Malinowskiauthor=E.+M.+McAvoyauthor=D.+D.+Nahasauthor=R.+G.+Robinsonauthor=H.+E.+Huber&title=Identification+and+characterization+of+pleckstin-homology-domain-dependent+and+isoenzyme-specfic+Akt+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DHancock%26aufirst%3DP.%2BJ.%26aulast%3DHaskell%26aufirst%3DK.%2BM.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DKahana%26aufirst%3DJ.%2BA.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DLeander%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DL.%2BL.%26aulast%3DMalinowski%26aufirst%3DJ.%26aulast%3DMcAvoy%26aufirst%3DE.%2BM.%26aulast%3DNahas%26aufirst%3DD.%2BD.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520pleckstin-homology-domain-dependent%2520and%2520isoenzyme-specfic%2520Akt%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D385%26spage%3D399%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Application of combinatorial chemistry science on modern drug discovery</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc700187t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=345-354&author=J.+P.+Kennedyauthor=L.+Williamsauthor=T.+M.+Bridgesauthor=R.+N.+Danielsauthor=C.+D.+Weaverauthor=C.+W.+Lindsley&title=Application+of+combinatorial+chemistry+science+on+modern+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Combinatorial Chemistry Science on Modern Drug Discovery</span></div><div class="casAuthors">Kennedy, J. Phillip; Williams, Lyndsey; Bridges, Thomas M.; Daniels, R. Nathan; Weaver, David; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-354</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The science that established combinatorial chem. as important new discipline in the 1980s and 1990s, has reemerged and infiltrated every subdiscipline within modern drug discovery and has profound impact.  The application of combinatorial chem. science has revolutionized high-throughput screening paradigms, chem. lead optimization, library purifn. and postpurifn. sample handling, as well as in vitro and in vivo drug metab. and pharmacokinetic assays.  Although no longer in the spotlight and heralded as the savior of the drug industry, combinatorial chem. is alive and well: actually, combinatorial chem. science is more prevalent and widespread than ever before.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_FItqaRFGt7Vg90H21EOLACvtfcHk0liLX3tsb0-B9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFShsLo%253D&md5=b97fdb2d165b9b8645d773edf48d44fa</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcc700187t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc700187t%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DApplication%2520of%2520combinatorial%2520chemistry%2520science%2520on%2520modern%2520drug%2520discovery%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2008%26volume%3D10%26spage%3D345%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sootome, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatsuru, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majumder, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, H.</span><span> </span><span class="NLM_article-title">MK-2206, an allosteric Akt inhibitor, enhances tumor efficacy by standard chemotherapetuic agents or molecular targetd drugs in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1956</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1158%2F1535-7163.MCT-09-1012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=20571069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFertbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1956-1967&author=H.+Hiraiauthor=H.+Sootomeauthor=Y.+Nakatsuruauthor=K.+Miyamaauthor=S.+Taguchiauthor=K.+Tsukiokaauthor=Y.+Uenoauthor=H.+Hatchauthor=P.+K.+Majumderauthor=B.-S.+Panauthor=H.+Kotani&title=MK-2206%2C+an+allosteric+Akt+inhibitor%2C+enhances+tumor+efficacy+by+standard+chemotherapetuic+agents+or+molecular+targetd+drugs+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo</span></div><div class="casAuthors">Hirai, Hiroshi; Sootome, Hiroshi; Nakatsuru, Yoko; Miyama, Katsuyoshi; Taguchi, Shunsuke; Tsujioka, Kyoko; Ueno, Yoko; Hatch, Harold; Majumder, Pradip K.; Pan, Bo-Sheng; Kotani, Hidehito</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1956-1967</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The serine/threonine kinase Akt lies at a crit. signaling node downstream of phosphatidylinositol-3-kinase and is important in promoting cell survival and inhibiting apoptosis.  An Akt inhibitor may be particularly useful for cancers in which increased Akt signaling is assocd. with reduced sensitivity to cytotoxic agents or receptor tyrosine kinase inhibitors.  We evaluated the effect of a novel allosteric Akt inhibitor, MK-2206, in combination with several anticancer agents.  In vitro, MK-2206 synergistically inhibited cell proliferation of human cancer cell lines in combination with mol. targeted agents such as erlotinib (an epidermal growth factor receptor inhibitor) or lapatinib (a dual epidermal growth factor receptor/human epidermal growth factor receptor 2 inhibitor).  Complementary inhibition of erlotinib-insensitive Akt phosphorylation by MK-2206 was one mechanism of synergism, and a synergistic effect was found even in erlotinib-insensitive cell lines.  MK-2206 also showed synergistic responses in combination with cytotoxic agents such as topoisomerase inhibitors (doxorubicin, camptothecin), antimetabolites (gemcitabine, 5-fluorouracil), anti-microtubule agents (docetaxel), and DNA cross-linkers (carboplatin) in lung NCI-H460 or ovarian A2780 tumor cells.  The synergy with docetaxel depended on the treatment sequence; a schedule of MK-2206 dosed before docetaxel was not effective.  MK-2206 suppressed the Akt phosphorylation that is induced by carboplatin and gemcitabine.  In vivo, MK-2206 in combination with these agents exerted significantly more potent tumor inhibitory activities than each agent in the monotherapy setting.  These findings suggest that Akt inhibition may augment the efficacy of existing cancer therapeutics; thus, MK-2206 is a promising agent to treat cancer patients who receive these cytotoxic and/or mol. targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPgnWgk1SeALVg90H21EOLACvtfcHk0liLX3tsb0-B9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFertbnL&md5=f2d97ab64963cc82d97b35697e49b172</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1012%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DSootome%26aufirst%3DH.%26aulast%3DNakatsuru%26aufirst%3DY.%26aulast%3DMiyama%26aufirst%3DK.%26aulast%3DTaguchi%26aufirst%3DS.%26aulast%3DTsukioka%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DY.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DMajumder%26aufirst%3DP.%2BK.%26aulast%3DPan%26aufirst%3DB.-S.%26aulast%3DKotani%26aufirst%3DH.%26atitle%3DMK-2206%252C%2520an%2520allosteric%2520Akt%2520inhibitor%252C%2520enhances%2520tumor%2520efficacy%2520by%2520standard%2520chemotherapetuic%2520agents%2520or%2520molecular%2520targetd%2520drugs%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1956%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Calleja, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laguerre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larijani, B.</span><span> </span><span class="NLM_article-title">Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=189-200&author=V.+Callejaauthor=M.+Laguerreauthor=B.+Larijani&title=Role+of+a+novel+PH-kinase+domain+interface+in+PKB%2FAkt+regulation%3A+structural+mechanism+for+allosteric+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalleja%26aufirst%3DV.%26aulast%3DLaguerre%26aufirst%3DM.%26aulast%3DLarijani%26aufirst%3DB.%26atitle%3DRole%2520of%2520a%2520novel%2520PH-kinase%2520domain%2520interface%2520in%2520PKB%252FAkt%2520regulation%253A%2520structural%2520mechanism%2520for%2520allosteric%2520inhibition%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D189%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Okuzumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fielder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Inhibitor hijacking of Akt activation</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1038%2Fnchembio.183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=19465931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlarsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=484-493&author=T.+Okuzumiauthor=D.+Fielderauthor=C.+Zhangauthor=D.+C.+Grayauthor=B.+Aizensteinauthor=R.+Hoffmanauthor=K.+M.+Shokat&title=Inhibitor+hijacking+of+Akt+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor hijacking of Akt activation</span></div><div class="casAuthors">Okuzumi, Tatsuya; Fiedler, Dorothea; Zhang, Chao; Gray, Daniel C.; Aizenstein, Brian; Hoffman, Randy; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">484-493</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The kinase Akt plays a central role as a regulator of multiple growth factor input signals, thus making it an attractive anticancer drug target.  A-443654 is an ATP-competitive Akt inhibitor.  Unexpectedly, treatment of cells with A-443654 causes paradoxical hyperphosphorylation of Akt at its two regulatory sites (Thr308 and Ser473).  We explored whether inhibitor-induced hyperphosphorylation of Akt by A-443654 is a consequence of disrupted feedback regulation at a pathway level or whether it is a direct consequence of inhibitor binding to the ATP binding site of Akt.  Catalytically inactive mutants of Akt revealed that binding of an inhibitor to the ATP site of Akt is sufficient to directly cause hyperphosphorylation of the kinase in the absence of any pathway feedback effects.  We conclude that ATP-competitive Akt inhibitors impart regulatory phosphorylation of their target kinase Akt.  These results provide new insights into both natural regulation of Akt activation and Akt inhibitors entering the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWNjUB9YVue7Vg90H21EOLACvtfcHk0ljd0a12KAB_5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlarsrY%253D&md5=4edb5a0457fd9378850102a6414bfdb5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.183%26sid%3Dliteratum%253Aachs%26aulast%3DOkuzumi%26aufirst%3DT.%26aulast%3DFielder%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DGray%26aufirst%3DD.%2BC.%26aulast%3DAizenstein%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DR.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DInhibitor%2520hijacking%2520of%2520Akt%2520activation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D484%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors: physiology, pharmacology and disease</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=295-322&author=C.+M.+Niswenderauthor=P.+J.+Conn&title=Metabotropic+glutamate+receptors%3A+physiology%2C+pharmacology+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DMetabotropic%2520glutamate%2520receptors%253A%2520physiology%252C%2520pharmacology%2520and%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2010%26volume%3D50%26spage%3D295%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Emmittee, K. A.</span><span> </span><span class="NLM_article-title">Recent advances in the design and development of novel negative allosteric modulators of mGlu<sub>5</sub></span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn2000266" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=411-432&author=K.+A.+Emmittee&title=Recent+advances+in+the+design+and+development+of+novel+negative+allosteric+modulators+of+mGlu5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fcn2000266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2000266%26sid%3Dliteratum%253Aachs%26aulast%3DEmmittee%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%2520and%2520development%2520of%2520novel%2520negative%2520allosteric%2520modulators%2520of%2520mGlu5%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D411%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipe, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolkenberg, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theberge, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span> </span><span class="NLM_article-title">Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.2174%2F156802606777057599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=16719816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVahsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=771-785&author=C.+W.+Lindsleyauthor=W.+D.+Shipeauthor=S.+E.+Wolkenbergauthor=C.+R.+Thebergeauthor=D.+L.+Williamsauthor=C.+Surauthor=G.+G.+Kinney&title=Progress+towards+validating+the+NMDA+receptor+hypofunction+hypothesis+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia</span></div><div class="casAuthors">Lindsley, Craig W.; Shipe, William D.; Wolkenberg, Scott E.; Theberge, Cory R.; Williams, David L., Jr.; Sur, Cyrille; Kinney, Gene G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">771-785</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent progress towards validation of the N-methyl-D-aspartate (NMDA) receptor hypofunction hypothesis of schizophrenia in preclin. models.  Schizophrenia, a complex disease characterized by pos., neg. and cognitive symptoms, affects 1% of the world population and requires lifelong, daily maintenance therapy.  For the last several decades, thinking in this field has been dominated by the hypothesis that hyperfunction of dopamine pathways played a key role in schizophrenia.  However, the therapeutic agents developed from this hypothesis have a slow onset of action and tend to improve only the pos. symptoms of the disease.  The NMDA receptor antagonist PCP has been shown to induce the pos., neg. and cognitive symptoms of schizophrenia in healthy patients and cause a resurgence of symptoms in stable patients.  These observations led to the NMDA receptor hypofunction hypothesis as an alternative theory for the underlying cause of schizophrenia.  According to this hypothesis, any agent that can potentiate NMDA receptor currents has the potential to ameliorate the symptoms of schizophrenia.  To date, NMDA receptor currents can be modulated by either direct action on modulatory sites on the NMDA receptor (i.e., the glycine co-agonist binding site) or indirectly by activation of G-protein coupled receptors (GPCRs) known to potentiate NMDA receptor function (i.e., mGluR5).  This review will discuss the NMDA receptor hypofunction hypothesis, the NMDA receptor as an emerging target for the development of novel antipsychotic agents and progress towards in vivo target validation with GlyT1 inhibitors and mGluR5 pos. allosteric modulators.  Other potential targets for modulating NMDA receptor currents (polyamine sites, muscarinic receptors, etc...) will also be addressed briefly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnRBO2B8QD-rVg90H21EOLACvtfcHk0lgHD2IEfSI_Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVahsLw%253D&md5=4a9e3850e7b34bbb98b5a99ccc6ece07</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F156802606777057599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777057599%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DShipe%26aufirst%3DW.%2BD.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DTheberge%26aufirst%3DC.%2BR.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26atitle%3DProgress%2520towards%2520validating%2520the%2520NMDA%2520receptor%2520hypofunction%2520hypothesis%2520of%2520schizophrenia%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D771%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span> </span><span class="NLM_article-title">A family of highly selectiveallosteric modulators of the metabotropic glutamate receptor subtype 5</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=731-740&author=J.+A.+O%E2%80%99Brienauthor=W.+Lemaireauthor=T.+B.+Chenauthor=R.+S.+L.+Changauthor=M.+A.+Jacobsonauthor=S.+N.+Haauthor=C.+W.+Lindsleyauthor=H.+J.+Schaffhauserauthor=C.+Surauthor=D.+J.+Pettiboneauthor=P.+J.+Connauthor=D.+L.+Williams&title=A+family+of+highly+selectiveallosteric+modulators+of+the+metabotropic+glutamate+receptor+subtype+5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%2BB.%26aulast%3DChang%26aufirst%3DR.%2BS.%2BL.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DHa%26aufirst%3DS.%2BN.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26atitle%3DA%2520family%2520of%2520highly%2520selectiveallosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D731%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4098</span><span class="NLM_x">–</span> <span class="NLM_lpage">5101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1016%2Fj.bmcl.2008.05.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=18550372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslequro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4098-5101&author=S.+Sharmaauthor=A.+L.+Rodriguezauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Synthesis+and+SAR+of+a+mGluR5+allosteric+partial+antagonist+lead%3A+unexpected+modulation+of+pharmacology+with+slight+structural+modifications+to+a+5-%28phenylethynyl%29pyrimidine+scaffold"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: Unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold</span></div><div class="casAuthors">Sharma, Sameer; Rodriguez, Alice L.; Conn, P. Jeffrey; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4098-4101</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This Letter describes the synthesis and SAR, developed through an iterative analog library approach, of a mGluR5 allosteric partial antagonist lead based on a 5-(phenylethynyl)pyrimidine scaffold I (R = H, 3-Me, 3,5-F2, etc.).  With slight structural modifications to the distal Ph ring, analogs demonstrated a range of pharmacol. activities from mGluR5 partial antagonism to full antagonism/neg. allosteric modulation to pos. allosteric modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQBeYocKgYurVg90H21EOLACvtfcHk0ljFT8TNJs7FFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslequro%253D&md5=323d229f189185ed5d237e0a6e37e9a8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.091%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520a%2520mGluR5%2520allosteric%2520partial%2520antagonist%2520lead%253A%2520unexpected%2520modulation%2520of%2520pharmacology%2520with%2520slight%2520structural%2520modifications%2520to%2520a%25205-%2528phenylethynyl%2529pyrimidine%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4098%26epage%3D5101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedrowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of molecular switches that modulate modes of mGlu5 pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4103</span><span class="NLM_x">–</span> <span class="NLM_lpage">4106</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900654c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4103-4106&author=S.+Sharmaauthor=J.+Kedrowskiauthor=A.+L.+Rodriguezauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Discovery+of+molecular+switches+that+modulate+modes+of+mGlu5+pharmacology+in+vitro+and+in+vivo+within+a+series+of+functionalized%2C+regioisomeric+2-+and+5-%28phenylethynyl%29pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm900654c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900654c%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKedrowski%26aufirst%3DJ.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520molecular%2520switches%2520that%2520modulate%2520modes%2520of%2520mGlu5%2520pharmacology%2520in%2520vitro%2520and%2520in%2520vivo%2520within%2520a%2520series%2520of%2520functionalized%252C%2520regioisomeric%25202-%2520and%25205-%2528phenylethynyl%2529pyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4103%26epage%3D4106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">“Molecular Switches” on mGluR allosteric ligands that modulate modes of pharmacology</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2403</span><span class="NLM_x">–</span> <span class="NLM_lpage">2410</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi200129s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=2403-2410&author=M.+R.+Woodauthor=C.+R.+Hopkinsauthor=J.+T.+Broganauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=%E2%80%9CMolecular+Switches%E2%80%9D+on+mGluR+allosteric+ligands+that+modulate+modes+of+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fbi200129s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200129s%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DBrogan%26aufirst%3DJ.%2BT.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3D%25E2%2580%259CMolecular%2520Switches%25E2%2580%259D%2520on%2520mGluR%2520allosteric%2520ligands%2520that%2520modulate%2520modes%2520of%2520pharmacology%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D2403%26epage%3D2410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1124%2Fjpet.103.061747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=14747613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1yhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=568-577&author=J.+A.+O%E2%80%99Brienauthor=W.+Lemaireauthor=M.+Wittmannauthor=M.+A.+Jacobsonauthor=S.+N.+Haauthor=D.+D.+Wisnoskiauthor=C.+W.+Lindsleyauthor=H.+J.+Schaffhauserauthor=B.+Roweauthor=C.+Surauthor=D.+L.+Williamsauthor=P.+J.+Conn&title=A+novel+selective+allosteric+modulator+potentiates+the+activity+of+native+metabotropic+glutamate+receptor+subtype+5+in+rat+forebrain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain</span></div><div class="casAuthors">O'Brien, Julie A.; Wei, Lemaire; Wittmann, Marion; Jacobson, Marlene A.; Ha, Sookhee N.; Wisnoski, David D.; Lindsley, Craig W.; Schaffhauser, Herve J.; Rowe, Blake; Sur, Cyrille; Duggan, Mark E.; Pettibone, Douglas J.; Conn, P. Jeffrey; Williams, David L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">568-577</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We found that N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl) methyl]phenyl}-2-hydroxybenzamide (CPPHA), is a potent and selective pos. allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5).  CPPHA alone had no agonist activity and acted as a selective pos. allosteric modulator of human and rat mGluR5.  CPPHA potentiated threshold responses to glutamate in fluorometric Ca2+ assays 7- to 8-fold with EC50 values in the 400 to 800 nM range, and at 10 μM shifted mGluR5 agonist concn.-response curves to glutamate, quisqualate, and (R,S)-3,5-dihydroxyphenylglycine (DHPG) 4- to 7-fold to the left.  The only effect of CPPHA on other mGluRs was weak inhibition of mGluR4 and 8.  Neither CPPHA nor the previously described 3,3'-difluorobenzaldazine (DFB) affected [3H]quisqualate binding to mGluR5, but although DFB partially competed for [3H]3-methoxy-5-(2-pyridinylethynyl)pyridine binding, CPPHA had no effect on the binding of this 2-methyl-6-(phenylethynyl)pyridine analog to mGluR5.  Although the binding sites for the two classes of allosteric modulators seem to be different, these different allosteric sites can modulate functionally and mechanistically similar allosteric effects.  In electrophysiol. studies of brain slice prepns., it had been previously shown that activation of mGluR5 receptors by agonists increased N-methyl-D-aspartate (NMDA) receptor currents in the CA1 region of hippocampal slices.  We found that CPPHA (10 μM) potentiated NMDA receptor currents in hippocampal slices induced by threshold levels of DHPG, whereas having no effect on these currents by itself.  Similarly, 10 μM CPPHA also potentiated mGluR5-mediated DHPG-induced depolarization of rat subthalamic nucleus neurons.  These results demonstrate that allosteric potentiation of mGluR5 increases the effect of threshold agonist concns. in native systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobhO_ZGYafZbVg90H21EOLACvtfcHk0ljFT8TNJs7FFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1yhur0%253D&md5=7240162e8c2a4f9da3e010b2bbe2142a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.061747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.061747%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DHa%26aufirst%3DS.%2BN.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DRowe%26aufirst%3DB.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520novel%2520selective%2520allosteric%2520modulator%2520potentiates%2520the%2520activity%2520of%2520native%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520in%2520rat%2520forebrain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D568%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1386</span><span class="NLM_x">–</span> <span class="NLM_lpage">1391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1386-1391&author=Z.+Zhaoauthor=D.+D.+Wisnoskiauthor=W.+Lemaireauthor=J.+A.+O%E2%80%99Brienauthor=D.+L.+Williamsauthor=M.+A.+Jacobsonauthor=C.+W.+Lindsley&title=Challenges+in+the+development+of+mGluR5+positive+allosteric+modulators%3A+the+discovery+of+CPPHA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DChallenges%2520in%2520the%2520development%2520of%2520mGluR5%2520positive%2520allosteric%2520modulators%253A%2520the%2520discovery%2520of%2520CPPHA%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1386%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 (mGluR5) that potentiate receptor function in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5825</span><span class="NLM_x">–</span> <span class="NLM_lpage">5828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049400d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5825-5828&author=C.+W.+Lindsleyauthor=D.+D.+Wisnoskiauthor=M.+E.+Dugganauthor=W.+H.+Leisterauthor=G.+D.+Hartmanauthor=J.+R.+Huffauthor=D.+L.+Williamsauthor=J.+A.+O%E2%80%99Brienauthor=W.+Lemaireauthor=C.+Surauthor=G.+G.+Kinneyauthor=P.+J.+Connauthor=M.+E.+Duggan&title=Discovery+of+positive+allosteric+modulators+for+the+metabotropic+glutamate+receptor+subtype+5+%28mGluR5%29+that+potentiate+receptor+function+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm049400d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049400d%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520positive%2520allosteric%2520modulators%2520for%2520the%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520%2528mGluR5%2529%2520that%2520potentiate%2520receptor%2520function%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5825%26epage%3D5828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Kinney, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span> </span><span class="NLM_article-title">A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1124%2Fjpet.104.079244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=15608073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=199-206&author=G.+G.+Kinneyauthor=J.+A.+O%E2%80%99Brienauthor=W.+Lemaireauthor=M.+Burnoauthor=D.+J.+Bickelauthor=M.+K.+Clementsauthor=T.+B.+Chenauthor=D.+D.+Wisnoskiauthor=C.+W.+Lindsleyauthor=P.+R.+Tillerauthor=P.+J.+Connauthor=D.+L.+Williams&title=A+novel+selective+positive+allosteric+modulator+of+metabotropic+glutamate+receptor+subtype+5+has+in+vivo+activity+and+antipsychotic-like+effects+in+rat+behavioral+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models</span></div><div class="casAuthors">Kinney, Gene G.; O'Brien, Julie A.; Lemaire, Wei; Burno, Maryann; Bickel, Denise J.; Clements, Michelle K.; Chen, Tsing-Bau; Wisnoski, David D.; Lindsley, Craig W.; Tiller, Philip R.; Smith, Sheri; Jacobson, Marlene A.; Sur, Cyrille; Duggan, Mark E.; Pettibone, Douglas J.; Conn, P. Jeffrey; Williams, David L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We found that 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) is a potent and selective pos. allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5).  In Chinese hamster ovary cells expressing human mGluR5, CDPPB potentiated threshold responses to glutamate in fluorometric Ca2+ assays more than 7-fold with an EC50 value of approx. 27 nM.  At 1 μM, CDPPB shifted mGluR5 agonist concn. response curves to glutamate, quisqualate, and (R,S)-3,5-dihydroxyphenylglycine 3- to 9-fold to the left.  At higher concns., CDPPB exhibited agonist-like activity on cells expressing mGluR5.  No other activity was obsd. on any other mGluR or cell type at concns. up to 10 μM.  CDPPB had no effect on [3H]quisqualate binding to mGluR5 but did compete for binding of [3H]methoxyPEPy, an analog of the selective mGluR5 neg. allosteric modulator MPEP.  CDPPB was found to be brain penetrant and reversed amphetamine-induced locomotor activity and amphetamine-induced deficits in prepulse inhibition in rats, two models sensitive to antipsychotic drug treatment.  These results demonstrate that pos. allosteric modulation of mGluR5 produces behavioral effects, suggesting that such modulation serves as a viable approach to increasing mGluR5 activity in vivo.  These effects are consistent with the hypothesis that allosteric potentiation of mGluR5 may provide a novel approach for development of antipsychotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5MND_DZkDL7Vg90H21EOLACvtfcHk0lgXTjdnpr5zSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLg%253D&md5=371bb91ca8ac48cdf8b38c95634385da</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.079244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.079244%26sid%3Dliteratum%253Aachs%26aulast%3DKinney%26aufirst%3DG.%2BG.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DChen%26aufirst%3DT.%2BB.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DTiller%26aufirst%3DP.%2BR.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26atitle%3DA%2520novel%2520selective%2520positive%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520has%2520in%2520vivo%2520activity%2520and%2520antipsychotic-like%2520effects%2520in%2520rat%2520behavioral%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Stauffer, S. R.</span><span> </span><span class="NLM_article-title">Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGlu<sub>5</sub>)</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn2000519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFCmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=450-470&author=S.+R.+Stauffer&title=Progress+toward+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+subtype+5+%28mGlu5%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5)</span></div><div class="casAuthors">Stauffer, Shaun R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">450-470</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Review describes recent trends in the development of small mol. mGlu5 pos. allosteric modulators (PAMs).  A large body of pharmacol., genetic, electrophysiol., and in vivo behavioral evidence has accumulated over the past decade which continues to support the hypothesis and rationale for the activation of the metabotropic glutamate receptor subtype 5 (mGlu5) as a viable and promising target for the development of novel antipsychotics.  Until recently, functionally efficacious and potent mGlu5 PAMs have been somewhat structurally limited in scope and slow to emerge.  This Review will discuss efforts since late 2008 which have provided novel mGlu5 PAM chemotypes, offering ligands with a diverse range of pharmacol., physicochem., and DMPK properties that were previously unavailable.  In addn., significant biol. studies of importance in the past few years using the well established PAMs known as DFB, CPPHA, CDPPB, and ADX-47273 will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHnCTYtdTjz7Vg90H21EOLACvtfcHk0lgIthhjMrtIpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFCmsbY%253D&md5=496ce47a9c3efefdd078844493b8011e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fcn2000519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2000519%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26atitle%3DProgress%2520toward%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520%2528mGlu5%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D450%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Parmentier-Batteur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forest, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tynebor, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauré, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosahl, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span> </span><span class="NLM_article-title">Mechanism based neurotoxicity of mGlu5 positive allosteric modulators: development challenges for a promising novel antipsychotic target</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=161-173&author=S.+Parmentier-Batteurauthor=P.+H.+Hutsonauthor=K.+Menzelauthor=J.+M.+Uslanerauthor=B.+A.+Mattsonauthor=J.+A.+O%E2%80%99Brienauthor=B.+C.+Magliaroauthor=T.+Forestauthor=C.+A.+Stumpauthor=R.+M.+Tyneborauthor=N.+J.+Anthonyauthor=T.+J.+Tuckerauthor=X.+F.+Zhangauthor=R.+Gomezauthor=S.+L.+Huszarauthor=N.+Lambengauthor=H.+Faur%C3%A9author=E.+Le+Poulauthor=S.+Poliauthor=T.+W.+Rosahlauthor=J.+P.+Rocherauthor=R.+Hargreavesauthor=T.+M.+Williams&title=Mechanism+based+neurotoxicity+of+mGlu5+positive+allosteric+modulators%3A+development+challenges+for+a+promising+novel+antipsychotic+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParmentier-Batteur%26aufirst%3DS.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DMenzel%26aufirst%3DK.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DForest%26aufirst%3DT.%26aulast%3DStump%26aufirst%3DC.%2BA.%26aulast%3DTynebor%26aufirst%3DR.%2BM.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DTucker%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%2BF.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DLambeng%26aufirst%3DN.%26aulast%3DFaur%25C3%25A9%26aufirst%3DH.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DRosahl%26aufirst%3DT.%2BW.%26aulast%3DRocher%26aufirst%3DJ.%2BP.%26aulast%3DHargreaves%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26atitle%3DMechanism%2520based%2520neurotoxicity%2520of%2520mGlu5%2520positive%2520allosteric%2520modulators%253A%2520development%2520challenges%2520for%2520a%2520promising%2520novel%2520antipsychotic%2520target%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D82%26spage%3D161%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogliotti, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span> </span><span class="NLM_article-title">Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanism</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1714</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=1703-1714&author=T.+M.+Bridgesauthor=J.+R.+Rookauthor=M.+J.+Noetzelauthor=R.+D.+Morrisonauthor=Y.+Zhouauthor=R.+D.+Gogliottiauthor=P.+N.+Vinsonauthor=Z.+Xiangauthor=C.+K.+Jonesauthor=C.+M.+Niswenderauthor=C.+W.+Lindsleyauthor=S.+R.+Staufferauthor=P.+J.+Connauthor=S.+J.+Daniels&title=Biotransformation+of+a+novel+positive+allosteric+modulator+of+metabotropic+glutamate+receptor+subtype+5+contributes+to+seizure-like+adverse+events+in+rats+involving+a+receptor+agonism-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DRook%26aufirst%3DJ.%2BR.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26atitle%3DBiotransformation%2520of%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520contributes%2520to%2520seizure-like%2520adverse%2520events%2520in%2520rats%2520involving%2520a%2520receptor%2520agonism-dependent%2520mechanism%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D1703%26epage%3D1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouliot, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Unique signaling profiles of positive allosteric modulators of metabotropic mlutamate receptor subtype 5 determine differences in in vivo activity</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1016%2Fj.biopsych.2012.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=23140665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GktLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=501-509&author=J.+M.+Rookauthor=M.+J.+Noetzelauthor=W.+A.+Pouliotauthor=T.+M.+Bridgesauthor=P.+N.+Vinsonauthor=H.+P.+Choauthor=Y.+Zhouauthor=S.+R.+Staufferauthor=C.+M.+Niswenderauthor=S.+J.+Danielsauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Unique+signaling+profiles+of+positive+allosteric+modulators+of+metabotropic+mlutamate+receptor+subtype+5+determine+differences+in+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Unique Signaling Profiles of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Determine Differences in In Vivo Activity</span></div><div class="casAuthors">Rook, Jerri M.; Noetzel, Meredith J.; Pouliot, Wendy A.; Bridges, Thomas M.; Vinson, Paige N.; Cho, Hyekyung P.; Zhou, Ya; Gogliotti, Rocco D.; Manka, Jason T.; Gregory, Karen J.; Stauffer, Shaun R.; Dudek, F. Edward; Xiang, Zixiu; Niswender, Colleen M.; Daniels, J. Scott; Jones, Carrie K.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">501-509</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Metabotropic glutamate receptor subtype 5 (mGlu5) activators have emerged as a novel approach to the treatment of schizophrenia.  Pos. allosteric modulators (PAMs) of mGlu5 have generated tremendous excitement and fueled major drug discovery efforts.  Although mGlu5 PAMs have robust efficacy in preclin. models of schizophrenia, preliminary reports suggest that these compds. may induce seizure activity.  Prototypical mGlu5 PAMs do not activate mGlu5 directly but selectively potentiate activation of mGlu5 by glutamate.  This mechanism may be crit. to maintaining normal activity-dependence of mGlu5 activation and achieving optimal in vivo effects.Using specially engineered mGlu5 cell lines incorporating point mutations within the allosteric and orthosteric binding sites, as well as brain slice electrophysiol. and in vivo electroencephalog. and behavioral pharmacol., we found that some mGlu5 PAMs have intrinsic allosteric agonist activity in the absence of glutamate.  Both in vitro mutagenesis and in vivo pharmacol. studies demonstrate that VU0422465 is an agonist PAM that induces epileptiform activity and behavioral convulsions in rodents.  In contrast, VU0361747, an mGlu5 PAMs optimized to eliminate allosteric agonist activity, has robust in vivo efficacy and does not induce adverse effects at doses that yield high brain concns.Loss of the abs. dependence of mGlu5 PAMs on glutamate release for their activity can lead to severe adverse effects.  The finding that closely related mGlu5 PAMs can differ in their intrinsic agonist activity provides crit. new insights that is essential for advancing these mols. through clin. development for treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEnfOyxRj5nrVg90H21EOLACvtfcHk0ljta0bNKRs5ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GktLrM&md5=f8aba766e4ddf4fb28b3e3166ce8cd8c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DPouliot%26aufirst%3DW.%2BA.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DUnique%2520signaling%2520profiles%2520of%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520mlutamate%2520receptor%2520subtype%25205%2520determine%2520differences%2520in%2520in%2520vivo%2520activity%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D73%26spage%3D501%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Schann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frauli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuville, P.</span><span> </span><span class="NLM_article-title">Chemical switch of a metabotropic glutamate receptor 2 silent sllosteric modulator into dual metabotropic glutamate receptor 2/3 negative/positive allosteric modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8775</span><span class="NLM_x">–</span> <span class="NLM_lpage">8779</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101069m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8775-8779&author=S.+Schannauthor=S.+Mayerauthor=C.+Franchetauthor=M.+Frauliauthor=E.+Steinbergauthor=M.+Thomasauthor=L.+Baronauthor=P.+Neuville&title=Chemical+switch+of+a+metabotropic+glutamate+receptor+2+silent+sllosteric+modulator+into+dual+metabotropic+glutamate+receptor+2%2F3+negative%2Fpositive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm101069m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101069m%26sid%3Dliteratum%253Aachs%26aulast%3DSchann%26aufirst%3DS.%26aulast%3DMayer%26aufirst%3DS.%26aulast%3DFranchet%26aufirst%3DC.%26aulast%3DFrauli%26aufirst%3DM.%26aulast%3DSteinberg%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DBaron%26aufirst%3DL.%26aulast%3DNeuville%26aufirst%3DP.%26atitle%3DChemical%2520switch%2520of%2520a%2520metabotropic%2520glutamate%2520receptor%25202%2520silent%2520sllosteric%2520modulator%2520into%2520dual%2520metabotropic%2520glutamate%2520receptor%25202%252F3%2520negative%252Fpositive%2520allosteric%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8775%26epage%3D8779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Utley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddenham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salovich, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamorano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: unexpected “molecular switch” from a closely related mGlu4 positive allosteric modulator</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6955</span><span class="NLM_x">–</span> <span class="NLM_lpage">6959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6955-6959&author=T.+Utleyauthor=D.+Haddenhamauthor=J.+M.+Salovichauthor=R.+Zamoranoauthor=P.+N.+Vinsonauthor=C.+W.+Lindsleyauthor=C.+R.+Hopkinsauthor=C.+M.+Niswender&title=Synthesis+and+SAR+of+a+novel+metabotropic+glutamate+receptor+4+%28mGlu4%29+antagonist%3A+unexpected+%E2%80%9Cmolecular+switch%E2%80%9D+from+a+closely+related+mGlu4+positive+allosteric+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUtley%26aufirst%3DT.%26aulast%3DHaddenham%26aufirst%3DD.%26aulast%3DSalovich%26aufirst%3DJ.%2BM.%26aulast%3DZamorano%26aufirst%3DR.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520a%2520novel%2520metabotropic%2520glutamate%2520receptor%25204%2520%2528mGlu4%2529%2520antagonist%253A%2520unexpected%2520%25E2%2580%259Cmolecular%2520switch%25E2%2580%259D%2520from%2520a%2520closely%2520related%2520mGlu4%2520positive%2520allosteric%2520modulator%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6955%26epage%3D6959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Digby, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamsal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebois, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding mode</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn300103e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWru7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1025-1036&author=G.+J.+Digbyauthor=T.+J.+Utleyauthor=A.+Lamsalauthor=C.+Sevelauthor=D.+J.+Shefflerauthor=E.+P.+Leboisauthor=T.+M.+Bridgesauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Chemical+modification+of+the+M%281%29+agonist+VU0364572+reveals+molecular+switches+in+pharmacology+and+a+bitopic+binding+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Modification of the M1 Agonist VU0364572 Reveals Molecular Switches in Pharmacology and a Bitopic Binding Mode</span></div><div class="casAuthors">Digby, Gregory J.; Utley, Thomas J.; Lamsal, Atin; Sevel, Christian; Sheffler, Douglas J.; Lebois, Evan P.; Bridges, Thomas M.; Wood, Michael R.; Niswender, Colleen M.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1025-1036</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously reported the discovery of VU0364572 and VU0357017 as M1-selective agonists that appear to activate M1 through actions at an allosteric site.  Previous studies have revealed that chem. scaffolds for many allosteric modulators contain mol. switches that allow discovery of allosteric antagonists and allosteric agonists or pos. allosteric modulators (PAMs) based on a single chem. scaffold.  Based on this, we initiated a series of studies to develop selective M1 allosteric antagonists based on the VU0364572 scaffold.  Interestingly, two lead antagonists identified in this series, VU0409774 and VU0409775, inhibited ACh-induced Ca2+ responses at rat M1-5 receptor subtypes, suggesting they are nonselective muscarinic antagonists.  VU0409774 and VU0409775 also completely displaced binding of the nonselective radioligand [3H]-NMS at M1 and M3 mAChRs with affinities similar to their functional IC50 values.  Finally, Schild anal. revealed that these compds. inhibit M1 responses through a fully competitive interaction at the orthosteric binding site.  This surprising finding prompted further studies to det. whether agonist activity of VU0364572 and VU0357017 may also engage in previously unappreciated actions at the orthosteric site on M1.  Surprisingly, both VU0364572 and VU0357017 completely displaced [3H]-NMS binding to the orthosteric site of M1-M5 receptors at high concns.  Furthermore, evaluation of agonist activity in systems with varying levels of receptor reserve and Furchgott anal. using a cell line expressing M1 under control of an inducible promotor was consistent with an action of these compds. as weak orthosteric partial agonists of M1.  However, consistent with previous studies suggesting actions at a site that is distinct from the orthosteric binding site, VU0364572 or VU0357017 slowed the rate of [3H]-NMS dissocn. from CHO-rM1 membranes.  Together, these results suggest that VU0364572 and VU0357017 act as bitopic ligands and that novel antagonists in this series act as competitive orthosteric site antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8v_k1NUXafLVg90H21EOLACvtfcHk0lg4tTwGmN0vBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWru7fI&md5=16540c6580d192252e09013a9ffffb17</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fcn300103e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300103e%26sid%3Dliteratum%253Aachs%26aulast%3DDigby%26aufirst%3DG.%2BJ.%26aulast%3DUtley%26aufirst%3DT.%2BJ.%26aulast%3DLamsal%26aufirst%3DA.%26aulast%3DSevel%26aufirst%3DC.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DLebois%26aufirst%3DE.%2BP.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DChemical%2520modification%2520of%2520the%2520M%25281%2529%2520agonist%2520VU0364572%2520reveals%2520molecular%2520switches%2520in%2520pharmacology%2520and%2520a%2520bitopic%2520binding%2520mode%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D1025%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Luker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sargent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paine, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairaudeau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougall, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millichip, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInally, T.</span><span> </span><span class="NLM_article-title">Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acids</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3616</span><span class="NLM_x">–</span> <span class="NLM_lpage">3621</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3616-3621&author=T.+Lukerauthor=R.+Bonnertauthor=R.+Schmidtauthor=C.+Sargentauthor=S.+W.+Paineauthor=S.+Thomauthor=G.+Pairaudeauauthor=A.+Patelauthor=R.+Mohammedauthor=E.+Akamauthor=I.+Dougallauthor=A.+M.+Davisauthor=S.+Abbottauthor=I.+Millichipauthor=T.+McInally&title=Switching+between+agonists+and+antagonists+at+CRTh2+in+a+series+of+highly+potent+and+selective+biaryl+phenoxyacetic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuker%26aufirst%3DT.%26aulast%3DBonnert%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DSargent%26aufirst%3DC.%26aulast%3DPaine%26aufirst%3DS.%2BW.%26aulast%3DThom%26aufirst%3DS.%26aulast%3DPairaudeau%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DMohammed%26aufirst%3DR.%26aulast%3DAkam%26aufirst%3DE.%26aulast%3DDougall%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DAbbott%26aufirst%3DS.%26aulast%3DMillichip%26aufirst%3DI.%26aulast%3DMcInally%26aufirst%3DT.%26atitle%3DSwitching%2520between%2520agonists%2520and%2520antagonists%2520at%2520CRTh2%2520in%2520a%2520series%2520of%2520highly%2520potent%2520and%2520selective%2520biaryl%2520phenoxyacetic%2520acids%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3616%26epage%3D3621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Cheung, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haibo, Yu.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiping, Xu.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beiyan, Zou</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span> </span><span class="NLM_article-title">Discovery of a series of 2-phenyl-<i>N</i>-(2-(pyrrolidin-1-yl) phenyl) acetamides as novel molecular switches that modulate modes of Kv7. 2 (KCNQ2) channel</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6975</span><span class="NLM_x">–</span> <span class="NLM_lpage">6979</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300700v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6975-6979&author=Y.+Y.+Cheungauthor=Yu.+Haiboauthor=Xu.+Kaipingauthor=Zou+Beiyanauthor=C.+W.+Lindsleyauthor=M.+Liauthor=C.+R.+Hopkins&title=Discovery+of+a+series+of+2-phenyl-N-%282-%28pyrrolidin-1-yl%29+phenyl%29+acetamides+as+novel+molecular+switches+that+modulate+modes+of+Kv7.+2+%28KCNQ2%29+channel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm300700v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300700v%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DY.%2BY.%26aulast%3DHaibo%26aufirst%3DYu.%26aulast%3DKaiping%26aufirst%3DXu.%26aulast%3DBeiyan%26aufirst%3DZou%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%25202-phenyl-N-%25282-%2528pyrrolidin-1-yl%2529%2520phenyl%2529%2520acetamides%2520as%2520novel%2520molecular%2520switches%2520that%2520modulate%2520modes%2520of%2520Kv7.%25202%2520%2528KCNQ2%2529%2520channel%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6975%26epage%3D6979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure–function studies and structure–activity relationships</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=860-875&author=K.+J.+Gregoryauthor=M.+J.+Noetzelauthor=J.+M.+Rookauthor=P.+N.+Vinsonauthor=S.+R.+Staufferauthor=A.+L.+Rodriguezauthor=K.+A.+Emmitteauthor=C.+M.+Niswenderauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Investigating+metabotropic+glutamate+receptor+5+allosteric+modulator+cooperativity%2C+affinity%2C+and+agonism%3A+enriching+structure%E2%80%93function+studies+and+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DInvestigating%2520metabotropic%2520glutamate%2520receptor%25205%2520allosteric%2520modulator%2520cooperativity%252C%2520affinity%252C%2520and%2520agonism%253A%2520enriching%2520structure%25E2%2580%2593function%2520studies%2520and%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D860%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenthur, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruner, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrington, S. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogi, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vamos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu<sub>3</sub>) NAM probe (ML289) derived from a closely related mGlu<sub>5</sub> PAM</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3921</span><span class="NLM_x">–</span> <span class="NLM_lpage">3925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3921-3925&author=D.+J.+Shefflerauthor=C.+R.+Wenthurauthor=J.+A.+Brunerauthor=S.+J.+S.+Carringtonauthor=P.+N.+Vinsonauthor=K.+K.+Gogiauthor=A.+L.+Blobaumauthor=R.+D.+Morrisonauthor=M.+Vamosauthor=N.+D.+P.+Cosfordauthor=S.+R.+Staufferauthor=S.+J.+Danielsauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Development+of+a+novel%2C+CNS-penetrant%2C+metabotropic+glutamate+receptor+3+%28mGlu3%29+NAM+probe+%28ML289%29+derived+from+a+closely+related+mGlu5+PAM"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DWenthur%26aufirst%3DC.%2BR.%26aulast%3DBruner%26aufirst%3DJ.%2BA.%26aulast%3DCarrington%26aufirst%3DS.%2BJ.%2BS.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DGogi%26aufirst%3DK.%2BK.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DVamos%26aufirst%3DM.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDevelopment%2520of%2520a%2520novel%252C%2520CNS-penetrant%252C%2520metabotropic%2520glutamate%2520receptor%25203%2520%2528mGlu3%2529%2520NAM%2520probe%2520%2528ML289%2529%2520derived%2520from%2520a%2520closely%2520related%2520mGlu5%2520PAM%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3921%26epage%3D3925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Wenthur, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engers, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byers, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-(2-fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-hydroxypiperidin-1-yl)methanone (ML337), an mGlu<sub>3</sub> selective and CNS penetrant negative allosteric modulator (NAM)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5308</span><span class="NLM_x">–</span> <span class="NLM_lpage">5212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5308-5212&author=C.+J.+Wenthurauthor=R.+Morrisonauthor=A.+S.+Feltsauthor=K.+A.+Smithauthor=J.+L.+Engersauthor=F.+W.+Byersauthor=J.+S.+Danielsauthor=K.+A.+Emmitteauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Discovery+of+%28R%29-%282-fluoro-4-%28%28-4-methoxyphenyl%29ethynyl%29phenyl%29+%283-hydroxypiperidin-1-yl%29methanone+%28ML337%29%2C+an+mGlu3+selective+and+CNS+penetrant+negative+allosteric+modulator+%28NAM%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWenthur%26aufirst%3DC.%2BJ.%26aulast%3DMorrison%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DSmith%26aufirst%3DK.%2BA.%26aulast%3DEngers%26aufirst%3DJ.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520%2528R%2529-%25282-fluoro-4-%2528%2528-4-methoxyphenyl%2529ethynyl%2529phenyl%2529%2520%25283-hydroxypiperidin-1-yl%2529methanone%2520%2528ML337%2529%252C%2520an%2520mGlu3%2520selective%2520and%2520CNS%2520penetrant%2520negative%2520allosteric%2520modulator%2520%2528NAM%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5308%26epage%3D5212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Notartomaso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappulla, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagioni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarselli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lionetto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmaco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battaglia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Signore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span> </span><span class="NLM_article-title">Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1</span> <span class="citation_source-journal">Mol. Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1650</span><span class="NLM_x">–</span> <span class="NLM_lpage">1666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1650-1666&author=S.+Notartomasoauthor=C.+Zappullaauthor=F.+Biagioniauthor=M.+Cannellaauthor=D.+Bucciauthor=G.+Mascioauthor=P.+Scarselliauthor=F.+Fazioauthor=F.+Weiszauthor=L.+Lionettoauthor=M.+Simmacoauthor=R.+Gradiniauthor=G.+Battagliaauthor=M.+Signoreauthor=A.+Pulitiauthor=F.+Nicoletti&title=Pharmacological+enhancement+of+mGlu1+metabotropic+glutamate+receptors+causes+a+prolonged+symptomatic+benefit+in+a+mouse+model+of+spinocerebellar+ataxia+type+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNotartomaso%26aufirst%3DS.%26aulast%3DZappulla%26aufirst%3DC.%26aulast%3DBiagioni%26aufirst%3DF.%26aulast%3DCannella%26aufirst%3DM.%26aulast%3DBucci%26aufirst%3DD.%26aulast%3DMascio%26aufirst%3DG.%26aulast%3DScarselli%26aufirst%3DP.%26aulast%3DFazio%26aufirst%3DF.%26aulast%3DWeisz%26aufirst%3DF.%26aulast%3DLionetto%26aufirst%3DL.%26aulast%3DSimmaco%26aufirst%3DM.%26aulast%3DGradini%26aufirst%3DR.%26aulast%3DBattaglia%26aufirst%3DG.%26aulast%3DSignore%26aufirst%3DM.%26aulast%3DPuliti%26aufirst%3DA.%26aulast%3DNicoletti%26aufirst%3DF.%26atitle%3DPharmacological%2520enhancement%2520of%2520mGlu1%2520metabotropic%2520glutamate%2520receptors%2520causes%2520a%2520prolonged%2520symptomatic%2520benefit%2520in%2520a%2520mouse%2520model%2520of%2520spinocerebellar%2520ataxia%2520type%25201%26jtitle%3DMol.%2520Brain%26date%3D2013%26volume%3D19%26spage%3D1650%26epage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span> </span><span class="NLM_article-title">Re-exploration of the PHCCC scaffold: discovery of improved positive allosteric modulators of mGlu4</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn9000318" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivVOgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=411-419&author=R.+Williamsauthor=Y.+Zhouauthor=C.+M.+Niswenderauthor=Q.+Luoauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+R.+Hopkins&title=Re-exploration+of+the+PHCCC+scaffold%3A+discovery+of+improved+positive+allosteric+modulators+of+mGlu4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Re-exploration of the PHCCC Scaffold: Discovery of Improved Positive Allosteric Modulators of mGluR4</span></div><div class="casAuthors">Williams, Richard; Zhou, Ya; Niswender, Colleen M.; Luo, Qingwei; Conn, P. Jeffrey; Lindsley, Craig W.; Hopkins, Corey R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">411-419</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes a detailed structure-activity relation (SAR) anal. of the metabotropic glutamate receptor 4 (mGluR4) pos. allosteric modulator, (-)-N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide (PHCCC).  The authors have now developed compds. with improved potency and efficacy; in addn., compds. are presented that show selectivity for mGluR4 vs. the other mGluR subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK2WcP_RojsbVg90H21EOLACvtfcHk0lgXVlJ_PNhPlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivVOgu70%253D&md5=e2d43eefe332164e71002af710ba1fd8</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fcn9000318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn9000318%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DRe-exploration%2520of%2520the%2520PHCCC%2520scaffold%253A%2520discovery%2520of%2520improved%2520positive%2520allosteric%2520modulators%2520of%2520mGlu4%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D411%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engers, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogliotti, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamorano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrsion, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span> </span><span class="NLM_article-title">Discovery, synthesis, and structure–activity relationship development of a series of <i>N</i>-4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu<sub>4</sub>) with oral efficacy in an antiparkinsonian animal model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7639</span><span class="NLM_x">–</span> <span class="NLM_lpage">7647</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200956q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7639-7647&author=C.+K.+Jonesauthor=D.+W.+Engersauthor=A.+D.+Thompsonauthor=J.+R.+Fieldauthor=A.+L.+Blobaumauthor=S.+R.+Lindsleyauthor=Y.+Zhouauthor=R.+D.+Gogliottiauthor=S.+Jadhavauthor=R.+Zamoranoauthor=Y.+Smithauthor=R.+Morrsionauthor=S.+J.+Danielsauthor=C.+D.+Weaverauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+M.+Niswenderauthor=C.+R.+Hopkins&title=Discovery%2C+synthesis%2C+and+structure%E2%80%93activity+relationship+development+of+a+series+of+N-4-%282%2C5-dioxopyrrolidin-1-yl%29phenylpicolinamides+%28VU0400195%2C+ML182%29%3A+characterization+of+a+novel+positive+allosteric+modulator+of+the+metabotropic+glutamate+receptor+4+%28mGlu4%29+with+oral+efficacy+in+an+antiparkinsonian+animal+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm200956q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200956q%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DEngers%26aufirst%3DD.%2BW.%26aulast%3DThompson%26aufirst%3DA.%2BD.%26aulast%3DField%26aufirst%3DJ.%2BR.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DLindsley%26aufirst%3DS.%2BR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DJadhav%26aufirst%3DS.%26aulast%3DZamorano%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DY.%26aulast%3DMorrsion%26aufirst%3DR.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520development%2520of%2520a%2520series%2520of%2520N-4-%25282%252C5-dioxopyrrolidin-1-yl%2529phenylpicolinamides%2520%2528VU0400195%252C%2520ML182%2529%253A%2520characterization%2520of%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25204%2520%2528mGlu4%2529%2520with%2520oral%2520efficacy%2520in%2520an%2520antiparkinsonian%2520animal%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7639%26epage%3D7647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engers, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span> </span><span class="NLM_article-title">A novel class of succinimide-derived negative allosteric modulators of metabotropic glutamate receptor subtype 1 provides insight into a disconnect in activity between the rat and human receptors</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn5000343" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlKmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=597-610&author=H.+P.+Choauthor=D.+W.+Engersauthor=D.+F.+Venableauthor=C.+M.+Niswenderauthor=C.+W.+Lindsleyauthor=P.+J.+Connauthor=K.+A.+Emmitteauthor=A.+L.+Rodriguez&title=A+novel+class+of+succinimide-derived+negative+allosteric+modulators+of+metabotropic+glutamate+receptor+subtype+1+provides+insight+into+a+disconnect+in+activity+between+the+rat+and+human+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Class of Succinimide-Derived Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Provides Insight into a Disconnect in Activity between the Rat and Human Receptors</span></div><div class="casAuthors">Cho, Hyekyung P.; Engers, Darren W.; Venable, Daryl F.; Niswender, Colleen M.; Lindsley, Craig W.; Conn, P. Jeffrey; Emmitte, Kyle A.; Rodriguez, Alice L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">597-610</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent progress in the discovery of mGlu1 allosteric modulators has suggested the modulation of mGlu1 could offer possible treatment for a no. of central nervous system disorders; however, the available chemotypes are inadequate to fully investigate the therapeutic potential of mGlu1 modulation.  To address this issue, we used a fluorescence-based high-throughput screening assay to screen an allosteric modulator-biased library of compds. to generate structurally diverse mGlu1 neg. allosteric modulator hits for chem. optimization.  Herein, we describe the discovery and characterization of a novel mGlu1 chemotype.  This series of succinimide neg. allosteric modulators, exemplified by VU0410425 (I), exhibited potent inhibitory activity at rat mGlu1 but was, surprisingly, inactive at human mGlu1.  VU0410425 and a set of chem. diverse mGlu1 neg. allosteric modulators previously reported in the literature were utilized to examine this species disconnect between rat and human mGlu1 activity.  Mutation of the key transmembrane domain residue 757 and functional screening of VU0410425 and the literature compds. suggests that amino acid 757 plays a role in the activity of these compds., but the contribution of the residue is scaffold specific, ranging from crit. to minor.  The operational model of allosterism was used to est. the binding affinities of each compd. to compare to functional data.  This novel series of mGlu1 neg. allosteric modulators provides valuable insight into the pharmacol. underlying the disconnect between rat and human mGlu1 activity, an issue that must be understood to progress the therapeutic potential of allosteric modulators of mGlu1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprK6LSEGOtMrVg90H21EOLACvtfcHk0lgbvw_4pm1Lgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlKmu7k%253D&md5=54af5fcfaeb7393c3a175751dde74264</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fcn5000343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn5000343%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DEngers%26aufirst%3DD.%2BW.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26atitle%3DA%2520novel%2520class%2520of%2520succinimide-derived%2520negative%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25201%2520provides%2520insight%2520into%2520a%2520disconnect%2520in%2520activity%2520between%2520the%2520rat%2520and%2520human%2520receptors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D597%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barrantes, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morriosn, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Chemical modulation of mutant mGlu1receptors derived from deleterious GRM1 mutations found in schizophrenics: development of novel mGlu1 PAMs via a “double molecular switch” of an mGlu4 PAM chemotype</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/cb500560h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500560h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.+P.+Choauthor=P.+M.+Garcia-Barrantesauthor=J.+T.+Broganauthor=C.+R.+Hopkinsauthor=C.+M.+Niswenderauthor=A.+L.+Rodriguezauthor=D.+Venableauthor=R.+D.+Morriosnauthor=M.+Bubserauthor=S.+J.+Danielsauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Chemical+modulation+of+mutant+mGlu1receptors+derived+from+deleterious+GRM1+mutations+found+in+schizophrenics%3A+development+of+novel+mGlu1+PAMs+via+a+%E2%80%9Cdouble+molecular+switch%E2%80%9D+of+an+mGlu4+PAM+chemotype&doi=10.1021%2Fcb500560h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fcb500560h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500560h%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DGarcia-Barrantes%26aufirst%3DP.%2BM.%26aulast%3DBrogan%26aufirst%3DJ.%2BT.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DVenable%26aufirst%3DD.%26aulast%3DMorriosn%26aufirst%3DR.%2BD.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DChemical%2520modulation%2520of%2520mutant%2520mGlu1receptors%2520derived%2520from%2520deleterious%2520GRM1%2520mutations%2520found%2520in%2520schizophrenics%253A%2520development%2520of%2520novel%2520mGlu1%2520PAMs%2520via%2520a%2520%25E2%2580%259Cdouble%2520molecular%2520switch%25E2%2580%259D%2520of%2520an%2520mGlu4%2520PAM%2520chemotype%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26doi%3D10.1021%2Fcb500560h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlo, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahhav, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy <i>N</i>-benzyl isatins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3445</span><span class="NLM_x">–</span> <span class="NLM_lpage">3448</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900286j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3445-3448&author=T.+M.+Bridgesauthor=J.+E.+Marloauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=S.+B.+Jahhavauthor=P.+R.+Gentryauthor=H.+P.+Choauthor=C.+D.+Weaverauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Discovery+of+the+first+highly+M5-preferring+muscarinic+acetylcholine+receptor+ligand%2C+an+M5+positive+allosteric+modulator+derived+from+a+series+of+5-trifluoromethoxy+N-benzyl+isatins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm900286j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900286j%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DMarlo%26aufirst%3DJ.%2BE.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DJahhav%26aufirst%3DS.%2BB.%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520first%2520highly%2520M5-preferring%2520muscarinic%2520acetylcholine%2520receptor%2520ligand%252C%2520an%2520M5%2520positive%2520allosteric%2520modulator%2520derived%2520from%2520a%2520series%2520of%25205-trifluoromethoxy%2520N-benzyl%2520isatins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3445%26epage%3D3448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breininger, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Chemical lead optimization of a Ppan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: Development of a potent and highly selective M1 PAM</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1972</span><span class="NLM_x">–</span> <span class="NLM_lpage">1975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1972-1975&author=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=M.+J.+Noetzelauthor=M.+L.+Breiningerauthor=P.+R.+Gentryauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Chemical+lead+optimization+of+a+Ppan+Gq+mAChR+M1%2C+M3%2C+M5+positive+allosteric+modulator+%28PAM%29+lead.+Part+II%3A+Development+of+a+potent+and+highly+selective+M1+PAM"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DBreininger%26aufirst%3DM.%2BL.%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DChemical%2520lead%2520optimization%2520of%2520a%2520Ppan%2520Gq%2520mAChR%2520M1%252C%2520M3%252C%2520M5%2520positive%2520allosteric%2520modulator%2520%2528PAM%2529%2520lead.%2520Part%2520II%253A%2520Development%2520of%2520a%2520potent%2520and%2520highly%2520selective%2520M1%2520PAM%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1972%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Mirza, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparks, R. G.</span><span> </span><span class="NLM_article-title">Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1111%2Fj.1527-3458.2003.tb00247.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=12847557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsl2qt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=159-186&author=N.+R.+Mirzaauthor=D.+Petersauthor=R.+G.+Sparks&title=Xanomeline+and+the+antipsychotic+potential+of+muscarinic+receptor+subtype+selective+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists</span></div><div class="casAuthors">Mirza, Naheed R.; Peters, Dan; Sparks, Robin G.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drug Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-186</span>CODEN:
                <span class="NLM_cas:coden">CDREFB</span>;
        ISSN:<span class="NLM_cas:issn">1080-563X</span>.
    
            (<span class="NLM_cas:orgname">Neva Press</span>)
        </div><div class="casAbstract">A review.  Binding studies initially suggested that the muscarinic agonist, xanomeline, was a subtype selective muscarinic M1 receptor agonist, and a potential new treatment for Alzheimer's disease.  However, later in vitro and in vivo functional studies suggest that this compd. is probably better described as a subtype selective M1/M4 muscarinic receptor agonist.  This subtype selectivity profile has been claimed to explain the limited classical cholinomimetic side effects, particularly gastrointestinal, seen with xanomeline in animals.  However, in both healthy volunteers and Alzheimer's patients many of these side effects have been reported for xanomeline and in the patient population this led to a >50% discontinuation rate.  Clearly, the preclin. studies have not been able to predict this adverse profile of xanomeline, and this suggests that either xanomeline is not as subtype selective as predicted from preclin. research or that there are differences between humans and animals with regard to muscarinic receptors.  Nevertheless, in Alzheimer's patients xanomeline dose-dependently improves aspects of behavioral disturbance and social behavior including a redn. in hallucinations, agitation, delusions, vocal outbursts and suspiciousness.  The effects on cognition are not as robust and mainly seen at the highest doses tested.  These effects in Alzheimer's patients have given impetus to the suggestion that muscarinic agonists have potential antipsychotic effects.  The current review assesses the antipsychotic profile of xanomeline within the framework of the limited clin. studies with cholinergic agents in man, and the preclin. research on xanomeline using various models commonly used for the assessment of new antipsychotic drugs.  In general, xanomeline has an antipsychotic-like profile in various dopamine models of psychosis and this agrees with the known interactions between the cholinergic and dopaminergic systems in the brain.  Moreover, current data suggests that the actions of xanomeline at the M4 muscarinic receptor subtype might mediate its antidopaminergic effects.  Particularly intriguing are studies showing that xanomeline, even after acute administration, selectively inhibits the firing of mesolimbic dopamine cells relative to dopamine cell bodies projecting to the striatum.  This data suggest that xanomeline would have a faster onset of action compared to current antipsychotics and would not induce extrapyramidal side effects.  The preclin. data on the whole are promising for an antipsychotic-like profile.  If in a new formulation (i.e., transdermal) xanomeline has less adverse effects, this drug may be valuable in the treatment of patients with psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvVnKMP2LfgbVg90H21EOLACvtfcHk0lhKtKY5AT6wIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsl2qt7o%253D&md5=cf96dec926979e17599b2673a49f11c2</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2003.tb00247.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2003.tb00247.x%26sid%3Dliteratum%253Aachs%26aulast%3DMirza%26aufirst%3DN.%2BR.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DSparks%26aufirst%3DR.%2BG.%26atitle%3DXanomeline%2520and%2520the%2520antipsychotic%2520potential%2520of%2520muscarinic%2520receptor%2520subtype%2520selective%2520agonists%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2003%26volume%3D9%26spage%3D159%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawawy, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lah, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Novel selective allosteric activator of the M<sub>1</sub> muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">10422</span><span class="NLM_x">–</span> <span class="NLM_lpage">10433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1523%2FJNEUROSCI.1850-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=18842902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=10422-10433&author=C.+K.+Jonesauthor=A.+E.+Bradyauthor=A.+A.+Davisauthor=Z.+Xiangauthor=M.+Bubserauthor=M.+N.+Tawawyauthor=A.+S.+Kaneauthor=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=S.+R.+Bradleyauthor=T.+E.+Petersonauthor=M.+S.+Ansariauthor=R.+M.+Baldwinauthor=R.+M.+Kesslerauthor=A.+Y.+Deutchauthor=J.+L.+Lahauthor=A.+I.+Leveyauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Novel+selective+allosteric+activator+of+the+M1+muscarinic+acetylcholine+receptor+regulates+amyloid+processing+and+produces+antipsychotic-like+activity+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span></div><div class="casAuthors">Jones, Carrie K.; Brady, Ashley E.; Davis, Albert A.; Xiang, Zixiu; Bubser, Michael; Tantawy, Mohammed Noor; Kane, Alexander S.; Bridges, Thomas M.; Kennedy, J. Phillip; Bradley, Stefania R.; Peterson, Todd E.; Ansari, M. Sib; Baldwin, Ronald M.; Kessler, Robert M.; Deutch, Ariel Y.; Lah, James J.; Levey, Allan I.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10422-10433</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies suggest that subtype-selective activators of M1/M4 muscarinic acetylcholine receptors (mAChRs) may offer a novel approach for the treatment of psychotic symptoms assocd. with schizophrenia and Alzheimer's disease.  Previously developed muscarinic agonists have provided clin. data in support of this hypothesis, but failed in clin. development because of a lack of true subtype specificity and adverse effects assocd. with activation of other mAChR subtypes.  We now report characterization of a novel highly selective agonist for the M1 receptor with no agonist activity at any of the other mAChR subtypes, termed TBPB [1-((1'-2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one].  Mutagenesis and mol. pharmacol. studies revealed that TBPB activates M1 through an allosteric site rather than the orthosteric acetylcholine binding site, which is likely crit. for its unprecedented selectivity.  Whole-cell patch-clamp recordings demonstrated that activation of M1 by TBPB potentiates NMDA receptor currents in hippocampal pyramidal cells but does not alter excitatory or inhibitory synaptic transmission, responses thought to be mediated by M2 and M4.  TBPB was efficacious in models predictive of antipsychotic-like activity in rats at doses that did not produce catalepsy or peripheral adverse effects of other mAChR agonists.  Finally, TBPB had effects on the processing of the amyloid precursor protein toward the non-amyloidogenic pathway and decreased Aβ prodn. in vitro.  Together, these data suggest that selective activation of M1 may provide a novel approach for the treatment of symptoms assocd. with schizophrenia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5LP3cEBPDvbVg90H21EOLACvtfcHk0lgIp-syTs6cmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF&md5=25b306eb2aa00bdce1c08ad24bd59b35</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1850-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1850-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DTawawy%26aufirst%3DM.%2BN.%26aulast%3DKane%26aufirst%3DA.%2BS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DBradley%26aufirst%3DS.%2BR.%26aulast%3DPeterson%26aufirst%3DT.%2BE.%26aulast%3DAnsari%26aufirst%3DM.%2BS.%26aulast%3DBaldwin%26aufirst%3DR.%2BM.%26aulast%3DKessler%26aufirst%3DR.%2BM.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26aulast%3DLah%26aufirst%3DJ.%2BL.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520selective%2520allosteric%2520activator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520regulates%2520amyloid%2520processing%2520and%2520produces%2520antipsychotic-like%2520activity%2520in%2520rats%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D10422%26epage%3D10433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Lebois, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meiler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M<sub>1</sub> receptor function in the central nervous system</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn900003h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKms7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=104-121&author=E.+P.+Leboisauthor=T.+M.+Bridgesauthor=M.+L.+Lewisauthor=E.+S.+Dawsonauthor=A.+S.+Kaneauthor=Z.+Xiangauthor=S.+B.+Jadhavauthor=H.+Yinauthor=J.+P.+Kennedyauthor=J.+Meilerauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+D.+Weaverauthor=C.+W.+Lindsley&title=Discovery+and+characterization+of+novel+subtype-selective+allosteric+agonists+for+the+investigation+of+M1+receptor+function+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of Novel Subtype-Selective Allosteric Agonists for the Investigation of M1 Receptor Function in the Central Nervous System</span></div><div class="casAuthors">Lebois, Evan P.; Bridges, Thomas M.; Lewis, L. Michelle; Dawson, Eric S.; Kane, Alexander S.; Xiang, Zixiu; Jadhav, Satyawan B.; Yin, Huiyong; Kennedy, J. Phillip; Meiler, Jens; Niswender, Colleen M.; Jones, Carrie K.; Conn, P. Jeffrey; Weaver, C. David; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">104-121</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cholinergic transmission in the forebrain is mediated primarily by five subtypes of muscarinic acetylcholine receptors (mAChRs), termed M1-M5.  Of the mAChR subtypes, M1 is among the most heavily expressed in regions that are crit. for learning and memory and has been viewed as the most crit. mAChR subtype for memory and attention mechanisms.  Unfortunately, it has been difficult to develop selective activators of M1 and other individual mAChR subtypes, which has prevented detailed studies of the functional roles of selective activation of M1.  Using a functional high-throughput screening and subsequent diversity-oriented synthesis approach, the authors have discovered a novel series of highly selective M1 allosteric agonists.  These compds. activate M1 with EC50 values in the 150-500 nM range and have unprecedented, clean ancillary pharmacol. (no substantial activity at 10 μM across a large panel of targets).  Targeted mutagenesis revealed a potentially novel allosteric binding site in the third extracellular loop of the M1 receptor for these allosteric agonists.  Optimized compds., such as VU0357017, provide excellent brain exposure after systemic dosing and have robust in vivo efficacy in reversing scopolamine-induced deficits in a rodent model of contextual fear conditioning.  This series of selective M1 allosteric agonists provides crit. research tools to allow dissection of M1-mediated effects in the CNS and potential leads for novel treatments for Alzheimer's disease and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoobcQ3CSd337Vg90H21EOLACvtfcHk0lgIp-syTs6cmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKms7vJ&md5=7395771d4a98649d299da7530d807b9e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fcn900003h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn900003h%26sid%3Dliteratum%253Aachs%26aulast%3DLebois%26aufirst%3DE.%2BP.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DLewis%26aufirst%3DM.%2BL.%26aulast%3DDawson%26aufirst%3DE.%2BS.%26aulast%3DKane%26aufirst%3DA.%2BS.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DJadhav%26aufirst%3DS.%2BB.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520novel%2520subtype-selective%2520allosteric%2520agonists%2520for%2520the%2520investigation%2520of%2520M1%2520receptor%2520function%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D104%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarr, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrington, S. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digby, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisewnder, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Further exploration of M<sub>1</sub> allosteric agonists: subtle structural changes abolish M<sub>1</sub> allosteric agonism and result in pan-mAChR orthosteric antagonism</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=223-227&author=D.+J.+Shefflerauthor=C.+Sevelauthor=U.+Leauthor=K.+M.+Lovellauthor=J.+C.+Tarrauthor=S.+J.+S.+Carringtonauthor=H.+P.+Choauthor=G.+J.+Digbyauthor=C.+M.+Nisewnderauthor=P.+J.+Connauthor=C.+R.+Hopkinsauthor=M.+R.+Woodauthor=C.+W.+Lindsley&title=Further+exploration+of+M1+allosteric+agonists%3A+subtle+structural+changes+abolish+M1+allosteric+agonism+and+result+in+pan-mAChR+orthosteric+antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DSevel%26aufirst%3DC.%26aulast%3DLe%26aufirst%3DU.%26aulast%3DLovell%26aufirst%3DK.%2BM.%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DCarrington%26aufirst%3DS.%2BJ.%2BS.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DDigby%26aufirst%3DG.%2BJ.%26aulast%3DNisewnder%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DFurther%2520exploration%2520of%2520M1%2520allosteric%2520agonists%253A%2520subtle%2520structural%2520changes%2520abolish%2520M1%2520allosteric%2520agonism%2520and%2520result%2520in%2520pan-mAChR%2520orthosteric%2520antagonism%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D223%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Digby, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebois, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemirovsky, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennenga, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bimonte-Nelson, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Italiano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrsion, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olive, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Novel allosteric agonists of M<sub>1</sub> muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">8532</span><span class="NLM_x">–</span> <span class="NLM_lpage">8544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1523%2FJNEUROSCI.0337-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=22723693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2iu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=8532-8544&author=G.+J.+Digbyauthor=M.+J.+Noetzelauthor=M.+Bubserauthor=T.+J.+Utleyauthor=A.+G.+Walkerauthor=N.+E.+Byunauthor=E.+P.+Leboisauthor=Z.+Xiangauthor=D.+J.+Shefflerauthor=H.+P.+Choauthor=A.+A.+Davisauthor=N.+E.+Nemirovskyauthor=S.+E.+Mennengaauthor=B.+W.+Campauthor=H.+A.+Bimonte-Nelsonauthor=J.+Bodeauthor=K.+Italianoauthor=R.+Morrsionauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=M.+F.+Oliveauthor=C.+W.+Lindsleyauthor=C.+K.+Jonesauthor=P.+J.+Conn&title=Novel+allosteric+agonists+of+M1+muscarinic+acetylcholine+receptors+induce+brain+region-specific+responses+that+correspond+with+behavioral+effects+in+animal+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models</span></div><div class="casAuthors">Digby, Gregory J.; Noetzel, Meredith J.; Bubser, Michael; Utley, Thomas J.; Walker, Adam G.; Byun, Nellie E.; Lebois, Evan P.; Xiang, Zixiu; Sheffler, Douglas J.; Cho, Hyekyung P.; Davis, Albert A.; Nemirovsky, Natali E.; Mennenga, Sarah E.; Camp, Bryan W.; Bimonte-Nelson, Heather A.; Bode, Jacob; Italiano, Kimberly; Morrison, Ryan; Daniels, J. Scott; Niswender, Colleen M.; Olive, M. Foster; Lindsley, Craig W.; Jones, Carrie K.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8532-8544</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">M1 muscarinic acetylcholine receptors (mAChRs) represent a viable target for treatment of multiple disorders of the central nervous system (CNS) including Alzheimer's disease and schizophrenia.  The recent discovery of highly selective allosteric agonists of M1 receptors has provided a major breakthrough in developing a viable approach for the discovery of novel therapeutic agents that target these receptors.  Here we describe the characterization of two novel M1 allosteric agonists, VU0357017 and VU0364572, that display profound differences in their efficacy in activating M1 coupling to different signaling pathways including Ca2+ and β-arrestin responses.  Interestingly, the ability of these agents to differentially activate coupling of M1 to specific signaling pathways leads to selective actions on some but not all M1-mediated responses in brain circuits.  These novel M1 allosteric agonists induced robust electrophysiol. effects in rat hippocampal slices, but showed lower efficacy in striatum and no measureable effects on M1-mediated responses in medial prefrontal cortical pyramidal cells in mice.  Consistent with these actions, both M1 agonists enhanced acquisition of hippocampal-dependent cognitive function but did not reverse amphetamine-induced hyperlocomotion in rats.  Together, these data reveal that M1 allosteric agonists can differentially regulate coupling of M1 to different signaling pathways, and this can dramatically alter the actions of these compds. on specific brain circuits important for learning and memory and psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh138Eac3vNrVg90H21EOLACvtfcHk0li6n6A5ElUnug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2iu7w%253D&md5=6278ee1366f8e159729c23ef8ecc880d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0337-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0337-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DDigby%26aufirst%3DG.%2BJ.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DUtley%26aufirst%3DT.%2BJ.%26aulast%3DWalker%26aufirst%3DA.%2BG.%26aulast%3DByun%26aufirst%3DN.%2BE.%26aulast%3DLebois%26aufirst%3DE.%2BP.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DNemirovsky%26aufirst%3DN.%2BE.%26aulast%3DMennenga%26aufirst%3DS.%2BE.%26aulast%3DCamp%26aufirst%3DB.%2BW.%26aulast%3DBimonte-Nelson%26aufirst%3DH.%2BA.%26aulast%3DBode%26aufirst%3DJ.%26aulast%3DItaliano%26aufirst%3DK.%26aulast%3DMorrsion%26aufirst%3DR.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DOlive%26aufirst%3DM.%2BF.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520allosteric%2520agonists%2520of%2520M1%2520muscarinic%2520acetylcholine%2520receptors%2520induce%2520brain%2520region-specific%2520responses%2520that%2520correspond%2520with%2520behavioral%2520effects%2520in%2520animal%2520models%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D8532%26epage%3D8544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graufelds, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCampbell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shughrue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danziger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascarella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span> </span><span class="NLM_article-title">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">15950</span><span class="NLM_x">–</span> <span class="NLM_lpage">15955</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1073%2Fpnas.0900903106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=19717450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15950-15955&author=L.+Maauthor=M.+A.+Seagerauthor=M.+Wittmannauthor=M.+Jacobsonauthor=D.+Bickelauthor=M.+Burnoauthor=K.+Jonesauthor=V.+K.+Graufeldsauthor=G.+Xuauthor=M.+Pearsonauthor=A.+McCampbellauthor=R.+Gasparauthor=P.+Shughrueauthor=A.+Danzigerauthor=C.+Reganauthor=R.+Flickauthor=D.+Pascarellaauthor=S.+Garsonauthor=S.+Doranauthor=C.+Kreatsoulasauthor=L.+Vengauthor=C.+W.+Lindsleyauthor=W.+Shipeauthor=S.+Kudukauthor=C.+Surauthor=G.+Kinneyauthor=G.+R.+Seabrookauthor=W.+J.+Ray&title=Selective+activation+of+the+M1+muscarinic+acetylcholine+receptor+achieved+by+allosteric+potentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span></div><div class="casAuthors">Ma, Lei; Seager, Matthew; Wittmann, Marion; Jacobson, Marlene; Bickel, Denise; Burno, Maryann; Jones, Keith; Graufelds, Valerie Kuzmick; Xu, Guangping; Pearson, Michelle; McCampbell, Alexander; Gaspar, Renee; Shughrue, Paul; Danziger, Andrew; Regan, Christopher; Flick, Rose; Pascarella, Danette; Garson, Susan; Doran, Scott; Kreatsoulas, Constantine; Veng, Lone; Lindsley, Craig W.; Shipe, William; Kuduk, Scott; Sur, Cyrille; Kinney, Gene; Seabrook, Guy R.; Ray, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">15950-15955, S15950/1-S15950/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The forebrain cholinergic system promotes higher brain function in part by signaling through the M, muscarinic acetylcholine receptor (mAChR).  During Alzheimer's disease (AD), these cholinergic neurons degenerate, therefore selectively activating M1 receptors could improve cognitive function in these patients while avoiding unwanted peripheral responses assocd. with non-selective muscarinic agonists.  We describe here benzyl quinolone carboxylic acid (BQCA), a highly selective allosteric potentiator of the M1 mAChR.  BQCA reduces the concn. of ACh required to activate M1 up to 129-fold with an inflection point value of 845 nM.  No potentiation, agonism, or antagonism activity on other mAChRs is obsd. up to 100 ArM.  Furthermore studies in M1-/- mice demonstrates that BQCA requires M1 to promote inositol phosphate turnover in primary neurons and to increase c-fos and arc RNA expression and ERK phosphorylation in the brain.  Radioligand-binding assays, mol. modeling, and site-directed mutagenesis expts. indicate that BQCA acts at an allosteric site involving residues Y179 and W400.  BQCA reverses scopolamine-induced memory deficits in contextual fear conditioning, increases blood flow to the cerebral cortex, and increases wakefulness while reducing delta sleep.  In contrast to M1 allosteric agonists, which do not improve memory in scopolamine-challenged mice in contextual fear conditioning, BQCA induces 13-arrestin recruitment to M1, suggesting a role for this signal transduction mechanism in the cholinergic modulation of memory.  In summary, BQCA exploits an allosteric potentiation mechanism to provide selectivity for the M1 receptor and represents a promising therapeutic strategy for cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0SGRL-coGErVg90H21EOLACvtfcHk0ljXJ4KPUjYvAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL&md5=4470732fd762f761a18d2bc96220dcb1</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900903106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900903106%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DGraufelds%26aufirst%3DV.%2BK.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcCampbell%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DDanziger%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DFlick%26aufirst%3DR.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DShipe%26aufirst%3DW.%26aulast%3DKuduk%26aufirst%3DS.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520achieved%2520by%2520allosteric%2520potentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D15950%26epage%3D15955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Tarr, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turlington, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pancani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Targeting selective activation of M<sub>1</sub> for the treatment of Alzheimer’s disease: further chemical optimization and pharmacological characterization of the M<sub>1</sub> positive allosteric modulator ML169</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn300068s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=884-895&author=J.+C.+Tarrauthor=M.+L.+Turlingtonauthor=P.+R.+Reidauthor=T.+J.+Utleyauthor=D.+J.+Shefflerauthor=H.+P.+Choauthor=R.+Klarauthor=T.+Pancaniauthor=M.+T.+Kleinauthor=T.+M.+Bridgesauthor=R.+D.+Morrisonauthor=A.+L.+Blobaumauthor=Z.+Xiangauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=M.+R.+Woodauthor=C.+W.+Lindsley&title=Targeting+selective+activation+of+M1+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+further+chemical+optimization+and+pharmacological+characterization+of+the+M1+positive+allosteric+modulator+ML169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Selective Activation of M1 for the Treatment of Alzheimer's Disease: Further Chemical Optimization and Pharmacological Characterization of the M1 Positive Allosteric Modulator ML169</span></div><div class="casAuthors">Tarr, James C.; Turlington, Mark L.; Reid, Paul R.; Utley, Thomas J.; Sheffler, Douglas J.; Cho, Hyekyung P.; Klar, Rebecca; Pancani, Tristano; Klein, Michael T.; Bridges, Thomas M.; Morrison, Ryan D.; Blobaum, Anna L.; Xiang, Zixui; Daniels, J. Scott; Niswender, Colleen M.; Conn, P. Jeffrey; Wood, Michael R.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">884-895</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The M1 muscarinic acetylcholine receptor is thought to play an important role in memory and cognition, making it a potential target for the treatment of Alzheimer's disease (AD) and schizophrenia.  Moreover, M1 interacts with BACE1 and regulates its proteasomal degrdn., suggesting selective M1 activation could afford both palliative cognitive benefit as well as disease modification in AD.  A key challenge in targeting the muscarinic acetylcholine receptors is achieving mAChR subtype selectivity.  Our lab has previously reported the M1 selective pos. allosteric modulator ML169.  Herein we describe our efforts to further optimize this lead compd. by prepg. analog libraries and probing novel scaffolds.  We were able to identify several analogs that possessed submicromolar potency, with our best example displaying an EC50 of 310 nM.  The new compds. maintained complete selectivity for the M1 receptor over the other subtypes (M2-M5), displayed improved DMPK profiles, and potentiated the carbachol (CCh)-induced excitation in striatal MSNs.  Selected analogs were able to potentiate CCh-mediated non-amyloidogenic APPα release, further strengthening the concept that M1 PAMs may afford a disease-modifying role in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1gJudWdQ8i7Vg90H21EOLACvtfcHk0ljXJ4KPUjYvAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7jI&md5=dd85b45664febaaa063a2c53d5379c50</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fcn300068s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300068s%26sid%3Dliteratum%253Aachs%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DTurlington%26aufirst%3DM.%2BL.%26aulast%3DReid%26aufirst%3DP.%2BR.%26aulast%3DUtley%26aufirst%3DT.%2BJ.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DKlar%26aufirst%3DR.%26aulast%3DPancani%26aufirst%3DT.%26aulast%3DKlein%26aufirst%3DM.%2BT.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DTargeting%2520selective%2520activation%2520of%2520M1%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520further%2520chemical%2520optimization%2520and%2520pharmacological%2520characterization%2520of%2520the%2520M1%2520positive%2520allosteric%2520modulator%2520ML169%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D884%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Byun, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grannan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosanelli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowrishankar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelm, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melancon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarr, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1578</span><span class="NLM_x">–</span> <span class="NLM_lpage">1593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=1578-1593&author=N.+E.+Byunauthor=M.+Grannanauthor=M.+Bubserauthor=R.+L.+Barryauthor=A.+Thompsonauthor=J.+Rosanelliauthor=R.+Gowrishankarauthor=N.+D.+Kelmauthor=S.+Damonauthor=T.+M.+Bridgesauthor=B.+J.+Melanconauthor=J.+C.+Tarrauthor=J.+T.+Broganauthor=M.+J.+Avisonauthor=A.+Y.+Deutchauthor=J.+Wessauthor=M.+R.+Woodauthor=C.+W.+Lindsleyauthor=J.+C.+Goreauthor=P.+J.+Connauthor=C.+K.+Jones&title=Antipsychotic+drug-like+effects+of+the+selective+M4+muscarinic+acetylcholine+receptor+positive+allosteric+modulator+VU0152100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DByun%26aufirst%3DN.%2BE.%26aulast%3DGrannan%26aufirst%3DM.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DBarry%26aufirst%3DR.%2BL.%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DRosanelli%26aufirst%3DJ.%26aulast%3DGowrishankar%26aufirst%3DR.%26aulast%3DKelm%26aufirst%3DN.%2BD.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DBrogan%26aufirst%3DJ.%2BT.%26aulast%3DAvison%26aufirst%3DM.%2BJ.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DGore%26aufirst%3DJ.%2BC.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DAntipsychotic%2520drug-like%2520effects%2520of%2520the%2520selective%2520M4%2520muscarinic%2520acetylcholine%2520receptor%2520positive%2520allosteric%2520modulator%2520VU0152100%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D1578%26epage%3D1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dencker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grannan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/cn500128b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500128b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Bubserauthor=T.+M.+Bridgesauthor=D.+Denckerauthor=R.+W.+Gouldauthor=M.+D.+Grannanauthor=J.+Wesauthor=M.+E.+Dugganauthor=J.+Dunlopauthor=M.+R.+Woodauthor=C.+W.+Lindsleyauthor=P.+J.+Connauthor=C.+K.+Jones&title=Selective+activation+of+M4+muscarinic+acetylcholine+receptors+reverses+MK-801-induced+behavioral+impairments+and+enhances+associative+learning+in+rodents&doi=10.1021%2Fcn500128b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fcn500128b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500128b%26sid%3Dliteratum%253Aachs%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DDencker%26aufirst%3DD.%26aulast%3DGould%26aufirst%3DR.%2BW.%26aulast%3DGrannan%26aufirst%3DM.%2BD.%26aulast%3DWes%26aufirst%3DJ.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DSelective%2520activation%2520of%2520M4%2520muscarinic%2520acetylcholine%2520receptors%2520reverses%2520MK-801-induced%2520behavioral%2520impairments%2520and%2520enhances%2520associative%2520learning%2520in%2520rodents%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26doi%3D10.1021%2Fcn500128b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Dore, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okrasa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Vega, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazayeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiggin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span> </span><span class="NLM_article-title">Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">511</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1038%2Fnature13396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=25042998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ChurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2014&pages=557-562&author=A.+S.+Doreauthor=K.+Okrasaauthor=J.+C.+Patelauthor=M.+Serrano-Vegaauthor=K.+Bennettauthor=R.+M.+Cookeauthor=J.+C.+Erreyauthor=A.+Jazayeriauthor=S.+Khanauthor=B.+Tehanauthor=M.+Weirauthor=G.+R.+Wigginauthor=F.+H.+Marshall&title=Structure+of+class+C+GPCR+metabotropic+glutamate+receptor+5+transmembrane+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain</span></div><div class="casAuthors">Dore, Andrew S.; Okrasa, Krzysztof; Patel, Jayesh C.; Serrano-Vega, Maria; Bennett, Kirstie; Cooke, Robert M.; Errey, James C.; Jazayeri, Ali; Khan, Samir; Tehan, Ben; Weir, Malcolm; Wiggin, Giselle R.; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">7511</span>),
    <span class="NLM_cas:pages">557-562</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metabotropic glutamate receptors are class C G-protein-coupled receptors which respond to the neurotransmitter glutamate.  Structural studies have been restricted to the amino-terminal extracellular domain, providing little understanding of the membrane-spanning signal transduction domain.  Metabotropic glutamate receptor 5 (mGlu5 receptor) is of considerable interest as a drug target in the treatment of fragile X syndrome, autism, depression, anxiety, addiction and movement disorders.  Here we report the crystal structure of the transmembrane domain of the human receptor in complex with the neg. allosteric modulator, mavoglurant.  The structure provides detailed insight into the architecture of the transmembrane domain of class C receptors including the precise location of the allosteric binding site within the transmembrane domain and key micro-switches which regulate receptor signaling.  This structure also provides a model for all class C G-protein-coupled receptors and may aid in the design of new small-mol. drugs for the treatment of brain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4LiHVA8klWLVg90H21EOLACvtfcHk0lgpxRv7v50g-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ChurnK&md5=43a1f0b72a923044fa718729f97c075d</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnature13396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13396%26sid%3Dliteratum%253Aachs%26aulast%3DDore%26aufirst%3DA.%2BS.%26aulast%3DOkrasa%26aufirst%3DK.%26aulast%3DPatel%26aufirst%3DJ.%2BC.%26aulast%3DSerrano-Vega%26aufirst%3DM.%26aulast%3DBennett%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DR.%2BM.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DJazayeri%26aufirst%3DA.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DWiggin%26aufirst%3DG.%2BR.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DStructure%2520of%2520class%2520C%2520GPCR%2520metabotropic%2520glutamate%2520receptor%25205%2520transmembrane%2520domain%26jtitle%3DNature%26date%3D2014%26volume%3D511%26spage%3D557%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Selvy, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavieri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span> </span><span class="NLM_article-title">Phospholipase D: enzymology, signaling, and chemical modulation</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">6064</span><span class="NLM_x">–</span> <span class="NLM_lpage">6119</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr200296t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=6064-6119&author=P.+E.+Selvyauthor=R.+Lavieriauthor=C.+W.+Lindsleyauthor=H.+A.+Brown&title=Phospholipase+D%3A+enzymology%2C+signaling%2C+and+chemical+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fcr200296t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200296t%26sid%3Dliteratum%253Aachs%26aulast%3DSelvy%26aufirst%3DP.%2BE.%26aulast%3DLavieri%26aufirst%3DR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26atitle%3DPhospholipase%2520D%253A%2520enzymology%252C%2520signaling%252C%2520and%2520chemical%2520modulation%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D6064%26epage%3D6119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Monovich, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugrage, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toscano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommasi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaSala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P.</span><span> </span><span class="NLM_article-title">Optimization of halopemide for phospholipase D2 inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2310</span><span class="NLM_x">–</span> <span class="NLM_lpage">2311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2310-2311&author=L.+Monovichauthor=B.+Mugrageauthor=E.+Quadrosauthor=K.+Toscanoauthor=R.+Tommasiauthor=S.+LaVoieauthor=E.+Liuauthor=Z.+M.+Duauthor=D.+LaSalaauthor=W.+Boyarauthor=P.+Steed&title=Optimization+of+halopemide+for+phospholipase+D2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonovich%26aufirst%3DL.%26aulast%3DMugrage%26aufirst%3DB.%26aulast%3DQuadros%26aufirst%3DE.%26aulast%3DToscano%26aufirst%3DK.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DLaVoie%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DDu%26aufirst%3DZ.%2BM.%26aulast%3DLaSala%26aufirst%3DD.%26aulast%3DBoyar%26aufirst%3DW.%26aulast%3DSteed%26aufirst%3DP.%26atitle%3DOptimization%2520of%2520halopemide%2520for%2520phospholipase%2520D2%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2310%26epage%3D2311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">De Cuyper, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstraeten, D.</span><span> </span><span class="NLM_article-title">The clinical significance of halpemide, a dopamine-blocker related to butyrphenones</span> <span class="citation_source-journal">Neuropsychobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1984&pages=211-216&author=H.+De+Cuyperauthor=D.+Verstraeten&title=The+clinical+significance+of+halpemide%2C+a+dopamine-blocker+related+to+butyrphenones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BCuyper%26aufirst%3DH.%26aulast%3DVerstraeten%26aufirst%3DD.%26atitle%3DThe%2520clinical%2520significance%2520of%2520halpemide%252C%2520a%2520dopamine-blocker%2520related%2520to%2520butyrphenones%26jtitle%3DNeuropsychobiology%26date%3D1984%26volume%3D12%26spage%3D211%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Scott, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvy, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criswell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span> </span><span class="NLM_article-title">Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1038%2Fnchembio.140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm5011786&amp;key=19136975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm5011786&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktValtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=108-117&author=S.+A.+Scottauthor=P.+E.+Selvyauthor=J.+Buckauthor=H.+P.+Choauthor=T.+L.+Criswellauthor=A.+L.+Thomasauthor=M.+D.+Armstrongauthor=C.+Arteagaauthor=C.+W.+Lindsleyauthor=H.+A.+Brown&title=Design+of+isoform-selective+phospholipase+D+inhibitors+that+modulate+cancer+cell+invasiveness"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness</span></div><div class="casAuthors">Scott, Sarah A.; Selvy, Paige E.; Buck, Jason R.; Cho, Hyekyung P.; Criswell, Tracy L.; Thomas, Ashley L.; Armstrong, Michelle D.; Arteaga, Carlos L.; Lindsley, Craig W.; Brown, H. Alex</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">108-117</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phospholipase D (PLD) is an essential enzyme responsible for the prodn. of the lipid second messenger phosphatidic acid.  Phosphatidic acid participates in both G protein-coupled receptor and receptor tyrosine kinase signal transduction networks.  The lack of potent and isoform-selective inhibitors has limited progress in defining the cellular roles of PLD.  We used a diversity-oriented synthetic approach and developed a library of PLD inhibitors with considerable pharmacol. characterization.  Here we report the rigorous evaluation of that library, which contains highly potent inhibitors, including the first isoform-selective PLD inhibitors.  Specific members of this series inhibit isoforms with >100-fold selectivity both in vitro and in cells.  A subset of inhibitors was shown to block invasiveness in metastatic breast cancer models.  These findings demonstrate the power of diversity-oriented synthesis combined with biochem. assays and mass spectrometric lipid profiling of cellular responses to develop the first isoform-selective PLD inhibitors-a new class of antimetastatic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeuImMQ0J3KLVg90H21EOLACvtfcHk0ljb6FnpX8nNrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktValtA%253D%253D&md5=52aed3879c88eecc13d60a6b611fa2a9</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.140%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DS.%2BA.%26aulast%3DSelvy%26aufirst%3DP.%2BE.%26aulast%3DBuck%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DCriswell%26aufirst%3DT.%2BL.%26aulast%3DThomas%26aufirst%3DA.%2BL.%26aulast%3DArmstrong%26aufirst%3DM.%2BD.%26aulast%3DArteaga%26aufirst%3DC.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26atitle%3DDesign%2520of%2520isoform-selective%2520phospholipase%2520D%2520inhibitors%2520that%2520modulate%2520cancer%2520cell%2520invasiveness%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D108%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Lewis, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavieri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvy, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoops, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures on PLD1 specificity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1919</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1916-1919&author=J.+A.+Lewisauthor=S.+A.+Scottauthor=R.+Lavieriauthor=J.+R.+Buckauthor=P.+E.+Selvyauthor=S.+L.+Stoopsauthor=M.+D.+Armstrongauthor=H.+A.+Brownauthor=C.+W.+Lindsley&title=Design+and+synthesis+of+isoform-selective+phospholipase+D+%28PLD%29+inhibitors.+Part+I%3A+Impact+of+alternative+halogenated+privileged+structures+on+PLD1+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%2BA.%26aulast%3DScott%26aufirst%3DS.%2BA.%26aulast%3DLavieri%26aufirst%3DR.%26aulast%3DBuck%26aufirst%3DJ.%2BR.%26aulast%3DSelvy%26aufirst%3DP.%2BE.%26aulast%3DStoops%26aufirst%3DS.%2BL.%26aulast%3DArmstrong%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520isoform-selective%2520phospholipase%2520D%2520%2528PLD%2529%2520inhibitors.%2520Part%2520I%253A%2520Impact%2520of%2520alternative%2520halogenated%2520privileged%2520structures%2520on%2520PLD1%2520specificity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1916%26epage%3D1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Lavieri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvy, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of halogenated <i>N</i>-(2-(4-oxo-1-phenyl-1,3,8-triazasprio[4.5]decan-8-yl)ethylbenzamides: discovery of an isoform selective small-molecule phospholipase D2 (PLD2) inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6706</span><span class="NLM_x">–</span> <span class="NLM_lpage">6719</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100814g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6706-6719&author=R.+Lavieriauthor=S.+A.+Scottauthor=P.+E.+Selvyauthor=H.+A.+Brownauthor=C.+W.+Lindsley&title=Design%2C+synthesis+and+biological+evaluation+of+halogenated+N-%282-%284-oxo-1-phenyl-1%2C3%2C8-triazasprio%5B4.5%5Ddecan-8-yl%29ethylbenzamides%3A+discovery+of+an+isoform+selective+small-molecule+phospholipase+D2+%28PLD2%29+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm100814g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100814g%26sid%3Dliteratum%253Aachs%26aulast%3DLavieri%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DS.%2BA.%26aulast%3DSelvy%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520halogenated%2520N-%25282-%25284-oxo-1-phenyl-1%252C3%252C8-triazasprio%255B4.5%255Ddecan-8-yl%2529ethylbenzamides%253A%2520discovery%2520of%2520an%2520isoform%2520selective%2520small-molecule%2520phospholipase%2520D2%2520%2528PLD2%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6706%26epage%3D6719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">O’Reilly, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oquin, T. H.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Development of dual PLD1/2 and PLD2 selective inhibitors from a common 1,3,8-triazaspiro[4.5]decane core; discovery of ML298 and ML299 that decrease invasive migration in U87-MG glioblastoma cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2695</span><span class="NLM_x">–</span> <span class="NLM_lpage">2699</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301782e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2695-2699&author=M.+C.+O%E2%80%99Reillyauthor=S.+A.+Scottauthor=K.+A.+Brownauthor=T.+H.+Oquinauthor=P.+G.+Thomasauthor=J.+S.+Danielsauthor=R.+Morrisonauthor=H.+A.+Brownauthor=C.+W.+Lindsley&title=Development+of+dual+PLD1%2F2+and+PLD2+selective+inhibitors+from+a+common+1%2C3%2C8-triazaspiro%5B4.5%5Ddecane+core%3B+discovery+of+ML298+and+ML299+that+decrease+invasive+migration+in+U87-MG+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fjm301782e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301782e%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%2BC.%26aulast%3DScott%26aufirst%3DS.%2BA.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26aulast%3DOquin%26aufirst%3DT.%2BH.%26aulast%3DThomas%26aufirst%3DP.%2BG.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DMorrison%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDevelopment%2520of%2520dual%2520PLD1%252F2%2520and%2520PLD2%2520selective%2520inhibitors%2520from%2520a%2520common%25201%252C3%252C8-triazaspiro%255B4.5%255Ddecane%2520core%253B%2520discovery%2520of%2520ML298%2520and%2520ML299%2520that%2520decrease%2520invasive%2520migration%2520in%2520U87-MG%2520glioblastoma%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2695%26epage%3D2699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Brunz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span> </span><span class="NLM_article-title">Phospholipase D<sub>2</sub> mediates survival signaling through direct regulation of Akt in glioblastoma cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=600-616&author=R.+Brunzauthor=H.+E.+Taylorauthor=C.+W.+Lindsleyauthor=H.+A.+Brown&title=Phospholipase+D2+mediates+survival+signaling+through+direct+regulation+of+Akt+in+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunz%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DH.%2BE.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26atitle%3DPhospholipase%2520D2%2520mediates%2520survival%2520signaling%2520through%2520direct%2520regulation%2520of%2520Akt%2520in%2520glioblastoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D600%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Oguin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. A.</span><span> </span><span class="NLM_article-title">Phospholipase D facilitates efficient entry of influenza virus allowing escape from innate mmune inhibition</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1074/jbc.M114.558817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm5011786&amp;key=10.1074%2Fjbc.M114.558817" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+Oguinauthor=S.+Sharmaauthor=A.+D.+Stuartauthor=C.+K.+Jonesauthor=J.+S.+Danielsauthor=C.+W.+Lindsleyauthor=P.+G.+Thomasauthor=H.+A.+Brown&title=Phospholipase+D+facilitates+efficient+entry+of+influenza+virus+allowing+escape+from+innate+mmune+inhibition&doi=10.1074%2Fjbc.M114.558817"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.558817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.558817%26sid%3Dliteratum%253Aachs%26aulast%3DOguin%26aufirst%3DT.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DStuart%26aufirst%3DA.%2BD.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DThomas%26aufirst%3DP.%2BG.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26atitle%3DPhospholipase%2520D%2520facilitates%2520efficient%2520entry%2520of%2520influenza%2520virus%2520allowing%2520escape%2520from%2520innate%2520mmune%2520inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26doi%3D10.1074%2Fjbc.M114.558817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5011786&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm5011786%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5011786" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799be670f093ca6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
